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SUMMARY.
1. The use of sera and monoclonal antibodies has 
permitted the serological definition of three polymorphic 
genetic loci HLA-A, HLA-B, and HLA-C, which encode the 45kDa 
heavy chains of the classical class I transplantation 
antigens. These molecules were identified because they 
elicited strong allograft rejection. Their true function is 
to serve as restriction elements by presenting peptidic 
antigens for recognition by cytotoxic T lymphocytes in MHC 
restricted responses. Molecular genetic analyses revealed 
that the vertebrate class I gene family was larger than 
expected, and there is evidence that at least some of these 
genes encode polypeptides whose structure and perhaps 
function is different from those of the classical class I 
loci.
2. Some forms of trophoblast express class I molecule(s)
which raises the question of how this semi-allogeneic tissue 
is able to escape maternal immune recognition. The work 
described in this thesis is a study of class I molecules 
expressed by a malignant form of cytotrophoblast: the
choriocarcinoma cell line JEG-3. Immunoprecipitation 
analysis of JEG-3 cells using two anti-class I monoclonal 
antibodies (W6/32 and 61D2) revealed the expression of two 
different molecular weight class I species (45kDa and 41kDa) 
which differed in their ability to bind 61D2. The smaller 
component was expressed to higher levels than the 45kDa 
polypeptide and did not cross react with 61D2.
3. Initially, it was thought necessary to induce JEG-3 
cells with gamma-interferon in order to increase the level of 
class I transcripts and thereby facilitate their analysis and 
cloning. Total RNA was isolated from JEG-3 cells which had 
been treated with varying amounts of gamma-interferon (upto 
0-10,000U/ml for 30hrs.). No obvious gamma-interferon 
induction of class I transcripts was apparent after 
hybridization of a class I HLA-B7 cDNA probe to quantitated 
RNA immobilized on dot-blot and Northern filters. The size 
of class I mRNA was shown to be approximately 1.6Kb.
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4. In order to investigate these molecules further, a
lambda gtlO cDNA library was constructed using mRNA isolated 
from JEG-3 cells treated with gamma-interferon (500U/ml for 
30hrs.). The percentage of recombinants containing inserts 
was primarily calculated by a comparison of data with control 
experiments and subsequently determined empirically by 
analysis of random picked individual plaques. The insert 
frequency of the library was approximately 70% and thus from 
1.8x10^ plaques, 1x10^ were true recombinants. The cDNA 
library was screened with the HLA-B7 cDNA probe under reduced 
stringency conditions and six independent class I positive 
cDNA clones (JW1-6) were recovered. After restriction 
endonuclease mapping, each was subcloned into M13mpl8 for 
sequence determination. JW1 (1.4Kb) was identical to JW5 in 
both length and sequence, encompassing 15 bases of poly A 
tail and extending forward in the coding region as far as and 
including the alpha-2 domain. JW4 was shorter (1.2Kb) in the 
5' end and differed further by a 7bp (AATCCGC) deletion 5' to 
the polyadenylation site.
5. Nucleotide and amino acid sequence comparisons of JWl, 
JW4 and JW5 with HLA-A, HLA-B and HLA-C locus sequences 
clearly indicated that these clones were derived from the 
HLA-C locus (Ward et al. submitted for publication). From 
the Northern data it was inferred that the largest clone was 
incomplete and a strategy was devised to clone the remaining 
5' portion of the gene. Subsequent sequence analysis 
showed that the first 221bp of the 5 1 most region of JW1 was 
extremely homologous (>97%) to the intron 2 sequences of HLA- 
C locus genes. Thus JWl was an incompletely spliced pre- 
mRNA. Although the cloning strategy was frustrated by the 
presence of intron-2 in JWl it did generate a subclone that 
was necessary in order to complete sequencing.
JWl as far as it extended was found to be identical to 
the cDNA BeWo C.l cloned from the BeWo choriocarcinoma 
published this summer (Ellis et al. 1989). The latter is 
predicted to code for a 45kDa polypeptide.
6. Using an HLA-6.0 specific probe, work in collaboration
with T.Rinke de Wit (Leiden) and Dr. P.L.Stern (Manchester)
Vshowed that HLA-6.0 homologous transcripts were expressed in 
JEG-3 cells. It is possible that these HLA-6.0 homologous 
transcripts encode a 41kDa polypeptide corresponding to that 
immunoprecipitated from JEG-3 cells.
7. HLA-C antigens are polymorphic, and at least one
allele (Cw3) has been shown to be capable of presenting 
antigens in MHC restricted responses. Those molecules 
derived from the maternal haplotype might present antigens to 
the maternal immune system as a means of protecting the 
foetus from infection whilst those derived from the paternal 
haplotype might act as allogeneic stimuli (if these differ 
from the maternal haplotype. 'The question which still 
remains to be answered is "What is the origin and nature of 
the 41kDa molecule?" The full length clones of both 
molecules are necessary in order to perform functional assays 
in an amenable system and to test whether they can present 
antigens to T lymphocytes.
Further cloning of a number of class I cDNA's ought to 
give an indication of the level of polymorphism at the loci 
considered. It may be possible to construct specific DNA 
probes to investigate the extent of expression of these 
transcripts in other tissues. This data may indicate whether 
the molecules have specialized functions (they might only be 
expressed on trophoblast) or whether they have more 
generalized roles in immunity.
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GENERAL INTRODUCTION.
1.1.1.
The widespread application of the techniques of 
molecular cloning has complemented earlier classical 
immunogenetic studies and has enabled remarkable progress in 
understanding the molecular basis of immune recognition. The
elucidation of the structure of the genes and cDNA's for
antibody, T cell receptor and the Major Histocompatibility 
Complex (MHC) has enabled immunologists to gain understanding 
of some of the main ways in which the specificity of the
immune system functions.
The immune system protects self by the recognition 
and elimination of non/altered-self. This task of
discrimination relies upon antibodies that are produced by B 
lymphocytes and T lymphocyte receptors. Self or non-self 
antigens bind to antibodies, or are presented in association 
with cell surface MHC class I and class II molecules for
recognition by T cells. The MHC is known as such for
historical reasons since class I molecules were first 
discovered because they elicited strong allograft rejection. 
The class I molecules (which are the subject of this thesis) 
are known as the major classical transplantation antigens and 
are used in surgery as the major determinants in directing 
choice of tissue grafts. There are also a large number of 
minor histocompatibility loci scattered throughout the genome 
including H-X and H-Y, on the sex chromosomes which 
individually evoke a relatively weak rejection response.
Specific alloantisera and monoclonal antibodies 
prepared by the appropriate cross-immunizations of inbred and 
recombinant strains have provided much information about the 
mouse MHC complex (H-2). MHC studies in man (HLA - human 
leucocyte antigen) originated with the discovery of 
antibodies in pregnant women and polytransfused individuals. 
Serological MHC analysis of inbred strains is performed 
differently from outbred species because the latter 
necessitates the use of a number of antisera which is much 
more complicated, and thus serological analyses of inbred 
mouse strains has enabled the definition of some class I loci 
in advance of their human equivalents. These analyses 
demonstrated that the classical class I transplantation 
antigens were extremely polymorphic.
Protein (Orr et al. 1979; Parham et al. 1988), DNA
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sequence analyses (Strachan et al. 1984; N'Guyen et al. 1985; 
Sodoyer et al. 1985) and X-ray crystallographic studies 
(Bjorkman et al. 1987a;b) are uncovering the overall 
molecular organization of the class I antigens, and the 
nature and location of their polymorphic regions. Sequence 
comparisons between strongly serologically cross-reactive 
specificities have provided a basis for evaluating the 
contributions of these polymorphic regions to the domains 
recognized by specific antibodies and T-cell receptors (Cowan 
et al. 1987; Lopez de Castro et al. 1982; 1985).
Two particularly active areas of research on MHC 
are the characterization of class I molecules, and those that 
lie outside of the classical loci (Roller et al. 1987, 1988,
1989; Orr et al. 1983; Srivastava et al. 1987) and 
investigation into the mechanism by which foreign antigens 
are presented to T cells ( Bjorkman et al. 1987a;b; Long and 
Jacobson, 1989; Townsend and Bodmer, 1989; Townsend et al. 
1989).
MAJOR HISTOCOMPATIBILITY COMPLEX (MHCK
1.1.2. Classes of Genes in the MHC.
The genes in this complex fall into three classes 
(I, II and III) which all play central roles in the 
functioning of the immune system. The class I genes encode 
the polymorphic alpha chain of a heterodimer, some of which 
are involved in the presentation of endogenously synthesized 
foreign (viral) antigens to cytotoxic T lymphocytes in both 
MHC-restricted and allogeneic responses. They are expressed 
on many but not all cell types (Daar et al. 1983). The class 
lb molecules are largely similar to class I in organization 
but their precise functions are as yet unknown and their 
expression seems to be limited to very few cell types 
(reviewed Strominger, 1989). Class II genes code for 
alpha/beta heterodimers which are involved in the 
presentation of exogenously acquired (endocytosed) foreign 
antigens. They are expressed mainly on B cells. The class 
III genes code for some of the plasma complement components.
In addition to these three classes of molecules there 
are other genes located in this area of the human (Carroll et 
al. 1987) and mouse chromosome (Abe et al. 1988).
2
Some of the molecules encoded within the MHC show 
homology with the immunoglobulins (Ig) at the nucleotide 
(exon), amino acid and structural levels. It has been 
suggested that molecules which exhibit this degree of 
homology (MHC class I and class II, B 2 _m, Thy-1, T-cell 
receptor, CD2, 4 and 8, and others) are members of an "Ig- 
superfamily" (Williams et al. 1984; 1985), and it is likely 
that the gene fragments encoding these homology regions arose 
from the duplication of a common ancestral gene segment. 
Some members of the group interact with each other at the 
cell surface suggesting that a possible primordial domain 
diverged into a sort of ligand and receptor recognition 
system. Lutz and Cresswell (1987) showed by Western blot 
analysis that a monoclonal antibody PAC.M1 reacted with a 
determinant shared by some members of the Ig superfamily 
although its precise location was not known.
1.1.3. Genomic Organization of the MHC.
The molecules of interest in this study are the Class 
I antigens which fall within the MHC. The classical class I 
genes map to three loci in man (HLA-A, HLA-B and HLA-C) and 
in mouse (H-2K, H-2D and H-2L). The genes carried on an 
individual chromosome form a haplotype. Each individual 
inherits one paternal and one maternal haplotype which are 
designated by a superscript after H-2 in the mouse, and by 
numbers after the appropriate locus (in letters) in humans.
Pulse field gel electrophoresis and molecular 
hybridization techniques using various DNA probes have been 
used to construct a linkage map (see figure 1.1.3a) of the 
human MHC (Carroll et al. 1987; Lawrance et al. 1987). The 
complex is located on the short arm of chromosome 6 at 6p21.1 
to 6p21.3 (Morton et al. 1984) and occupies approximately 
3500Kb (approx. l/3000th human genome). The analogous region 
in mouse (H-2) is located on chromosome 17.
Subsequent to the purification of HLA polypeptides, 
sequencing of the N-terminus (Orr et al. 1979) allowed the 
preparation of specific oligonucleotides. The
oligonucleotides were used to isolate various genomic and 
cDNA clones by homologous hybridization (Ploegh et al. 1980; 
Sood et al. 1981). Southern blotting of genomic DNA and the
3
Figure 1.1.3a. Organization of genes within the MHC on 
chromosome 6. nd - regions not completely identified by 
overlapping and contiguous fragments. This region also 
contains pairs of genes for Tumour Necrosis Factor (TNF 
alpha and beta) and 21-hydroxylase (21A and 21B). From 
Carroll et al. (1987(. HLA-F (5.4) and HLA-G (6.0) map 
more telomeric to HLA-A (see Roller et al. 1989).
Figure 1.1.3b. Genetic Map of the Murine H-2 MHC (Balb/c 
mouse). The class I genes map to the K, D, Q (Qa) and TL 
(Tla) regions. The I and S regions correspond to class 
II and class III (complement) genes respectively. The 
distance between the K, D and T regions is unknown 
(Brorson et al. 1989).
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use of various interspecies cross-hybridizing class I probes 
has revealed that the class I genes constitute a larger than 
expected gene family than that indicated from allo- 
serological analyses. There are in the order of 30 class I 
related sequences in mouse (Cami et al. 1981, Goodenow et al. 
1982), although fewer so far in man (Malissen et al. 1982), 
horse (Alexander et al. 1987) and chicken, (Guillemot et al. 
1989). Roller et al. (1987) mapped seventeen distinct class 
I sequences in the human lymphoblastoid cell line LCL. The 
number of class I genes in the BALB/c H-2d haplotype is 33 
(Steinmetz et al. 1982) and 26 in C57BL/10 (BIO) H-2*5 
haplotype mouse (Weiss et al. 1984). In actual fact, most 
class I genes are located outside the classical 
transplantation loci of mouse (H-2K, D and L) and man (HLA-A, 
-B and -C). In the mouse these "non-classical" loci map to 
the Q and TL regions (Winoto et al. 1983) while the majority 
of the other human class I genes are situated more towards 
the telomere from HLA-A (Orr and DeMars, 1983). The 
discrepancy between the number of phenotypically 
characterized class I molecules and gene sequences is under 
investigation.
The availability of inbred strains of mice and the 
linking up of cosmid clones (Weiss et al. 1984) has enabled 
the study of the overall gene organization of the mouse H-2 
in advance of the human MHC. The general arrangement of 
genes differs between mouse and human. In the HLA complex 
the class II loci are positioned between the centromere and 
class I loci, whereas the H-2 class II genes are between the 
H-2K locus and class III region (see figure 1.1.3b).
The genes are widely spaced, especially so in the 
human (Malissen et al. 1982a) and a comparison of their 
surrounding sequences shows both conserved and polymorphic 
regions which have probably resulted from deletions, 
insertions and translocations. However, Chimini et al. 
(1988) found very little size polymorphism in humans implying 
that expansion/contraction events due to unequal crossing 
over (as in the mouse) were comparatively infrequent. A 
difference in the number of class I genes seems to be 
tolerated between different strains of mice and across 
species (Weiss et al. 1984; Hammerling et al. 1985). If any 
of the genes have important and/or separate functions, then 
it might be expected that their sequences be conserved during
6
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Figure 1.1.3c. Exon/intron Organization of a Class I 
Gene. Exon 1 encodes the signal peptide, exons 2-4 
specify the alpha-1, alpha-2 and alpha-3 extracellular 
domains. Exon 5 codes for the transmembrane (Tm) region 
and exons 6-8 code for the cytoplasmic region (C). The 
hatched box represents the 3'UT region (see also Malissen 
et al. 1982; Sodoyer et al. 1984 and Strachan et al. 
1984) .
7
evolution.
Exon-intron Organization of a Class I Gene.
Figure 1.1.3c shows the exon-intron organization of 
a typical classical class I gene (see also Malissen et al. 
1981; Sodoyer et al. 1984; Strachan et al. 1984). The class 
I genes encode alpha heavy chains which vary in size 
(approximately 40-45kDa) depending upon the locus from which 
they are derived. The signal/leader peptide (of 
approximately 21-24 amino acids) is removed co- 
translationally in the ER and is coded for by the first 5 1 
most exon. The three extracellular domains (alpha-1,- 2 and 
-3) are approximately 90 amino acids and are encoded by exons 
2-4. Exon 5 corresponds to the transmembrane region which is 
approximately 40 amino acids. Depending upon the class I 
gene, the cytoplasmic region can be made up from between one 
to three exons (6, 7 and 8). In general the total number of 
exons in a class I gene varies between six and eight although 
novel alternative splicing combinations do occur (see section 
1.1.7)
1.1.4. Structure of a Classical Class I Molecule in relation 
to Function.
Class I transplantation molecules are highly 
polymorphic integral membrane glycoproteins formed by the 
non-covalent interaction between a heavy chain and B2- 
microglobulin (B2-m) (Silver and Hood, 1974). Structurally, 
the heterodimer is characterized by the presence of four 
extracellular regions; three alpha chain domains and B2-m. 
B2-m is an invariant non-glycosylated 12kDa protein encoded 
on chromosome 15 in man (Goodfellow et al. 1975). Murine 
and human cDNA's for B2-m have been obtained (Parnes et al. 
1981; Suggs et al. 1981). Figure 1.1.4a depicts the basic 
conformation of a class I molecule. The structure of a 
class I molecule (HLA-A2) has now been elucidated using X-ray 
crystallography (see below). The hydrophobic transmembrane 
region of the alpha chain is responsible for anchoring the 
whole complex into the plasma membrane. This region extends 
intracellularly to form the cytoplasmic region. Studies on 
H-2 (Steinmetz et al. 1981) and HLA (Malissen et al. 1982)
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Figure 1.1.4a. Schematic Representation of the four domains 
of HLA-A2. The alpha-1 and alpha-2 domains can be seen to 
form a platform and groove structure (Bjorkman et al. 1987a).
have shown that each domain of the class I protein is largely 
encoded by a separate exon. Sequence comparisons have
indicated that the alpha-1 and alpha-2 domains are highly 
polymorphic in defined regions within a common framework 
structure, whilst the proximal alpha-3 domain is less
variable and Ig-like in structure (Steinmetz and Hood, 1983). 
The degree and nature of this variation is thought to reflect 
the function of the molecule, indeed they are now known to 
interact with a very large number of antigens (see section 
1.1.10). The high level of conservation in the alpha-3 
domain is thought to reflect its importance in the
association with the I^-m subunit.
Alpha-1 and Alpha-2 Domains of Class I Molecules Interact to 
form Unique epitopes.
Exon shuffling of class I alpha-1 and alpha-2 domains 
and subsequent transfection into L cells by DNA-mediated gene 
transfer have enabled the identification of possible sites on 
different exons which are involved in the formation of class
1 epitopes. Ajitkumar et al. (1988) presented data which 
illustrated that multiple residues on both the alpha helices 
of the class I MHC molecule were simultaneously recognized by 
the T-cell receptor. Much evidence has accumulated recently 
demonstrating that class I molecules whose alpha-1 and alpha-
2 coding exons have been interchanged are no longer 
recognised by T-lymphocytes specific for the parental 
molecules. This loss of recognition and reactivity by 
monoclonal antibodies specific for the parental products is 
accompanied by the gain of immunodominant epitopes (Kanda et 
al. 1987).
X-Ray Crystallographic Studies.
The above functional assays were informative but 
the three-dimensional structure of the histocompatibility 
antigen was required in order to locate the polymorphic 
residues on the structure and to gain understanding of how 
and where antibodies and T cell receptors recognize the 
molecules and the foreign antigens that are presented.
The three-dimensional structure of a human class I 
antigen (HLA-A2) has been elucidated using X-ray 
crystallography at 3. 5A resolution (Bjorkman et al. 1987a;b). 
This work represents a valuable contribution in furthering
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our understanding of how these molecules perform their immune 
function. After papain cleavage of HLA-A2 (encompassing 
alpha-1, -2, -3 and I^-m), the polypeptides were purified
from 200 litres JY culture (homozygous at the HLA-A locus) 
and subsequently crystallized. The overall structure (figure 
1.1.4a) can be described as follows: alpha-3 and B 2 _m domains 
(which are closest to the cell membrane) support the alpha-1 
and alpha-2 domains, with B 2 ~m interacting with all three 
alpha domains.
Nature of the Antigen Recognition Site (ARS) and T cell
recognition regions.
The alpha-1 and alpha-2 domains both have similar 
secondary amino acid structure. The first 50 residues 
encompass four regions of beta-strands, followed by an alpha- 
helix in the remaining 40 residues. X-ray crystallography 
studies have illustrated the nature of the interaction 
between the alpha-1 and alpha-2 domains. This close 
association results in the formation of a platform/floor of 
an antiparallel single beta-pleated sheet which is topped by 
two long alpha helices (figure 1.1.4b). The resulting long 
pocket or groove is secured by disulphide links in the alpha 
and beta strands. This shallow area is aproximately 25A 
long, 10A wide and 11A deep and faces away from the cell
surface.
The structural information together with the knowledge 
of the polymorphic residues within the alpha-1 and alpha-2 
sequences have indicated the regions which might be involved 
in presenting the peptidic antigens. It is likely that the 
prominent groove on the surface of class I molecules is the 
foreign antigen recognition site since its polymorphic 
nature, location, size and shape are consistent with the 
binding of a processed peptide. A continuous region of 
electron density within this groove seemed likely to be the
image of a peptide or mixture of peptides that had co­
purified and co-crystallized with HLA-A2.
The known positions of the polymorphic residues within 
the alpha-1 and alpha-2 sequences can largely be divided into 
three groups. One group of variable residues is located on 
the inner sides of both domain alpha helices and point into 
the groove. Another group lies within the beta-strands and 
the residues point upwards into the pocket. These two groups
11
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Figure 1.1.4b. Representation of the upper surface (looking 
down into the groove) of the alpha-1 and alpha-2 domains. 
The platform is made up from four alpha-1 and four alpha-2 
strands of beta-pleated sheet which are topped by alpha-1 and 
alpha-2 alpha helices (Bjorkman et al. 1987a).
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are involved in peptide binding. A third group on the top
face of both alpha helices pointing away from the cell are
thought to be the ligands involved in specific recognition by 
the T cell receptor. Polymorphism at some amino acid 
residues is thought to direct the specificity of recognition 
by T-cells and the degree of responsiveness to various 
foreign antigens.
A number of residues pointing into the ARS are
absolutely conserved in at least 22 human sequences and are
nearly all conserved in at least 13 mouse sequences. These
residues may recognize a common feature of the short peptide. 
Other conserved residues which face away from the ARS may 
form the structural framework of the class I molecule or may 
be candidates for interaction with T cells.
Other functional residues are located on the site
edges where they may be recognized by a T-cell receptor. 
Specific residues involved in the recognition by CTL's have 
been identified by characterization of H-2K*5 class I
spontaneous mutants and occur both within and outside of the 
ARS (reviewed Bjorkman et al. 1987b).
Interaction with B2-microglobulin.
Various studies using somatic hybrids and cell
lines (human Daudi and mouse RI) with defective B2-m genes
indicate that B2-m is required for the cell surface 
expression of class I heavy chains (Arce-Gomez, 1978; Parnes 
et al. 1982; de Preval et al. 1983). The latter accumulate 
in the ER in a glycosylated form and can not be processed any 
further. B2-m is thought to influence the correct 
conformation of the class I heavy chain such that it can be 
translocated from the ER to the trans-Golgi compartment where 
it can be terminally glycosylated (reviewed Maloy and 
Coligan, 1985; Lancet et al. 1979). Section 1.1.11 describes 
ways in which B2-m might affect the regulation of class I 
molecule expression. X-ray crystallography has shown that 
B2-m interacts with the central beta-strands and loops of the 
alpha-l-alpha-2 beta-pleated-sheet. Ferrier et al. (1985) 
had previously suggested that critical interactions between 
B2-m and both the alpha-1 and alpha-2 domains were required 
since some mouse B2-m/human A3, B7 and Cw3 hybrids could not 
be serologically detected (Ab recognition) and certain human 
alloimmune CTL's failed to recognize such hybrid molecules
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(Bernabeu et al. 1983).
Glycosylation of Class I molecules.
Human class I molecules are glycosylated at position
Asn86 which is found in the connecting loop between the
alpha-1 and alpha-2 domains and extends away from the
molecule. Both amino-terminal domains are glycosylated in 
mouse class I antigens but some, such as H-2L^ are also
glycosylated in the alpha-3 domain at position 256Asn
(Kimball and Coligan, 1983). Miyazaki et al. (1986) showed
that non-glycosylated H-2L^ was unchanged in its overall 
serological specificities and was recognized by alloreactive 
T cells, suggesting that carbohydrates were not essential for 
the immunological function of class I antigens. Since the 
cell surface expression of nonglycosylated antigen was much 
reduced compared to the fully processed H-2L^ polypeptide 
(non attributable to degradation or rapid shedding) they 
concluded that carbohydrate facilitated intracellular 
transport of the nascent protein to the plasma membrane. In 
addition to this, it is possible that carbohydrate is
involved in molecular recognition processes in ways that are 
not dependent on antigen specificity.
The characteristics of the class I genes and their 
products from individual loci have been described below - 
some of which will be referred to again in later sections.
1.1.5. Characteristics of individual Class I Loci of Mouse 
H-2.
The class I genes of the mouse H-2 complex have been 
mapped to four genetic loci/regions; H-2K, H-2D/H-2L, Q and 
TL.
The "classical11 H-2K, D and L molecules are highly 
polymorphic, expressed on many nucleated somatic cells and 
are considered to be the 45kDa major classical class I 
transplantation antigens. The mouse Qa and Tla products of 
the Q and TL genes respectively are considerably less 
polymorphic (Mellor et al. 1984; Steinmetz et al. 1981), have 
a lower molecular weight (approximately 40kDa) (Michaelson et 
al. 1981) and their expression is limited to certain
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subpopulations of haemopoetic-derived cells (reviewed by Lew 
et al. 1986). Q gene products (Qa) have been shown to act as 
very weak transplantation antigens since they can stimulate 
graft rejection in vivo (Flaherty, 1976), although the
function of Q and TL genes is largely unknown.
The H-2K Region.
Overlapping cosmid clones of the C57BL/10 mouse have 
shown that two H-2K region genes (H-2K and H-2K1) are
separated by approximtely 15Kb and are arranged in a head to 
tail configuration (Weiss et al. 1984).
The H-2D/H-2L Region.
In most laboratory strains of mice two classical 
transplantation antigens are usually co-expressed and these 
are coded for by the H-2K and H-2D loci. Transformation of L 
cells with cosmid clones and analysis with specific 
antibodies has allowed the identification of the H--2L 
products on H-2^ and H-2^ haplotypes. The number of class I
genes located in the D/L region of the BALB/c (H-2^) and BIO
(H-2^) mouse differs (Weiss et al. 1984; Flaherty et al.
1981). Five genes are present in the H-2^ mouse and two of 
these encode serologically detectable H-2D^ and H-2L^ 
antigens. Apparently there is no equivalent BIO "H-2D 11
j
molecule in this mouse. Whether the other three BALB/c H-2 
genes (D2^, D3^ and D4^) are functional remains to be seen, 
although Mann and Forman (1988) have a cytotoxic T lymphocyte 
clone which recognizes one of these molecules.
The Q Region.
This region spans approximately 200Kb and is distal to 
the D/L region. Molecular genetic analyses have shown that 
the number of genes within the Q region differs between mouse 
strains. There are eight BALB/c and ten BIO class I Q 
genes (Q1-Q10) all arranged in a head to tail, 5' to 3 1 
orientation. The BIO Q3 gene is absent in BALB/c mice 
(Goodenow et al. 1982). Analysis of surrounding sequences 
suggests that the BALB/c Q8/9 gene has resulted from a non­
reciprocal recombination event of the individual Q8 and Q9 
genes (Mellor, 1985). Strong homology between the Q6-Q7 and 
Q8-Q9 class I gene pairs in the C57B1/10 Q region suggests 
that this region has evolved by the duplication of the gene
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pairs.
Some distinct class I gene products have been 
identified by serological and biochemical studies; Qa-1 
(Stanton and Boyse, 1976), Qa-2,3 (Flaherty, 1976), Qb-1 
(Robinson, 1985) and Q10 (Devlin et al. 1985a). The heavy 
chains of some Q gene products are approximately 40kDa 
(Michaelson et al. 1981). The Qa-2,3 serological determinant 
was originally thought to be a single species until 
variations in molecular weight and isoelectric point revealed 
that there was more than one gene involved, i.e. the Q6, Q7,
Q8 and Q9 genes in the BIO mouse (Sherman et al. 1984). The 
non-polymorphic Q10 protein lacks a complete transmembrane 
region and is secreted specifically in mouse liver (Devlin et 
al. 1985a; Maloy et al. 1984). The Qa-1 antigens are an 
allelic series of molecules (Stanton et al. 1981), and seem 
to be expressed on most tissues (Aldrich et al. 1988). At 
least three products from this region are ultimately secreted 
from the cell and these are discussed in section 1.1.7.
The TL Region.
The TL (Tla-thymus leukaemia antigen) region is 
located most distal in the MHC and contains the largest 
number of class I genes in mice; thirteen in BIO and eighteen 
(T1 - T18) in BALB/c (Hammerling et al. 1985; Fisher et al.
1985), although T18 is an incomplete class I gene.
The TL antigens are expressed on thymocytes, activated 
T lymphocytes and on some thymic leukaemias which suggests a 
different/modified role in immunity although T18 has been 
found to be expressed to 10-25% of the levels of the 
classical loci (reviewed by Strominger, 1989). Six antigenic 
specificities have been observed on thymocytes and T cell 
leukaemias. Amongst the Tla haplotypes (a-f), the levels of 
expression of TL antigens varies both qualitatively and 
quantitatively (see Pampeno and Meruelo, 1988).
The integration of TLevl (a retroviral element) into 
the Tla locus of a common ancestor of the species Mus 
musculus. with its subsequent loss from certain mouse genomes 
e.g. C57B1/10, reflects evolutionary rearrangements or 
polymorphisms (Pampeno and Meruelo, 1988). Pontarotti et al. 
(1986) have suggested that the T3C and T13c genes of the 
Balb/c mouse (Tlac haplotype) may have arisen by duplication 
since they show extraordinary high sequence conservation.
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The T3*3 gene contains only six exons, the first coding for a 
signal peptide that is five amino acids longer than all other 
class I molecules whilst the last exon encodes a complete 
cytoplasmic tail. A unique feature of the T3b and T13c third 
intron is a 1.1Kb insertion flanked by a lObp inverted 
inexact repeat which suggests that these may be homologues or 
alleles. Generally there are high levels of homology between 
Tlaa , Tla*3 and Tlac haplotypes (Fisher et al. 1985; Obata et 
al. 1985; Pontarotti et al. 1986).
Further non-classical class I genes have recently been 
identified. Singer et al. (1988) have reported a subfamily 
of mouse class I genes mapping telomeric to Q which so far 
consists of two to three members. One of these, Mb-1, is 
predicted to contain five exons and its expression seems to 
be highly regulated. The overall nucleotide homology with 
other class I sequences is very low (60%) and it is no more 
related to class I genes from other species suggesting that 
it represents a primordial class I sequence. Fischer Lindahl 
et al. (1983) cloned the Hmt gene which encodes a non- 
classical class I molecule that associates with a 
mitochondrial peptide to form the maternally transmitted 
antigen (Mta). The Hmt gene lies within the Hmt region which 
is telomeric to TL. A further non-classical class I gene 
(Thyl9.4) has very recently been cloned and also maps to the 
Hmt region (Brorson et al. 1989). The overall homology of 
Thyl9.4 with other class I loci sequences ranges from 51-70%, 
and reaches 86-88% in the conserved alpha-3 domain. The 
overall homology of class I sequences in exons 1-5 is between 
82-93%. Thus, Mb-1 seems to be the most divergent member of 
the class I gene family so far (Singer et al. 1988).
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1.1.6. Characteristics of Individual HT.a (Mass I Loci.
Classical Class I Loci.
The human equivalents of the genes encoding the 
classical class I molecules map to the HLA-A, -B and -C loci 
and they are arranged as in figure 1.1.3a. Some of the 
expressed human class I genes identified are:
HLA-A2 Roller et al. (1985).
HLA-AW24 N'Guyen et al. (1985).
HLA-A3 Strachan et al. (1984).
HLA-A32 Wan et al. (1986).
HLA-A11 Cowan et al. (1987).
HLA-B44 Kottman et al. (1986).
HLA-B7 Sood et al. (1985).
HLA-BW58 Ways et al. (1985).
HLA-B27 Weiss et al. (1985).
HLA-Cwl Gussow et al. (1987).
HLA-CW2 Gussow et al. (1987).
HLA-CW3 Sodoyer et al. (1984).
HLA-Cw6 Mizuno et al. (1989).
HLA-CW7 Pohla et al. (1989).
HLA-CX52 Takata et al. (1988).
Although the class I sequences show an overall high 
degree of sequence homology and are highly polymorphic, there 
are regions within the gene which show locus specificity, 
that is, those regions which are highly conserved between 
alleles, but which differ significantly from other loci in 
these corresponding regions. Locus specificity can be 
defined as the percentage divergence between non-allelic
genes minus that which occurs between allelic genes.
Roller et al. (1984) described probes isolated from 
the 3 1UT region of the HLA-A an -B genes that hybridized only
to one locus under high stringency conditions (15mM
NaCl/1.5mM NaCitrate, pH7, 65°C). Similar studies were also 
completed for HLA-B (Coppin et al. 1985). Strachan et al.
(1986) analysed nucleotide sequence data of class I HLA genes 
and identified the seventh intron of HLA-C as being one of 
the regions which exhibited the highest degree of locus
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specificity. Indeed, Ronne et al. (1985) used differences in 
the sequences of introns in order to establish evolutionary 
relationships between various class I sequences. The HLA-C 
locus specific probe (pC250 - encompassing exon and intron 7) 
is largely lacking exon sequences and so specific 
oligonucleotide probes directed towards the transmembrane 
region are expected to be useful in mRNA/cDNA work (Strachan 
et al. 1986). At the amino acid level, locus specific 
regions are obvious in the transmembrane regions between HLA- 
A, -B and -C products (see figure 6.9.1 in chapter 6).
The preparation of locus specific probes and their 
use on genomic Southern blots to investigate restriction 
fragment length polymorphisms has indicated that the regions 
surrounding the loci are quite conserved (Coppin et al. 
1985b; Roller et al. 1984; Strachan et al. 1986).
Non-Classical Class I Loci.
Extensive efforts are underway to discover the human 
equivalents of the mouse non-classical loci. Class I genes 
that do not map to the classical loci have been broadly 
termed "New11 (Holmes, 1989), or "Class lb" (Strominger, 
1989), and their function(s) is unknown. Much less is known 
about the precise location of the various HLA class I genes 
since complete cosmid linking of human MHC chromosome remains 
to be done. However, many class I genes do map to a region 
telomeric to the HLA-A locus (Orr and DeMars, 1983). Chimini 
et al. (1988), discovered that most class I sequences were 
contained in a 340Kb Mlul fragment which carries the HLA-A 
gene. Srivastava et al. (1987) also suggested that this 
region could harbor the human equivalents of the mouse Q and 
TL regions.
Both genomic and cDNA clones of some genes have been 
obtained. Firstly, two class I pseudogenes, HLA12.4 
(Malissen et al. 1982) and LN11 (Biro et al. 1983) were 
cloned and found to be more than 80% homologous to the HLA-A, 
-B and -C genes. Srivastava et al. (1987) cloned a genomic 
class I gene, RS5, which was shown to have a number of 
distinct features which included promoter structure, a 
different translation initiation site, a carboxyl terminus 
frameshift mutation and Alu repeat elements. The derived 
amino acid sequence of the three external domains of RS5 
(Srivastava et al. 1987) revealed a level of divergence from
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HLA-A, -B and -C locus proteins comparable to that noted 
between classical H-2 and some of the Q and TL region genes 
(Fisher et al. 1985).
Harry Orr's laboratory and colleagues have recently 
cloned and sequenced three genomic class I genes from a T- 
lymphoblastoid cell line LCL-721, HLA-6.0 (Geraghty et al.
1987), HLA-5.4 (Shimizu et al. 1988) and HLA-E (Roller et al.
1988). All associate with B 2 “-m and upon transfection, 
translate into 38.5, 40 and 41kDa proteins respectively. The 
degree of polymorphism is unknown at these loci. HLA-E maps 
between HLA-C and HLA-A and is known to produce two classes 
of mRNA which are predicted to code for an identical protein 
product. The HLA-E gene is quite related to RS5 since it 
shares an aberrant translation start site and an Alu 
insertion in the 3'-UT region. However, RS5 lacks a further 
Alu element found in HLA-E intron 5 and a direct repeat in 
exon 8, and its overall amino acid sequence homology with 
HLA-E is 90%.
Although HLA-6.0 is similar in organization to 
classical class I genes, it may be a structural homologue of 
a murine Q class I gene since the cytoplasmic region is 
predicted to be considerably shorter than usual and its COOH 
terminus is most similar to that of the Q7 gene. In addition 
to this, the HLA-6.0 promoter region very much resembles 
those of the Qa genes (Geraghty et al. 1987).
Paul et al. (1987) developed an 800 base pair probe 
(JF11), flanking the 5 1 region of HLA-A in order to identify 
non-classical HLA genes. This probe detected a limited 
number of bands other than HLA-A, -B or -C associated 
fragments on Southern blots of genomic DNA. Cosmid 
transfectants of a mouse fibroblast cell line already 
expressing human B2-m were subsequently tested with the 
alloantiserum HA2 (human activated). HA2 is an antiserum 
(see Fauchet et al. 1986) that reacts with a component on 
HLA-A2 PHA-activated T-cells and Epstein-Barr virus (EBV)- 
transformed B cells but does not react with resting T or B 
cells. A cosmid clone P2B2 was isolated and subsequently 
mapped outside of the HLA-A locus. It was found not to react 
with W6/32. Paul proposed that this gene, specifically 
expressed on activated lymphocytes, could be related to HLA-A 
locus genes and be a possible analogue of a mouse Qa region 
gene. This gene seems to provide a link between the newly
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cloned genes and previous reports of alloantigens resembling 
class I molecules human T or HT (Gazit et al. 1980a;b) HA 
(Fauchet et al. 1986) and TCA (van Leeuwen et al. 1985).
According to a brief review by Holmes, (1989), 
Orr's group have isolated 14 other class I genes and by 
sequence analyses, 11 of these are pseudogenes and the other 
three remain to be analyzed. The function of these 
expressible "non-classical11 genes remains to be determined, 
as does the extent of the class I gene family. Strominger, 
(1989) described the CD1 molecules (Calabi et al. 1989) as 
being members of the class lb set of loci (see final 
discussion for details).
1.1.7. Soluble and Alternatively Spliced Forms of Class I 
Molecules.
Class I antigens are normally anchored into the 
membrane via a sequence of hydrophobic amino acids. Shedding 
(Emerson et al. 1981), and proteolytic removal of antigens 
from the membrane have been thought of as mechanisms 
producing soluble class I molecules. To date, soluble class 
I molecules are known to be generated by three mechanisms. 
Products of the Q and TL region may be secreted because they 
have shortened transmembrane segments (due to a STOP codon). 
The Q10 product is interesting because it is secreted 
specifically in the liver at a high rate (Devlin et al. 
1985a). Some mouse genes actually encode anchorless forms 
(Kress et al. 1983a,b). Soloski et al. (1986) studied the 
expression of the Qa-2 molecule in both resting and activated 
T-cell populations and noted upto a four-fold increase in 
biosynthesis after activation, but no concomitant increase in 
cell-surface levels. After activation, approximately 70% of 
newly synthesized Qa-2 were secreted as soluble molecules. 
This process is so far unique to Qa-2 and suggests a 
different functional role for this antigen. Further studies 
of resting and conA activated T and B spleen cells and their 
supernatants by surface and metabolic labelling has 
established that the Qa-2 molecule is inserted into the cell 
membrane and processed to a soluble form whereas the Qb-1 
antigen is secreted directly into the supernatant (Robinson,
1987). Stroynowski et al. (1987) have found that the Q7
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product (Qa-2 antigen) is anchored into liver cell membranes 
by a phosphatidyl inositol tail (Low et al. 1986). This 
feature is thought to be responsible for the expression of 
soluble/secreted and membrane forms of the Qa-2 antigen. Two 
alternatively spliced genes (excluded transmembrane region) 
are also secreted (Krangel et al. 1986; Cianneti et al.
1989).
The function of soluble class I molecules is unknown 
to date, and whether the transmembraneless gene of Krangel 
has a different function from its membrane counterpart 
remains to be seen. In general, it is not known whether 
alternative spliced class I molecules will have specific or 
different functions. The functional importance of Q10 must 
be viewed with caution since not all H-2 haplotypes express 
such a gene (Lew et al. 1986). Alternative splicing is 
known to direct the synthesis of membrane bound versus 
sereted IgM (Early et al. 1980), fibronectin (Kornblihtt et 
al. 1985) and the products of viral genomes. A series of 
alternatively spliced class I molecules have been discovered 
and are listed below.
Kress et al. (1983) discovered the use of an 
alternative splice acceptor site in intron 7 of the H-2K^ 
gene leading to an addition of nine amino acids to the 
cytoplasmic tail. Similar results were obtained for the H- 
2K^ and H-2K^ molecules by Archibald et al. (1986). 
McCluskey et al. (1986) reported a deletion of exon 7 of the 
H-2D^ gene which contains the important serine residue which 
is specifically phosphorylated in vivo. Variation in the 
first aminoJterminal antigen binding domain has been achieved 
by alternative splicing within the second exon causing the 
formation of a hybrid alpha-1 domain (Transy et al. 1984). 
Cianneti et al. (1989) observed mature transcripts where 
alternative splicing had caused the absence of exon 5 
corresponding to the transmembrane region. Vogel et al. 
(1989) reported that 15 nucleotides from the 3 1 end of intron 
5 were inserted between the complete exons of the 
transmembrane and first cytoplasmic domain.
It is possible that some of the splicing events 
represent the error in pre-mRNA processing, since alternative 
forms often occur at low frequency (Kress et al. 1983b; 
Transy et al. 1984).
The normal function of class I molecules is to present
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antigen, and their polymorphism ensures interaction with a 
large number of different antigens. The lack of polymorphism 
for Q region products, whether they are membrane bound or 
soluble, certainly indicates that they may function in a
different manner, but whether they do or not remains to be
seen. Kress et al. (1983a) thought that soluble molecules 
might play a role in inducing self tolerance.
1.1.8 Evolution And Polymorphism.
The necessity for the immune system to detect 
different viruses in association with different MHC antigens 
could constitute the evolutionary pressure which has 
maintained not only the polymorphism but also a multiplicity 
of class I genes. Initially it was suggested that all class
I genes were represented by a set of polymorphic variants
present in the genomes of individuals (Bodmer, 1973), and 
that the diversity among cell surface antigens was achieved 
by a form of regulation but this is now known not to be the 
case. The occurrence of somatic gene rearrangements in the 
generation of diversity (c.f. immunoglobulin) have also been 
excluded (Tonegawa, 1983).
Several conclusions can be drawn concerning the 
evolution/origin of class I genes even though the sequence 
data is somewhat limited and unevenly distributed amongst 
alleles and species. Of the vertebrates studied, (man, 
mouse, chickens, dogs, pigs, hamsters, horses, monkeys, 
sheep, rabbits, goats and cows), class I antigens are highly 
related in sequence homology at both the nucleic acid and 
protein level although this is more obvious in the former. 
Extensive sharing of amino acids between species indicates 
that the structure of the molecule has been conserved and 
that only a small degree of remodelling has occurred since 
the evolution of placental mammals.
There are many different class I loci and the genes 
expressed are the most polymorphic known in vertebrates. The 
gene sequences have three features; complexity (many class I 
loci), diversity (since these molecules differ between 
individuals of the same species, that is, the H-2K,-D and -L 
do not have the same sequences as those of HLA-A, -B and -C) 
and polymorphism (a large number of alleles at a given 
locus).
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Klein and Figueroa (1986), proposed the existence of 
an original single ancestral molecule based on the presence 
of invariant amino acids throughout the sequences of current 
class I vertebrate genes. The presence of "two ancestral" 
residues at a given position indicates the early duplication 
of an ancestral molecule followed by tolerated mutations 
subsequent to the duplication. In such instances, the 
codons of the two amino acids differed by a single nucleotide 
and therefore supported this interpretation. They also 
proposed that the ancestral gene duplicated (probably more 
than once) before the separation of the evolutionary branches 
of the contemporary primitive lagomorphs and rodents. 
Subsequent to this, the duplicated genes began to diversify 
to form two gene clusters (the proto-Q and proto-T genes). A 
number of these sequences were selected to become the 
functional molecules which have been identified (H-2K, D and 
L, HLA-A, B and C and possibly others). These sequences came 
under selective pressure and became much more polymorphic. 
Mouse/rat-specific and human/rabbit-specific sequences are 
found to be distributed throughout the heavy chain and this 
led Klein and Figueroa (1986) to suggest that one ancestral 
gene gave rise to the mouse and rat sequences and another 
gave rise to the human and rabbit sequences, although this is 
a minimal hypothesis. They further proposed that the H-2K 
allele would be no more related to HLA-A than -B or -C.
The TL sequences are in fact the most divergent 
members of the class I gene family (Fisher et al. 1985; 
Hammerling et al. 1985; Obata et al. 1985; Pontarotti et al. 
1985; Rogers, 1985; Weiss et al. 1984;) since they contain 
some unique amino acid residues throughout the molecule (with 
the exception of the alpha-3 domain). However the TL 
sequences still share residues at normally invariant 
positions which clearly identify them as class I genes. This 
means either that the evolutionary branch leading to the TL 
genes separated early on or that they were able to accumulate 
more mutations than other class I genes. Rogers, (1985) 
reported that non-classical class I genes seemed to be poorly 
conserved in mammalian species since cross-hybridization 
studies showed much weaker homology suggesting that the Q and 
TL genes were not conserved even in rodents. This discovery 
led Rogers to propose that these genes were by-products of 
evolution and he expected some to have relatively unimportant
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but not worthless functions.
A comparison of class I sequences between humans and 
chimpanzees has revealed that polymorphism at the classical 
loci predates the divergence of these two species (Lawlor et 
al. 1988). Single HLA-A or -B alleles have been found to be 
more closely related to certain ChLA alleles than other human 
sequences and generally there are no special features that 
differentiate the two. This indicates that they existed as 
an ancestral sequence before diversification 3.7-7.7 million 
years ago into two separate species (trans-species 
evolution). One chimpanzee (CHla) sequence Ch28 seems to be 
the homologue of the non-classical human class I HLA 5.4 
gene; no function has yet been assigned to either of these 
two genes.
Mechanisms Known to Generate Polymorphism.
Three mechanisms are known to contribute to the 
diversity of class I molecules; single nucleotide 
substitutions, reciprocal recombination and gene conversion 
(non-reciprocal recombination). Gene conversion is a 
mechanism for rapid rearrangement and relies initially on the 
duplication and divergence as a source of variation. The 
size of the MHC class I gene family (upto 35 genes) would be 
able to provide a repertoire of sequences for these events. 
Here are examples of the above mechanisms generating 
diversity:-
(1)-The nucleotide substitutions between HLA-A2.1 and HLA-A3 
alleles are evenly distributed among the three extracellular 
exons (Roller et al. 1985).
(2)-Reciprocal recombination was shown to be the basis for 
the derivation of the Aw69 allele from Aw68.1 and Aw.l 
(Holmes and Parham, 1985).
(3)-Substitutions seem to occur in clusters and this is much 
more apparent at the nucleotide level. Sodoyer et al. 
(1985), illustrated this when comparing the allele sequences 
A2, A3, Aw24, A28 and pHLA12.4 (pseudogene) and proposed that 
an event analagous to gene conversion had occured. On this 
occasion over a span of eight amino acid residues (positions 
77-84) in Aw24 was found to be completely different from 
other classical HLA-A allele sequences but identical to 
pHLA12.4 in this region.
The discovery of spontaneous in vivo H-2K*3 mutants
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(bml, bm3 and bm8) also led Pease et al. (1983) to suggest 
that a copy mechanism analagous to gene conversion 
contributed to the polymorphism of class I molecules. 
Synthetic oligonucleotides with sequences to the clustered 
mutations were able to detect a class I gene on Southern 
blots of genomic DNA (presumably a donor gene). Four 
characteristics were consistent with the gene conversion 
hypothesis: firstly, the variant amino acids were present in
other class I molecues in the same positions, secondly, the 
mutations were clustered which would otherwise require 
multiple base substitutions (very unlikely). Thirdly, the 
nucleotide changes are identical to other sequences and 
lastly, identical and complex changes have occurred 
repeatedly. Thus it appeared that some sequences could 
behave as donors and others as recipients. Bregegere,
(1983), used a computer model to simulate the effect of gene 
conversion in a population of limited size and discussed gene 
conversion promoting allelic polymorphism whilst homogenizing 
the gene sequences. This mechanism would only generate 
polymorphism if it acted unidirectionally. The effect of 
gene conversion would be to generate diversity whilst 
maintaining a reasonable overall identity.
1.1.9 Nature and Extent of Class I Sequence Polymorphism.
Polymorphism Detected at the Amino Acid Level.
At the amino acid level, a consensus sequence of class 
I molecules is made possible since single residues 
predominate at most positions. The most up to date 
comparison of thirty-nine class I amino acid sequences 
(Parham et al. 1988) has shown that the polymorphism is 
derived from 20 high variability and 71 low variability 
residues. The majority of substitutions are located in 
clusters in the alpha-1 (positions 62-83) and alpha-2 (105- 
116) domains and across the residues 177-194 which span the 
alpha-2-alpha-3 boundary causing the homology to drop to as 
little as 30%, 50% and 50% respectively (Lopez de Castro,
1983). Monoclonal antibodies reacting with one allele at a 
locus have been isolated, and also with more than one allele 
(from more than one locus), but none have been generated 
which defines an allele according to its locus. A comparison
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of the three external domains between alleles at a single 
locus shows that they differ considerably from the consensus 
by 12-30/270 amino acids, whereas in other systems, alleles 
usually differ by only one or two residues.
The first amino acid and nucleotide sequence 
comparisons indicated that the HLA-A locus alleles were more 
closely related to each other than to alleles from other loci 
(N’Guyen et al. 1985). As more sequences became available 
the A-ness and B-ness at the amino acid level became
apparent. There may be species specific residues although
this is uncertain at the moment because of the limited sample
sizes. To date, there seem to be locus specific residues
located mostly in the transmembrane regions (see section 
6.9).
Nucleotide Sequence Polymorphism.
Nucleotide sequence comparisons show that high 
conservation extends throughout both the introns, exons and 
untranslated regions within loci (Jordan et al. 1985; Sodoyer 
et al. 1985; Srivastava et al. 1985). The polymorpism in the 
alpha-1 and alpha-2 domains is qualitatively different from 
that in the alpha-3 domain (N’Guyen et al. 1985). The 
nucleotide substitutions in the alpha-3 domain largely appear 
in the third position of the codon, which means that the 
substitution is conserved, silent or synonymous i.e. same 
amino acid. Replacement substitutions are abnormally 
frequent in the alpha-1 and alpha-2 domains and thus it 
appears that variation is selected for in the first two 
domains and against in the third. A comparison of the 
substitutions in HLA-A3 and HLA-Aw24 (N'Guyen et al. 1985) 
gives an idea of the magnitude of the polymorphism. There 
are fourteen relacement and one silent substitution in the 
alpha-1 domain, and fourteen and none respectively in the 
alpha-2 domain. In contrast, the silent substitutions in the 
alpha-3 domain outnumber the replacement substitutions by 
four to one.
Pairwise comparisons between sequences of six species 
(Lawlor et al. 1988) human, mouse, Syrian hamster, miniature 
swine, rabbit and cow exhibit a bimodal distribution in the 
number of nucleotide differences and give an indication of 
the levels of polymorphism. There is a range of 1-95 
nucleotide substitutions within a species (1-50 for allelic
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sequences and 45-100 for intra-locus comparisons) and a range 
of 100-200 substitutions when inter-species comparisons are 
made.
Molecules of the K and D loci are highly polymorphic 
whereas both clusters of Q and T loci display only limited 
polymorphism. Loci in the Q cluster are more homologous to 
each other than to the loci in the T cluster and vice versa.
The class I heavy chains vary in length according 
to the locus from which they were derived which is often due 
to the variation in the length of the cytoplasmic tail. 
Locus specificity can be observed also in the nucleotide 
sequence of the 3 1 UT region (see section 1.1.6) The 
environment surrounding a particular locus is recognizably 
similar between alleles and in this respect the genes at 
these loci can be considered to be classical alleles, meaning 
that they have not evolved from a single original sequence 
without its prior duplication.
1.1.10. Aspects of Antigen Presentation.
General Considerations.
Zinkernagel and Doherty, (1979) proposed that when a 
virus infected a cell, viral glycoprotein antigens which were 
inserted into the plasma membrane as a normal part of the 
viral life cycle subsequently associated with MHC molecules 
that were already resident. The work of Townsend et al.
(1984) demonstrated that the majority of mouse anti-influenza 
virus CTL's had specificity for self H-2 molecules in 
association with viral nucleocapsid rather than 
haemmaglutinin or neuraminidase (which are coat proteins) 
which is in contrast with the earlier proposal of Zinkernagel 
and Doherty, (1979). Further work (Townsend et al. 1985; 
1986a) suggested that proteins were digested intracellularly 
and presented as peptides in association with MHC antigens.
It is becoming clear that the natural function of 
class I and II molecules is to bind endogenously synthesized 
and exogenously acquired (endocytosed) antigens (peptides) 
respectively and present them to T lymphocyte receptors. 
Receptors on T-lymphocytes (TCR's) recognise antigens in the 
context of an MHC molecule (MHC restriction/recognition) CD3 
and various other cell surface accessory molecules (reviewed
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Allison and Lanier, 1987). Inducer T lymphocytes (T^) 
recognise antigen in association with a class II molecule and 
CD4, whilst cytotoxic T lymphocytes (Tc ) recognise antigen in 
the context of a class I molecule and CD8. The glycoprotein 
accessory molecules are thought to establish cell adhesion, 
play a role in T-cell recognition and possibly contribute 
either positive or negative signals which assist in T-cell 
activation. Immunochemistry with anti-CD8 MoAbs and W6/32 
showed that the CD8 (38kDa) accessory molecule was non- 
covalently associated with the HLA class I heavy chain on the 
surface of Con A activated human T-cells (Bushkin et al.
1988). The accessory molecules do not reveal any significant 
polymorphism and it is assumed that they associate with the 
monomorphic regions of MHC molecules. The experiments of 
Connolly et al. (1988) have suggested that CD8 binds to the 
alpha-3 domain of class I molecules, and this binding can be 
affected by a small amount of polymorphism in the alpha-3 
domain (Salter et al. 1989).
The vast diversity of the antibody repertoire derives 
largely from the fact that the heavy and light chain variable 
regions are encoded by a part of the chain that are 
diversified somatically from component germline segments
(Tonegawa, 1983). The heterodimeric T cell antigen receptor 
(TCR) is also encoded by genes that are assembled
somatically. In contrast with antibodies that are found to
bind to free soluble antigens or virus, T-cell receptors
recognize foreign antigens associated with a particular HLA 
molecule (Zinkernagel and Doherty, 1979). The nature of the 
association remains an uncertainty because it appears 
unlikely that the limited haplotype of an individual could 
complex with a vast number of foreign antigens. Nagy et al. 
(1989) proposed that it would appear reasonable to expect 
that the antigen binding site should not exhibit a high 
degree of affinity/specificity (as do A b ’s) [see below]. The 
variation of the immune response to particular antigens and 
the association of histocompatibility antigens with 
susceptibility to diseases (Zinkernagel, 1979) may be a 
direct result of the ability of particular HLA products to 
effectively bind foreign antigens. Some antigens/peptides 
are indeed presented better than others and it is not known 
whether they share any physical or structural properties or 
whether the class I molecule imposes a common conformation on
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the peptide in order to facilitate complex formation 
(reviewed Bjorkman et al. 1987b).
Alloreactivity.
A high percentage of CTL are capable of lysing 
uninfected cells bearing a foreign or alio class I molecule, 
a phenomenon known as alloreactivity, but it is still unclear 
as to whether this type of recognition involves peptide 
binding. There is the possibility that this peptide could be 
derived from the HLA molecule itself but this may not be so 
likely since at least six classical class I molecules are 
being expressed at the one time in an individual. The 
recognition of foreign HLA by alloreactive T cells is thought 
to be a cross reaction occurring because the structure of a 
self MHC molecule plus antigen resembles non-self or (alio) 
MHC molecule (Bevan, 1977). About 1:1(T3 H-2b lymphocytes 
respond to variant class I molecules that differ in only
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three or less amino acids from the wild type, whereas 1:10 
T cells in unimmunized mice recognize influenza virus 
antigens, implying that a very small difference in the MHC 
protein makes it about 100 times more immunogenic than a 
viral antigen (reviewed by Townsend and McMichael, 1987). A 
T cell receptor could directly contact the polymorphic 
residue on an alio HLA molecule to distinguish it from self, 
or the receptor could recognize the molecule complexed with a 
peptide. Although either is possible, the observation that 
the majority of alloreactive CTL variant residues are in the 
peptide binding site rather than on surfaces facing towards 
outside, suggests that alloreactivity may involve the 
recognition of a complex between alio HLA and some peptide 
(Bjorkman et al. 1987a;b). Lysis of a virus-infected cell, 
involves TCR recognition of viral antigen and class I 
molecule and it is not yet clear how exactly the T-cell 
receptor recognizes both together. It may be necessary to 
experimentally determine the three-dimensional structure of 
ternary TCR-MHC-peptide complexes.
Direct Binding between MHC Class I Molecules and Immunogenic 
Peptides.
Peptide binding to class II MHC proteins and T cell 
recognition of these complexes at the functional level has 
been demonstrated (see Bouillot et al. 1989 for references).
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Direct binding of class I molecules to peptides has been 
difficult to demonstrate, although the crystallographic 
structure of HLA-A2 (Bjorkman et al. 1987a;b) and peptide 
sensitization experiments (Gotch et al. 1987; Townsend et al. 
1986b) provide evidence for this. Chen and Parham, (1989), 
have described selective binding of an influenza matrix 
peptide to HLA-A2 and that of influenza nucleoprotein 
peptides to HLA-B37 using a gel filtration assay. Both 
peptides were previously shown to act as targets for HLA-A2 
and HLA-B37 restricted influenza-specific CTL's (Townsend et 
al. 1986; Gotch et al. 1987). Not all allospecificities can 
present these peptides to CTL's. Only 0.3% of the HLA 
molecules bound the peptides and this was thought to be 
limited by previously bound peptides which have also been 
found by Bjorkman et al. (1987 a;b). Collectively, this data 
indicates that the ARS has quite a high level of affinity for 
the peptides with which it interacts since they seem to have 
persisted throughout both isolation procedures. 
Subsequently, Bouillot (1989) described a simple quantitative 
and competition assay to measure the binding of radiolabelled 
MHC class I molecules to influenza specific peptides (known 
to be immunogenic) and some of their derivatives fixed on a 
solid phase support. Peptides bound preferentially to the 
restricting MHC class molecule as well as to others, whereas 
the control peptides (not known to be CTL epitopes) gave 
negative results. When the same test peptides were used in 
a cytolytic assay there was a correlation between binding of 
the peptides to (e.g. HLA-A2) class I and its capacity to 
sensitize HLA-A2+ cells for lysis by anti-influenza A virus 
CTL. The differences of binding are thought to reflect the 
patterns of MHC restriction in vivo. At a more functional 
level, by measuring the release of serine esterase, Kane et 
al. (1989) reported that purified class I proteins pulsed 
with influenza peptides triggered MHC restricted antigen- 
specific, TCR-mediated degranulation of CTL.
Townsend et al. (1989), have studied a mouse lymphoma, 
RLB-5 (RMA) and its EMS-induced mutant, RMA-S. The latter 
only expresses l/20th of the amount of H-2Db , H-2K*5 and B2-m 
at the cell surface when compared with its parent. RMA-S 
synthesizes both heavy and the light chains, although the 
heavy chains do not bear high mannose oligosaccharides, do 
not associate with B2-m and thus are not expressed at the
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cell surface. Exposure of RMA-S to certain influenza 
nucleocapsid peptides restored the association and cell 
surface expression of the class I complex suggesting that the 
association with the binding site of class I molecules may be 
required for correct folding of the heavy chain and its 
association with B2-m. The peptides may become enveloped 
within the class I binding site and indeed by instrumental in 
determining the final conformation. This may explain why 
various workers (Bouillot et al. 1989; Chen and Parham, 1989) 
have found it difficult to demonstrate peptides binding in 
vitro (Parham, 1989).
Pathways of Antigen Processing and Presentation.
Exogenous antigens are endocytosed and taken into the 
cell as endosomes and are supposedly unlikely to be presented 
by class I molecules, but do interact with class II molecules 
(see Long and Jacobson, 1989). These results suggested 
distinct requirements for class I and class II restricted 
presentation, and it was suggested that there were two 
separate pathways involved in presenting exogenously acquired 
and endogenously synthesized antigens. The association of 
the invariant chain (Sekaly et al. 1988) with MHC class II 
molecules has indicated its involvement in processing (Long 
and Jacobson, 1989). Townsend et al. (1986) showed that 
viral antigens synthesized in the cytoplasm could be 
processed and presented by class I molecules. How the 
processed antigens are generated, reach their site of 
association and associate with class I or class II and how 
the whole complex is translocated to the relevant site(s) is 
unknown.
Role of Class I in the Elimination of Somatic Mutants?
The results of Townsend et al. (1984) led Rajan
(1987) to raise a fundamental evolutionary question which was 
"Why would the CTL system have evolved to deal with viral 
intracellular proteins rather than viral glycoprotein 
antigens that are inserted in the cell membrane?" 
Nucleocapsid proteins are synthesized early in infection 
whereas neuraminidase and hemagglutinin are synthesized late 
and so it makes sense to eliminate the infected cell before 
it truly begins to support the production of virus. Such 
studies indicated the importance of dealing with
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novel/foreign intracellular proteins. This led Rajan to 
suggest that the presentation of viral antigen to T 
lymphocytes was only one aspect of a more general function of 
class I antigens. He proposed that class I molecules may 
also have a role in elimination of somatic mutants. The 
evidence which most supports this proposal comes from the 
turn- mutants (reviewed Boon and van Pel, 1989; Rajan, 1987). 
Subcutaneous injection of the DBA/2 mastocytoma P815 (diploid 
cells) into syngeneic mice normally results in local tumours. 
However, 50% mutagenized P815 cells failed to grow, and 
although the mice did not produce antibodies they generated 
CTL's to the tumour variants which did not cross-react with 
any other tumour isolate. Rajan proposed that this could be 
explained if one assumed that random mutations in the genome 
generate at least a heterozygote mutation. This novel peptide 
from the mutated genome would be presented to T cells in the
context of the cell1s MHC molecules and the cell would be
eliminated. The mutated form of the protein would not be 
present in intact form on the membrane (especially if not a 
membrane protein anyway) and so antibodies would not be made. 
However, most somatic mutants would be heterozygous and those 
few which would be homozygous may simply die. In addition to 
this, not all cells have been found to express class I
antigens (Daar et al. 1984) although this could be due to
very low levels of expression?
Boon and van Pel, (1989) have hypothesized that 
antigenic peptides are generated by autonomous transcription 
and translation of short subgenic regions (peptons) and not 
by degradation of intracellular proteins.
1.1.11. Regulation of Class I Antigen Expression.
The levels of class I antigens vary substantially 
between different cell types (Cosman et al. 1982; Kress et 
al. 1983b). Some cells do not constitutively express class 
I, namely certain exocrine cells of some glands, smooth or 
striated muscle cells, corneal endothelium and neurons of the 
central nervous system (Daar et al. 1984). Fibroblasts, 
muscle and nerve cells express very low levels while cells of 
the immune system have relatively high cell surface levels. 
During differentiation of embryonic cells and tumorigenesis
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the expresson of class I changes.
The modulation of HLA expression could potentially 
have dramatic biologic effects e.g. oncogenicity of certain 
tumours is closely associated with the degree of class I gene 
expression (Tanaka et al. 1988). The levels are thought to 
affect the ability of a cell to activate or be lysed by 
cytotoxic T cells, for example, transplanted AKR leukaemia 
cells are rejected after MHC DNA-mediated transfer (Hui et 
al. 1984). Expression of class I genes can be modulated by 
exogenous factors like mitogens, immunomodulators and 
infectious agents, and it would be quite interesting to 
define the regulatory regions involved.
Cis and Trans Regulation of Class I Gene Transcription.
Studies on the regulation of eukaryotic gene 
expression have focused on both the sequences (cis- 
regulation) required for expression and the cellular factors 
(trans-regulation) that specifically interact with these cis- 
elements. The expression of a gene is influenced by a wide 
variety of mechanisms acting at many control points.
Both positive and negative regulatory cis elements 
characteristic of eukaryotic promoter regions have been 
identified 5* of class I genes (Shirayoshi et al. ' 1987). 
Mouse genes have perfect CAAT and TATAAA promoter elements 5 1 
of the cap site whilst some promoters of human class I genes 
have a variant TATAAA sequence; TCTAAA. The lower levels of 
HLA-C expression compared to HLA-A and -B may be explained by 
the variant CGGT and TCTGAA sequences (Sodoyer et al. 1985). 
Kimura et al. (1986) described the detailed analysis of the 
H-2K*5 promoter in an attempt to decipher the way in which 
this gene was regulated. At least some of the important 
sequences were confirmed by a comparison with other H-2 class 
I genes and also B2-m since their expression seems to be co­
regulated (Croce et al. 1981; Morello et al. 1982). The 
class I enhancer-like sequences function poorly in 
undifferentiated embryonal carcinoma cells and are not the 
target of H-2 inhibition which was observed in Adenovirus 12 
transformed primary cells (Schrier et al. 1983). No sequence 
homology to these enhancer regions was found in the 5 1 - 
flanking region of the B2-m gene although enhancer activity 
was detected. The conclusion from these studies was that the 
lack of homology between sequences may reflect differentially
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regulated programs of expression during embryonic 
development. These regions were not found to be conserved in 
the Qa region class I promoters. These sequences however are 
not "true" enhancers since a reversal in orientation or 
positioning further upstream decreased their ability to 
facilitate transcription. Shirayoshi et al. (1987), 
discovered a conserved class I regulatory element (CRE) in 
the 5' region of the H-2L^ gene which was approximately 40 
base pairs long. The CRE acted as a negative regulatory 
element in undifferentiated F9 embryonal carcinoma cells 
which were HLA-ve. The same element acted as a positive 
regulator in cells expressing class I genes at high levels. 
The CRE bound three factors on three distinct sequences which 
corresponded to inverted and direct repeats. F9 cells seem 
to lack one of these factors and this may account for the 
above observations.
Fusion of two different somatic cell types which 
express different amounts of class I, T-LCL (low levels) and 
B-LCL (higher levels) results in increased expression of T- 
LCL molecules. This suggested that the T-LCL lacked an 
important factor that was able to diffuse between the two. 
Using gel retardation assays and in vitro "footprinting11 
Israel et al. (1987) analyzed the relationship between 
nuclear proteins, the 5' enhancer and interferon response 
sequences of the H-2K^ gene. The binding of a number of 
proteins to the class I enhancer and to a similar sequence 
(in opposite orientation) in the B2-niicroglobulin gene 
suggested a common regulatory mechanism.
Regulation of Class I Gene Expression by Immune Modulators.
Certain immune modulators have been shown to increase 
the level of class I mRNA. Collins et al. (1986). have shown 
that TNF (tumour necrosis factor) elevates both mRNA and cell 
surface levels of HLA-A, -B and -C antigens in human 
endothelial cells and dermal fibroblasts. This effect is 
thought to be mediated via the expression of a newly 
synthesized intermediate.
Interferons (also immune modulators) are a highly 
species specific family of secreted protein factors which are 
involved in the defence against viral infections and in the 
regulation of cell growth and differentiation. The 
interferons induce a common set of proteins as well as others
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which are only induced by the particular type and subtype of 
interferon.
Gamma-interferon has been used in this study (chapter 
4). Recombinant DNA technology has enabled the confirmation 
of the individual effects of type I (leucocyte IFN-alpha and 
fibroblast IFN-beta) and type II (immune iFN-gamma)
interferons, i.e. specific gene activation mediated by a 
distinct set of receptors. Interferons alpha and beta 
increase class I mRNA levels after one hour (Fellous et al.
1982).
Gamma-interferon is produced by both T-helper (Th^ 
and T-cytotoxic (Tc) cells under appropriate stimulation. It 
appears to be both a modulator as seen by its ability to 
enhance the level of class I and an inducer, able to activate 
the expression of MHC genes. Baldwin and Sharp, (1987) have 
found a cis-acting regulatory sequence that contributes to 
basal levels of gene expression and also to stimulation by 
gamma-interferon. Momburg et al. (1986) were able to show 
that in vivo application of IFN-gamma in B10.BR mice led to 
both induction and enhancement of MHC class I antigens in a 
variety of tissues although some were refractive to this
stimulation. Beta-interferon is known to be one of the 
developmental factors switching on class I expression during 
differentiation (Yarden et al. 1984).
Though interferon is species specific, stably 
transfected human class I genes in mouse cells can be induced
by treatment with mouse interferon (Rosa et al. 1983). This
suggests that the effects of interferon in this instance are 
modified by a trans-acting factor which does not discriminate 
between mouse and human class I genes.
Chen et al. (1986) studied the effects of IFN-gamma on 
HLA class I gene expression, differentiation and 
proliferative capacity of K562 human leukaemia cells. They 
found that IFN-gamma increased class I transcripts 
selectively in a dose dependent manner after 48 hours in the 
absence of differentiation and no change in proliferative 
capacity. Their kinetic analyses suggested that the 
mechanism by which IFN-gamma induced transcription might be 
different from that for IFN-alpha or IFN-beta. There was a 
longer delay before transcription activation after IFN-gamma 
induction than with type I IFN’s although IFN-gamma can 
induce rapid transcriptional activation of an early response
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gene which may be involved in this process. In addition 
there is the possibility that the down regulation of a labile 
repressor may be necessary before the activation of class I 
transcription takes place.
Vogel et al. (1986) dissected the H-2L^ gene in order 
to identify the potential control regions and located the 
presence of a transcriptional enhancer mapped within 350 base 
pairs of the transcriptional start site. Although the 
accumulation of class I transcripts increases after 
interferon treatment it is not yet clear from Vogel's studies 
whether the enhancement is entirely the result of an 
increased rate of transcription or of a combination of 
increased transcription and stabilization of mRNA. Israel 
et al. (1986) showed in a transient assay that the H-2K 
promoter could be induced by both types I and II interferons 
and that the interferon responsive sequence (IRS) was 
necessary for this induction. This IRS was active only when 
associated with a functional enhancer in the H-2K^ promoter 
and that of other class I genes.
Post-transcriptional Regulation of Class I Expression.
The formation of a cap at the 5' end of the mRNA and 
addition of poly(A) residues at the 3' end of the mRNA, 
intron excision and exon splicing form the basis of post- 
transcriptional control mechanisms in eukaryotes.
Shimizu et al. (1986) and references within, 
transferred and cloned class I genes into gamma-ray induced 
HLA-mutant lymphoblastoid cells. Although the steady state 
levels of class I mRNA were not reduced, cell surface 
expression was deficient. The conclusion drawn from these 
experiments was that expression of class I required a post- 
transcriptional function.
The independent expression of I^-m may be a potential 
step in the regulation by which the cell surface expression 
of class I molecules can be controlled although no cellular 
system has been identified in which this situation occurs 
(Morello et al. 1985). A more indirect control mechanism has 
been suggested by Klar and Hammerling (1989), who have shown 
that the association of the class I heavy chain with B 2 "iri 
requires an active cellular mechanism. They demonstrated 
that mouse class I and B 2 ~in chains could co-exist in the cell 
without assembling spontaneously and that assembly could be
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stimulated by gamma-interferon. The mechanisms required for 
this interaction probably involve either the induction of a 
positive factor or the down-regulation or neutralization of 
blocking/competitive factors.
Viral Regulation of Class I Expression.
Studies of cell lines transformed by mutant El region 
viruses showed that inactivation of class I gene expression 
is a function of the product of the Adl2 13S Ela mRNA. 
Bernards et al. (1983) and accompanying work of Schrier et 
al. (1983) showed that rejection of transformed cells 
correlated with the expression of adenovirus type 12 Ela 
sequences. A reduction of class I cell surface expression is 
often accompanied by a reduction in steady state mRNA levels. 
Vaessen et al. (1987), showed that Adl2 interfered with 
processing of nuclear precursors causing much reduced cell 
surface levels. The Rous sarcoma virus also reduces levels 
of class I mRNA (Gogusev et al. 1988).
Oncogene Influence on Class I Expression.
Both N-myc and c-myc oncogenes reduce the expression 
of MHC class I in neuroblastomas and melanomas, respectively 
(Versteeg et al. 1988; Lenardo et al. 1989). Versteeg et al.
(1988), showed an inverse correlation between c-myc and class 
I mRNA1 s. In addition to this, B 2 -m. mRNA levels were reduced 
concomitantly with class I mRNA and treatment with gamma- 
interferon restored both levels. Lenardo et al. (1989), 
identified two distinct class I promoter elements which were 
susceptible to N-myc-mediated suppression and one of these 
was an enhancer. Elevated expression of N-myc oncogene 
correlated with a reduction in binding of a transcription 
factor to the enhancer.
Other
Lambert et al. (1989) demonstrated that human 
fibroblast and keratinocytes were induced to express class I 
by several classes of DNA damaging agents. Cycloheximide, a 
protein synthesis inhibitor also induced class I suggesting 
that this may be a component of a derepressible cellular SOS 
pathway.
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1.2._______ CLASS I EXPRESSION ON PLACENTAL TROPHOBLASTS.
1.2.1 Immunological Paradox of Pregnancy.
A prerequisite of pregnancy is that no homozygous 
lethal genes be present in the conceptus and having satisfied 
this, the question of an immunological relationship with the 
mother may become critical. Mammals exhibit a high degree of 
tissue antigen polymorphism and as a consequence of outbred 
matings produce semi-allogeneic foeto-placental units. The 
fate of tissue grafts surgically transplanted across 
genetically dissimilar individuals has established the 
universality of allograft rejection. The ability of the 
maternal immune system to recognize and destroy non-self does 
not seem to be drastically impaired;indeed it is implied in 
the literature that maternal recognition of the embryo is 
essential for the maintenance of pregnancy (reviewed 
Billington, 1988). This coexistence highlights the 
paradoxical success of the foetus and has stimulated studies 
of placental trophoblast antigen expression and local uterine 
responses (Bulmer et al. 1988; Bulmer and Sunderland, 1984).
Transplantation immunology of pregnancy was 
initiated by Peter Medawar in 1953. He asked how a pregnant 
mother could nourish a foetus that was antigenically foreign 
and how might the foetus avoid presenting itself as such to 
the mother? There are many factors which are thought to 
enhance the success of a pregnancy and these have been 
reviewed (Billington, 1988; Hill and Anderson, 1988; Bulmer,
1988). One important suggestion made by Medawar to explain 
this mystery was the anatomical separation of the foetus from 
the mother by the placenta. Visualization of the placental 
interface under the light microscope shows that it separates 
foetal and maternal blood circulations. The absence of a 
combined circulatory system and the existence of the 
trophoblastic barrier effectively prevents the passage of any 
significant numbers of maternal immunocompetent cells into 
the foetus. Just as important is the traffic of foetal 
lymphocytes in the opposite direction which again has been 
shown to occur only to a limited degree (Hunziker et al.
1984).Understandably, the placental trophoblast cells in 
their key position at the maternal-foetal interface have been 
the major focus of attention. Some placental trophoblasts 
are in direct contact with maternal cells and blood. It
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would therefore seem necessary to arrest the expression of 
trophoblast antigens capable of eliciting a harmful immune 
response which would be ultimately aimed at the foetus. 
Obvious candidates for such antigens are the classical 
transplantation molecules that have been discussed earlier. 
The modification or loss of function, or total lack of class 
I antigen expression on the placenta might be the key answer 
to this "immunological paradox". Immunostaining experiments 
on placental sections using monoclonal antibodies have 
revealed that the.simple lack of class I expression is not 
the case and thus it seems that they are likely to play an 
essential role during pregnancy. It is now clear that only
some trophoblast subpopulations express class I
transplantation antigens and there are reasons to believe 
that these may not always be of the classical type.
Obviously the presence of MHC antigens on some populations of 
trophoblast raises questions concerning the susceptibility of 
these cells to maternal effectors such as cytotoxic T
lymphocytes and alloantibodies.
The following material discusses the structure of 
the placenta, and the nature and expression pattern of class 
I molecules.
1.2.2. Placental Development.
The human haemochorial placenta is an extremely 
complex organ of extra-embryonic origin and is comprised of 
different trophoblast populations and other foetal tissues 
such as endothelium, stroma and blood cells (Boyd and 
Hamilton, 1979). The junctional area is an admixture of 
foetally derived and maternal cells.
After fertilization and development as far as the 
morula (32-cell stage) there is further differentiation into 
the unilaminar blastocyst by a process of cavitation (see 
figure 1.2.2). The blastocyst can be divided into two parts, 
the inner cell mass which becomes the embryo proper and the 
trophoblast which differentiates into the placenta and other 
extra-embryonic membranes.
After implantation of the blastocyst the 
trophoblast differentiates into a peripheral layer of 
primitive syncytiotrophoblast (which eventually lines the 
intervillous blood space) and an inner layer of primitive
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Figure 1.2.2. Development of a fertilized ovum into an 
implantation blastocyst. Differentiation of trophoblast to 
form the syncytiotrophoblast and cytotrophoblast after 
implantation.
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cytotrophoblast which starts proliferating to form the 
precursors of the primary villi at approximately 11-12 days 
post-conception (reviewed by Pijnenborg et al. 1981a;b). 
Syncytiotrophoblast cells (syncytium) are recognized to be 
the differentiated derivative of cytotrophoblasts. Mesoderm 
growth leads to the formation of the secondary and tertiary 
villi, and cytotrophoblastic cell columns extend through the 
peripheral syncytium, fanning out to form the 
cytotrophoblastic shell.
After eight weeks, the continuity of the 
cytotrophoblast shell is broken down and trophoblast 
proliferation is mainly confined to the tips of the anchoring 
villi which make contact with the basal decidua. 
Intravascular retrograde migration of trophoblast into 
decidual spiral arteries begins with the cytotrophoblasts 
plugging into their distal tips. The walls of these arteries 
are converted into tubes of fibrinoid material embedded with 
trophoblast cells.
So in the human, the cytotrophoblastic elements are 
dispersed in the uterine basal plate, decidua and the 
subjacent myometrium in what is now termed the placental bed. 
After approximately four months the non-placental materno- 
foetal interface is composed of the amniochorion (amnion 
epithelium and chorionic cytotrophoblast) which now fills 
the uterine cavity and is in contact with maternal decidua. 
Amniotic epithelial cells arise from the inner cell mass.
1.2.3. Nature. Extent and Properties of the Trophoblast.
The villous syncytium (syncytiotrophoblast) is in 
direct contact with maternal blood. Not restricted to a 
villous form, trophoblast is found at several extra-villous 
locations (Earl et al. 1985). These include the 
cytotrophoblast cell islands of the chorionic plate at the 
foetal side of the placenta, interstitial trophoblast in the 
placental bed, decidual trophoblast in the placental bed 
nearest the uterine decidua and the membranous chorion 
(chorionic cytotrophoblasts) cells of variable size between 
the decidua parietalis (uterine wall) and connective tissue 
underlying the amniotic epithelium (figure 1.2.3).
When placental tissue (but not trophoblast alone) 
is moved to an extra-uterine site it is rejected in the
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the intervillous blood space. See text for details.
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normal immunological fashion (in Gill, 1984). Thus, the 
trophoblast seems able to survive by virtue of its own
properties. This tissue is normally resistant to immune
damage by lymphocytes and cytotoxic antibodies and is thought 
to form a physical barrier preventing immune effectors 
(except some antibody) from reaching the foetus (reviewed 
Billington, 1988). Trophoblasts are intrinsically resistant 
to lysis possibly due to low alloantigen density or efficient 
membrane repair mechanisms. They are thought to recruit or 
signal suppressor lymphocyte populations into the uterine
decidua and produce progesterone (an immunosuppressive agent) 
and other hormones in high local concentrations. 
Progesterone is important since it has an anti-inflammatory 
role and allows the trophoblast to penetrate and anchor to 
the uterine decidua.
1.2.4. Immunostaininq Analysis revealing the Pattern and 
Nature of h t .a  Class I Expression in the Human Extra-Embryonic 
Membranes.
Immunohistological staining of placental sections 
using monoclonal antibodies has illustrated the absence of 
Class II antigens throughout pregnancy both in mouse 
(Chatterjee-Hasrouni et al. 1981) and man (Goodfellow et al. 
1976; reviewed by Redman, 1983) and these will not be 
mentioned further. Syncytiotrophoblast (major area of 
exchange) has been shown to be HLA-ve by immunohistology 
(Bulmer and Johnson, 1985; Faulk et al. 1977; Sunderland et 
al. 1981b) and by recent in situ hybridization studies (Hunt 
et al. 1988b). They are also resistant to gamma-interferon- 
mediated induction of class I (Hunt et al. 1987). Villous 
cytotrophoblasts are also negative for class I (Sunderland et 
al. 1981b) and contain very low levels of class I HLA mRNA 
(Kawata et al. 1984b).
It is now very clear that class I antigens are 
expressed on certain trophoblast subpopulations which are in 
intimate contact with both maternal decidua and blood. 
Their low levels of expression have brought slight confusion 
to the literature, but such situations have now been 
clarified. Early work reported the lack of detectable class 
I antigens in human chorionic villous trophoblast (Faulk et 
al. 1977) which unfortunately led to extrapolation of this
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data to other trophoblast populations. However, Goodfellow 
et al. (1976) had already found very low levels of class I 
antigens on whole placental cell membranes.
The amnion epithelial cells and chorionic 
cytotrophoblasts compose two distinct layers of the extra- 
placental amniochorion membrane. Initial work of Hunt and 
Wood (1986) reported lack of class I surface expression on 
amnion epithelial cells at least in a form or density that 
could be detected immunohistologically. The cell surface 
expression of these antigens could be induced with gamma- 
interferon. Hunt et al. (1988b) have now confirmed that some 
amnion epithelial cells do express class I antigens.
Hsi et al. (1982) reported that the chorionic 
cytotrophoblasts of the amniochorion were negative for class 
I whereas Hunt et al. (1988a) have often found that, like 
nearby amnion epithelial cells, chorion membrane 
cytotrophoblasts were class I HLA positive. However, 
although the amnion cells seem very responsive to gamma- 
interferon, chorionic cytotrophoblasts do not seem to be 
(Hunt et al. 1987).
HLA antigens have been found in the villous stroma 
(Redman et al. 1984; Sunderland et al. 1981 a;b). The
antibodies used in this study were W6/32 (directed against a 
common class I determinant (Barnstable et al. 1978) and NDOG, 
specific for a villous syncytiotrophoblast antigen which 
distinguishes maternal and foetal tissues. Using an 
indirect immunoperoxidase staining technique these studies 
showed that extravillous trophoblast in the cytotrophoblastic 
shell of an 8 week placenta stained positive. Redman et al.
(1984) further investigated the expression of class I 
antigens in placental tissues taken from first, second and 
third trimester pregnancies. A battery of monoclonal 
antibodies was used in order to thoroughly distinguish 
maternal and foetal cell types (see Redman et al. (1984) for 
these antibodies). Monoclonal antibodies directed against 
monomorphic (W6/32) and polymorphic determinants of HLA-A and 
HLA-B antigens revealed that the class I antigens failed to 
bind HLA-A and HLA-B antibodies specific for the foetal 
phenotype (paternal antigens). No antibodies for HLA-C loci 
antigens were available and so they concluded that the 
antigen expressed may be restricted to HLA-C or some other 
serologically undefined class I antigen.
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Hsi et al. (1984) studied class I expression on 
normal human term amniochorions and found that the 
extravillous cytotrophoblasts (called metatrophoblasts) could 
be stained with anti-B2 ~m and W6/32, but not with 61D2 
(Ugolini et al. 1980). 61D2 is a monoclonal antibody which
recognizes a different class I determinant to W6/32. They 
suggested that class I antigen expression may be incomplete 
(probably meaning that the molecule was incomplete), or that 
there may be a contribution of an antigen from another region 
of the MHC - possibly extra-embryonic. Wells et al. (1984) 
used both W6/32 and 61D2 to stain the cytotrophobast shell of 
the placental basal plate. Although class I antigens were 
detected here with W6/32, no staining with 61D2 was observed.
Using trophoblast-reactive monoclonal antibodies 
and anti-class I antibodies Earl et al. (1985) compared the 
antigen expression of villous and extra-villous trophoblasts 
of ectopic (extra-uterine) implantations with that of normal 
pregnancy. Identical staining patterns were observed between 
both, and these studies also confirmed the lack of reactivity 
when using 61D2. Hsi et al. (1984) suggested that the 
determinant recognized by 61D2 may be situated nearer to the 
distal end of the class I heavy chain than the epitope 
recognized by W6/32. The absence of 61D2 reactivity with 
these trophoblast antigens may indicate a modified structure. 
This is an interesting proposal since an incomplete or 
modified molecule may be only weakly immunogenic. Earl et al.
(1985) suggested that such a molecule might stimulate a local 
"protective immune response". Similar patterns of expression 
were identified on chorionic villi of complete or partial 
molar pregnancies; the staining being confined to the villous 
mesoderm and absent from the syncytiotrophoblast layers 
(Fisher and Lawler, 1984; Sunderland et al. 1985).
1.2.5. Pattern of HT.A Expression on Mouse. Rat and Baboon 
Placentae Investigated by Immunostaininq.
There are two instances in which the pattern of 
staining of class I antigens differs from that of human 
placenta. Firstly, in vivo studies by Chatterjee-Hasrouni and 
Lala (1982) using radiolabelled anti-class I antibodies 
showed positive signals in the labyrinthine trophoblast 
(exchange area) rather than in the spongiotrophoblast but
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these studies have not been confirmed. Secondly, Stern et 
al. (1987) found class I molecules on baboon villous 
syncytiotrophoblast using monoclonal antibodies raised to 
human MHC determinants.
Jenkinson and Owen (1980) detected very low levels 
of H-2 antigens on 13-14 day labyrinth (counterpart of human 
villous trophoblast) and clear expression on the 
spongiotrophoblast (major placental cytotrophoblast region) 
which is accessible to the maternal circulation. Rat 
placenta expresses an apparently non-classical class I 
antigen (Pa) which is found predominantly in the 
spongiotrophoblast region (Ho et al. 1987; MacPherson et al. 
1986) and seems to have the classical molecular weight (Ghani 
et al. 1984). The use of allospecific mouse anti-rat 
monoclonals has led to the detection of paternally-inherited 
class I antigens on spongy-zone trophoblast. No staining of 
rat labyrinthine trophoblast was observed even with a 
monoclonal recognizing a monomorphic determinant of RTla 
(Billington and Burrows, 1989).
1.2.6. Immunoprecipitation and Western Blot Studies of Class 
I Expression on Placentae and Choriocarcinomas.
It is now apparent that the antigens expressed on 
certain trophoblast subpopulations in some species are not 
always classical MHC structures. The first indication of 
this was when 61D2 did not register any reactivity with class 
I positive cells as described above. Immunoprecipitation 
(using W6/32 and 61D2) and electrophoretic studies have added 
weight to this observation since some of the class I 
molecules have a lower molecular weight (40-41kDa) than do 
the classical class I antigens. Immunoprecipitation studies 
have shown that the class I heavy chains on both human 
chorionic cytotrophoblasts, a human choriocarcinoma cell line 
BeWo (Ellis et al. 1986) and on baboon syncytiotrophoblast 
(Stern et al. 1987) are approximately 40kDa and 41kDa 
respectively. Stern et al. (1988), immunoprecipitated 45kDa 
and 41kDa components from the human choriocarcinoma cell 
line, BeWo which were both associated with B 2 ~m. Billington 
and Burrows, (1989) also have evidence for the existence of a 
40kDa class I molecule as well as a 45kDa component detected 
by Western blotting on trophoblast enriched rat placental
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cells.
Together these data suggest that trophoblast 
expresses a novel class I antigen in addition to an 
apparently classical antigen. There is the possibility that 
the smaller molecule may be the product of a common but 
alternatively spliced classical mRNA or that post- 
transcriptional modifications such as differential 
glycosylation have occurred. Stroynowski et al. (1987), have 
reported that the Q7 gene product is anchored into liver cell 
membrane by a phosphatidyl inositol tail rather than the more 
conserved transmembrane region (section 1.1.5 and 1.1.7). 
The Q7 gene product has a molecular weight of 40kDa and so it 
may also be possible that the smaller 40kDa component has 
been inserted into the trophoblast membrane by a similar
mechanism. It is notable that the products of the mouse H-2
Q region genes are of a lower and similar molecular weight 
(reviewed Lew et al. 1986a). This work will be referred to
in the final discussion.
1.2.7 Regulation of Class I Expression on Trophoblast.
Anderson and Berkowitz (1985) found that the weakly 
HLA positive human choriocarcinoma cell line, BeWo, showed a 
marked increase in class I expression after incubation with 
the supernatants of PHA activated lymphocytes. Neither PHA 
alone or non-activated lymphocyte supernatant reproduced this 
effect. Subsequent to this they illustrated that IFN-gamma 
enhanced the expression of class I MHC antigen in BeWo after 
long term exposure (upto 30 days with 1,000 or 5,000U/ml). 
The HLA negative choriocarcinoma cell line, Jar, was not
responsive to this lymphokine, although it is not known
whether this cell line has gamma-interferon receptors. This 
implied that some degree of constitutive MHC expression may 
be a pre-requisite for IFN mediated antigen modulation in 
some trophoblast cell lines. These observations suggest that 
some trophoblast subpopulations regulate the expression of
class I molecules by different mechanisms. Although this
area of research is still not fully understood it is likely 
to involve complex regulatory mechanisms which vary between 
cell types and location.
Hunt et al. (1987) showed that syncytiotrophoblast
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explants of.normal placental villi could not be induced to 
express class I antigens with IFN-gamma although enhancement 
of mRNA synthesis occurred in foetal stromal cells and JEG-3 
choriocarcinoma. Hunt et al. (1987) suggested that at least 
in one respect a parallel could be drawn since some malignant 
(BeWo and JEG-3) and normal (primarily extravillous) 
trophoblasts expressed class I antigens, whereas other 
malignant (Jar) and normal (villous) trophoblasts did not. 
Zuckermann and Head, (1986) was able to show that gamma- 
interferon enhanced class I expression on short term cultures 
of mouse spongiotrophoblast from mid-gestation.
Methylation of cytosine residues of DNA has been 
proposed as a mechanism for permanent inactivation of 
eukaryotic genes (Razin and Riggs, 1980). Genomic DNA 
purified from the normally MHC-negative Jar cell line would 
not support the expression of class I MHC genes after 
transfection into recipient L cells as would other genomic 
DNA. Further work in this area using 5-azacytidine 
inhibition of DNA methylation in Jar cells restored the 
ability of the DNA to render L cells positive for class I MHC 
antigens (reviewed in Head et al. 1987). If the class I 
molecules that are expressed are capable of eliciting a 
destructive immune response, then their permanent switching 
off on certain spatially vulnerable trophoblasts would 
certainly be beneficial to the foetus, since it is known that 
high levels of type I interferons are now known to exist in 
human placentae (Chard et al. 1986; Duc-Goiran et al. 1986).
Thus it appears that class I antigens are expressed 
on trophoblasts of several species and they appear to be 
regulated at least in some cases to trophoblast outside the 
major materno-foetal exchange area. The functional 
implications of restricted expression are unknown. However, 
it is important to remember that the lack of MHC antigens on 
some trophoblast cell populations may not be so exceptional 
since other cell types show regulation to varying degrees 
(Daar et al. 1984) and so it becomes clearly important that 
the exact function of class I molecules on trophoblast needs 
to be determined.
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1.2.8 Alms of the Present Work.
Since class I antigens are known to evoke allograft 
rejection, their expression on placenta has raised many 
interesting questions concerning the immunological 
relationship between the mother and semi-allogeneic foetus. 
At the beginning of this study, our knowledge extended to the 
fact that the class I antigen expressed on extravillous 
trophoblast did not cross-react with 61D2 or antibodies 
specifically directed towards the foetal HLA phenotype. The 
work described in this thesis was concerned with the 
characterization and molecular cloning of human class I 
cDNA's expressed on a malignant form of cytotrophoblast; the 
choriocarcinoma JEG-3. It was hoped that the sequence of the 
class I cDNA(s) obtained would shed light on the nature of 
the molecule(s) expressed and ultimately afford clues as to 
the function.
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CHAPTER TWO.
2.1 STERILIZATION
Growth media were sterilized by autoclaving at 
120°C for 15 minutes, supplements and buffer solutions at 
108°C for 10 minutes and CaCl2 at 114°C for 10 minutes. Heat 
sensitive reagents were sterilized by filtration using 
disposable 0.45um membrane filters. Plastic-ware was 
sterilized by autoclaving at 120°C for 90 minutes.
2.2 CHEMICALS 
Chemicals
General Chemicals and 
solvents
Media
Biochemicals 
Agarose(s)
Radiochemicals 
Antibiotics 
Restriction Enzymes
DNA-modifying Enzymes
o
En^hance
Tissue Culture Media
2.3 BUFFER SOLUTIONS 
TE: lOmM Tris-Cl, ImM EDTA pH8
20xSSC: 3M NaCl, 300mM Sodium Citrate, pH7.
20XSSPE: 3.6M NaCl, 200mM NaH2P04 , 20mM EDTA (pH 7.4).
IOxTAE: 0.04M Tris-acetate, 0.001M EDTA
Protein Loading Gel Buffer: 5% SDS, 50% Glycerol, 0.01%
Bromophenol Blue, 50mM Tris (pH6.8), made upto 5% beta-
mercaptoethanol immediately prior to use.
2.4 BACTERIAL STRAINS
All are derivatives of Escherichia coli K-12 and 
are listed below.
HB101:F-, hsdS20 (rB , mB ) recA13, ara-14, proA2, lacYl, 
galK2, rpsL20 (Smr ), xyl-5, mtl-1, supE44, lambda- . Boyer, H
Source
B.D.H., Hopkins and 
Williams, Kochlight 
Laboratories, May and 
Baker.
Difco, Oxoid
Sigma, Pharmacia, BRL.
BRL.
NEN
Sigma
BRL, Boehringer mannheim 
Pharmacia.
BRL, Boehringer mannheim 
Dupont
Gibco, Northumbria 
Biologicals.
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W and Roulland-Doussoix, D. (1969).
JM101: (supE, thi (lac proA,B)/F' TraD36 proA,B lacl^ Z _M15) 
(Yannish-Perron et al. 1985) was used for experiments with 
M13mp-derived bacteriophage vectors.
L87: in Huynh et al. (1985); Scherer et al. (1981).
NM514:_Hf1 Murray et al. (1977).
2.5 ANTIBIOTICS
The concentrations of antibiotics used for both 
liquid and plate selections were as follows:- 
Antibiotics Selective cone11 Stock cone11 Storage temp.(°C) 
Ampicillin 50ug/ml 5mg/ml (water) -20
Tetracycline lOug/ml Img/ml (50% EthOH) -20
2.6 BACTERIOPHAGES
Lambda gtlO: genotype lambda srllambda 1° b527 srl lambda 3° 
imm434 (srI434+ ) srl lambda 4° srl lambda 5°. Lambda gtlO was 
constructed by in vitro techniques using the left arm of
lambda 518 and the right arm of lambda 607. (Hyunh et al.
1985). Lambda gtlO (imm434 b 527) contains a single EcoRI 
site within the phage repressor gene, cl.
M13mpl8: Cloning vector derived from M13 and used for
sequencing. (Norrander et al. 1983; Yannish-Perron et al.
1985). The vector contained the alpha-fragment of the lac Z 
gene that was able to complement the lac Z, _M15 deletion in 
bacterial host strains JM101. The loss of lac Z
complementation (beta-galactosidase activity) by insertion 
mutagenesis allowed the selection of recombinant (white) 
plaques and colonies according to the blue/white colour test 
depending on the action of beta-galactosidase on the 
chromogenic substrate, X-gal.
2.7 INDICATORS
X-gal (5-Bromo-4-chloro-3-indolyl-B-galactoside)
was used with the inducer IPTG and the host strain JM101 with 
M13 vectors. This provides a screen for insert containing 
vectors in the polylinker region. Recombinants are white 
against blue coloured parental vector. X-gal was stored in 
dimethylformamide (DMF) at -20°C and added to top agar at a 
concentration of 300ug/ml. IPTG was added to a top agar to a 
final concentration of 150ug/ml.
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2.8 MAMMALIAN CELL CULTURE
Cell Lines: JEG-3 Choriocarcinoma (Kohler and Bridson, 1971).
KN2  Namalva Lymphoblastoid Cell Line.
Culture Media: Both cell lines were maintained in RPMI Medium 
supplemented with 10% foetal calf serum and made upto 5 
litres as follows -
3850ml h 2o
450ml Foetal calf serum (Gibco)
450ml 10 x RPMI
75ml 1M NaOH
112.5ml Hepes (1M pH7.5)
50ml Glutamine (200mM)
50ml NaHC03 (7.5%)
90ml Penicillin/Streptomycin (10^U:10^ug/ml)
9ml Gentomycin Sulphate (50mg/ml)
2.25ml B 2 -mercaptoethanol (50mM)
conditions: Cells in routine culture were maintained
in 25cm^ plastic culture flasks (Falcon) under 10ml of medium 
at 37°C in an atmosphere containing 7%C02* The substrate 
cells were passaged (xl/4) when approaching confluency 
approximately every three to four days.
In order to pass cells the medium was apirated 
away. After washing with 10ml PBSA, the cells were 
subsequently detached by treatment with 1ml trypsin-versein 
for one minute. The cells were dislogded by gently tapping 
and were subsequently divided appropriately into new flasks 
with 10ml fresh medium. Fresh cultures were initiated with 
1/4 dilutions.
Large 75cm^ culture flasks were used for quickly 
growing stocks - all solutions used were scaled up 
accordingly.
PBSA 5mM NaHP04
7.5mM KH2P04 
2.75mM KCl 
170mM NaCl
Trypsin-Versein 0.025% Trypsin
500um EDTA 
0.0015% Phenol Red in PBSA
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2.9 MONOCLONAL ANTIBODIES.
W6/32 - Mouse anti-human leucocyte antigen (HLA)
directed against a HLA-A, -B and -C shared determinant (Sera-
lab) .
61D2 - Mouse anti-human leucocyte antigen (HLA)
obtained from BRL, Inc. Ugolini et al. (1981).
BM-63 - Mouse anti-human Beta2 “microglobulin (Bio
Yeda).
2.10 IMMUNOPRECIPITATION
This method followed the procedure outlined in 
Thompson et al. (1984) and is approximated for 
immunoprecipitation for ten samples.
Near confluent cells were removed from the tissue 
culture flask by trypsinization as described in section 2.8, 
and washed three times in a generous volume of PBS by 
repeated low speed centrifugation and resuspended to 2x10 
cells/ml PBS. Surface labelling was done collectively. 5ul 
lOOuM KI, 20ul 9% glucose (fresh) and 40ul glucose oxidase 
(G6500 Asp Nigeria type V from Sigma) were added to the cells 
follewed quickly by 20ul lmg/ml lactoperoxidase in PBS 
(Sigma). 5ul (500uCi) 125I-NaI (IM530-Amersham) was added 
and the contents mixed well before incubating at room 
temperature for 45 minutes. The labelled cells were washed 
•four times with PBS and transferred to a fresh tube. The 
supernatant was poured off and the cells finally resuspended 
in 1ml 0.5% NP40 in TBS (pH8.1) and lul PMSF. After 
incubation on ice for ten minutes, and centrifugation, the 
supernatant (approx. 1ml) was divided equally amongst the ten 
tubes (for ten antibodies). To lOOul supernatant, lOul of 
the appropriate antibody was added and this was left to 
incubate at room temperature for 30 minutes. 50ul of a 50% 
(w/v) suspension of protein A-Sepharose (Pharmacia) in 1% 
(v/v) NP40 in PBS and the samples were incubated again at 
room temperature for 30 minutes. Unbound material was gently 
centrifuged away from the Sepharose beads by five washes at 
4°C in 2.5ml 1% (v/v) NP40 in 50mM Tris.HCl (pH7.4), 0.15M
NaCl, 5mM EDTA and 0.02% (w/v) NaN3 . The antigen-antibody 
complexes were released from the beads by 50ul 2x SDS/PAGE 
sample buffer (no 2-mercaptoethanol), and the supernatants 
were boiled after the addition of 5% (v/v) 2-mercaptoethanol 
before loading for electrophoresis.
54
2.11 PROTEIN GEL ELECTROPHORESIS
Protein electrophoresis followed the procedure 
of Laemmli (1970). The samples were prepared by adding half 
the volume of protein gel loading buffer. Gel plates were 
separated with 0.8mm spacers. The running gel was poured 
leaving a 2cm gap between the top of the running gel and the 
top of the rabbit-eared smaller glass plate. 2% SDS was 
gently layered on top of the running gel to create a sharp 
interface. When the running gel had set, the stacking gel 
was poured and the comb put in position. After removing the 
comb the running buffer was poured into the gel tank to cover 
the wells. Residual acrylamide was flushed gently out of the 
wells. The gel was run until the blue dye had reached the 
bottom of the gel (approximately 40mA for 4 hours). The gel 
was then fixed in 35% methanol/10% glacial acetic acid for 1 
hour before being soaked in EN3HANCE for a further hour. The 
EN3HANCE was removed and the gel soaked in water for 30 
minutes before being vacuum dried onto Whatman 3MM paper and 
autoradiographed at room temperature against Kodak X-Omat S 
film.
Resolving Gel Buffer (RGB): 3M Tris-HCl pH8.8
Stacking Gel Buffer (SGB): 0.5M Tris-HCl pH6.8
10% Acrylamide Gel (30ml):
15.75ml water
225ul 10% fresh ammonium persulphate 
0.3ml 10% SDS 
3.75ml RGB
10ml 30% Acrylamide:Bisacrylamide (30:0.8)
+
15ul TEMED
Mix well.
4% Stacking Gel (20ml):
12.15ml Water
150ul 10% fresh ammonium persulphate 
0.2ml 10% SDS 
5ml SGB
2 . 5ml 30% Acrylamide:Bisacrylamide (30:0.8)
+
15ul TEMED
Running Buffer: 14.4g glycine, Ig SDS, 3.03g Tris-base in 1 
litre of distilled water.
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2.12 PREPARATION OF RNase-FREE SOLUTIONS AND APPARATUS
Ribonuclease activity was minimised during the 
preparation of RNA by treatment of solutions with 0.1% 
diethylpyrocarbonate (DEPC - Sigma) overnight and autoclaving 
twice. DEPC is unstable in the presence of tris buffers and 
so these solutions were made up with chemicals which were 
kept out of general use and so less likely to be contaminated 
with ribonucleases.
Glassware was baked overnight at 200°C.
Where possible sterile disposable plastic-ware was 
used (free from RNase).
2.13 PREPARATION OF RNA
This procedure is outlined in Maniatis et al.
(1983) ppl96 and takes advantage of the powerful denaturing 
properties of guanidinium isothiocyanate. This is a very
dangerous substance - wear gloves to cover the wrists and a 
full face mask!
4ml ice cold guanidinium isothiocyanate solution 
were added to a small cell pellet and vortexed until the
pellet had completely dissolved. Leave on ice for 15
minutes. Meanwhile prepare 1.2ml CsCl cushion in a 6ml SW50 
tube carefully so that none of this solution splashes up the 
sides of the tube.
Ig CsCl per 2.5ml cell homogenate was added and 
this was layered very slowly/carefully onto the cushion. 
Keep tubes upright and steady. Centrifuge at 35,000 rpm for 
12 hours at 20°C using the SW50.1 swing out rotor.
After centrifugation keep tubes upright and steady 
(use a rack and a piece of plasticeine) and remove the lipid 
"plug" which invariably forms (best done with a small rolled
up piece of tissue) and carefully suck off the rest of the
homogenate (in one attempt) using a wide pipette. 
Chromosomal DNA can be seen at this stage. With a fresh 
pipette remove the cushion very carefully and then tip the 
tube upside down on tissue paper to drain.
Use a new scalpel to cut off the bottom of the tube
to form a small cup. The RNA is usually visible as a glassy
pellet. Carefully flush the pellet with 80% ice cold ethanol 
(to flush away some of the CsCl). Usually, the pellet 
becomes white around the edges at this stage (due to 
contaminating proteins etc.) and is easily removed into a
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large 1.5ml eppendorf. Dry very briefly under vacuum. 
Resuspend the pellet in 0.6ml TE at 55°C and extract and re­
extract with an equal volume of phenol:chloroform:iso-amyl 
alcohol, (v/v) 25:24:1. The remaining aqueous phase (0.4ml) 
is precipitated with 0.1 volumes Na-Acetate pH5.2 and 2.5 
volumes ethanol at -20°C for 2 hours. Microcentrifuge for 30 
minutes and wash twice with 70% ethanol. Re-centrifuge for 5 
minutes and vacuum dry (do not overdo this!). Resuspend in 
either water or 0.lxTE and store at -70°C. Determine the 
amount of RNA by spectrophotometry; O.D^go is equivalent 
to 40ug/ml. Pure preparations of RNA have an O.D.260/280 
contaminating proteins reduce this value. Eukaryotic RNA of 
high quality shows three distinct bands corresponding to 28s, 
18s ribosomal and tRNA. Messenger RNA (mRNA) comprising 5% 
of total RNA can be seen as a background glow around the 
ribosomal RNA bands.
Guanidinium isothiocyanate solution:
4M Guanidinium isothiocyanate 
5mM Na-Citrate pH7 
lOmM EDTA
0.1M beta-mercaptoethanol
0.5% sarkosyl (Na-N-laurylsarcosine)
Caesium Chloride cushion:
5.7M CsCl 
lOmM EDTA
2.14 AGAROSE GEL ELECTROPHORESIS
Various sizes of agarose gel were used in this 
study and agarose concentrations varied from 0.5% to 1.5% 
(w/v) depending on the size of the fragments to be resolved 
(see below).
Amount of agarose in Efficient range separation
gel (%) of linear DNA molecules (Kb).
0.3 60 - 5
0.6 20 - 1
0.7 10 - 0.8
0.9 7 - 0.5
1.2 6 - 0.4
1.5 4 - 0.2
2.0 3 - 0.1
The rate of linear duplex migration is inversely
proportional to the log10 molecular weight. The extent of
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superhelical twist in covalent closed circular DNA, and 
whether the DNA is in the single stranded form affects its 
electrophoretic mobility. The concentration of ethidium 
bromide (used for visualization with ultra-violet light) in 
the gel was 0.5ug/ml.
Applied voltages varied between 2-10 Vcm 
depending on the time and resolution required.
Agarose was dissolved by boiling in electrophoresis 
buffer (TBE) replacing lost volume due to evaporation with 
distilled H 2 O. DNA samples were mixed with l/5th volume of 
5xFSB.
10 x TBE pH8.3 89mM Tris-base 
89mM boric acid 
2mM EDTA
5 x FSB 0.25% bromophenol blue 
0.25% xylene cyanol 
30% glycerol in water
2.15 NORTHERN FORMALDEHYDE DENATURING GEL ELECTROPHORESIS FOR 
RNA
Agarose (1-1.5%) was boiled in water and cooled to 
60°C. The appropriate volumes of lOxMOPS and 37% 
formaldehyde (deionized) were prewarmed in a 60^C water bath 
before pouring into the agarose. The final concentration of 
these components in the gel was IxMOPS and 6% formaldehyde. 
Electrophoresis running buffer was IxMOPS.
lOxMOPS 0.2M Morpholinopropanesulphonic Acid (41.8g/l) 
0.05M NaAcetate (4.1g/l)
0.01M Na2EDTA, pH7 (1.86g/l)
Store in the dark - do not autoclave!
FGLB 50% Glycerol
ImM EDTA 
0.4% Bromophenol Blue 
0.4% Xylene Cyanol 
MMF Formamide 500ul
37% Formaldehyde 162ul
lOx MOPS lOOul
H20 238ul
RNA samples (usually between 5-20ug) in small
volumes (not greater than 5ul) were heated for 15mins at 60°C 
after the addition of 30ul MMF. lOul formaldehyde gel 
loading buffer (FGLB) was added to the samples on ice. The
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samples were electrophoresed at 100-150volts for 
approximately 4hrs making sure that the buffer was 
recirculated. RNA samples and linear DNA markers (not 
absolutely accurate) were visualized by staining additional 
sample tracks with ethidium bromide after flushing 
formaldehyde out of the gel with five changes of water over a 
one hour period.
2.16 NORTHERN TRANSFER AND DOT BLOTTING.
After electrophoresis, the formaldehyde gel was laid 
upside down (samples have less distance to travel during 
blotting) on a support fed with transfer buffer (20xSSC). 
Filter paper or nappies were used to absorb the transfer 
buffer through the gel. Pal Biodyne^ membrane (nylon) was 
used to collect samples. The membrane was baked for one hour 
at 80°C.
20xSSC ph7 3M Nacl
0.3M Sodium citrate
For dot blotting, RNA samples were resuspended in
200ul 50% Formamide, 5xSSPE and denatured by heating (65°C
for ten minutes) before applying to the membrane. The
membrane was baked for one hour at 80°C.
2.17 NORTHERN FORMALDEHYDE PREHYBRIDIZATION AND HYBRIDIZATION
See Chapter 4 for optimization of this protocol.
The following prehybridization/hybridization
solution was empirically derived from existing protocols by 
varying the concentration of some of the components. It was 
hoped that the background level of hybridization could be 
reduced to a minimun as this was a serious problem when 
detecting very low levels of mRNA with probes of high 
specific activity. Prehybridization of filters was at 42°C 
in a plastic bag placed in a gently shaking water bath for at 
least 4 hours. Fresh hybridization solution was prepared and 
the denatured probe (by boiling for 5 minutes) added to it 
before pouring over the filters. Do not pour undiluted probe 
onto filters because this often results in splodgy background 
after autoradiography.
Pre/hybridization solution: 5x SSPE
50% Formamide 
lOx Denhardts
59
200ug/ml denatured salmon sperm 
lOOx Denhardts: 2% (w/v) BSA (bovine serum albumin)
2% (w/v) Ficoll
2% (w/v) Polyvinyl pyrollidone
Dissolve the BSA first!
It is very necessary to recirculate the gel tank 
buffer during formaldehyde gel electrophoresis since MOPS is 
known to be a weak buffering agent. Although fairly tight 
signals were obtained upon hybridization, these can be 
apparently improved by recirculating the buffer much more 
quickly.
Since mRNA constitutes only 5% (approximately) of 
total RNA, large amounts (upto 20ug) are required for 
electrophoresis especially if the mRNA of interest is 
expressed at relatively low levels. 20ug total RNA are 
generally loaded onto the gel in volumes of approximately 
40ul and consequently the gel wells become quite full. 
Unfortunately, formaldehyde leaches out of the gel during the 
running period and results in a concentration gradient. 
Consequently, part of the sample at the top of the well/gel 
(less formaldehyde due to leaching) migrates slightly quicker 
than the part of the sample which has sunk to the bottom of 
the well/gel (higher concentrations of formaldehyde). 
Visualization of DNA markers on formaldehyde gels using 
ethidium bromide revealed that they sloped in the direction 
of travel. This effect was not due to sloping gel wells and 
can be seen in figure 4.2.4. Formaldehyde was included in 
the running buffer and was found to alleviate the problem.
2.18 CULTURE MEDIA AND MICROBIOLOGICAL GROWTH CONDITIONS 
Culture Conditions: All liquid cultures were grown at 37°C
with vigorous shaking. Plates were incubated overnight at 
37°C upside down.
Storing Bacterial Cultures: Bacterial strains were stored in 
85% L-broth, 15% glycerol (v/v) at -20°C in a tightly sealed 
bijoux.
L-Broth: lOg tryptone, 5g yeast extract, 5g NaCl, lg
Glucose, 20mg thymine, made upto 1 litre in distilled water 
and adjusted to pH7 with NaOH.
L-Agar: As L-Broth without glucose and the addition of 15g/l
agar.
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Reagents used with Lambda phacre
L-Broth: lOg bactotryptone, 5g bacto-yeast extract, lOg NaCl, 
dissolve in 800ml, pH to 7 and make up to 1 litre.
L-agar plates: As L-Broth with the addition of 15g bacto-
agar.
Top agar: lg bactotryptone, 0.5g bacto-yeast extract, 0.5g 
NaCl, 0.25g MgS04 , lg bacto-agar - adjust to pH7 and make 
upto 100ml.
SM Buffer: 5.8g NaCl, 2g MgS04 .7H20, 5ml 1M Tris HCl pH7.5, 
5ml 2% gelatin - dissolve in 800ml water, adjust volume to 1 
litre and sterilize.
Reagents used with M13 ohaae
Minimal Agar: 7g K2HP04 , 2g KH2P04, 4g NH4S04 , 0.25g
trisodium citrate, 0.lg MgS04 .7H20, 17.5g agar, made upto 1 
litre with distilled water.
M9 Salts (xlO): 6g Na2HP04 , 3g KH2P04 , 0.5g NaCl, lg NH4Cl
in 1 litre of distilled water.
M9 Minimal Medium: 10ml M9 salts, 2ml glucose (20% w/v),
0.1ml 1M MgCl2, 0.1ml lOOmM CaCl2, 0.1ml (lmg/ml) vitamin Bl, 
2.5ml 20% casamino acids, made upto 100ml with distilled
water.
When required, supplements were added to minimal 
media to the following concentrations:- glucose 2mg/ml, 
thiamine vitamin Bl 20ug/ml.
YT Broth (x2): lOg tryptone, lOg yeast extract, 5g NaCl made
upto 1 litre with distilled water.
Phage Buffer: 7g Na2HP04, 3g KH2P04, 5g NaCl, 0.25g MgS04 ,
15mg CaCl2 .2H20, 1ml 1% gelatin made up to 1 litre in 
distilled water.
2.19 PREPARATION OF COMPETENT CELLS FOR TRANSFORMATION
Plasmids were introduced into strains by genetic 
transformation. A fresh culture of the recipient strain was 
grown from an overnight in 50ml L-Broth to an O.D. of 2.5x10 
cells/ml. The cells were harvested (12000g, 10 minutes, 4°C) 
and resuspended in lOmL 50mM CaCl2 and kept on ice for at 
least for 15 minutes. After recentrifugation, the cells were 
resuspended in 2.5ml 50mM CaCl2 and kept on ice for 15 
minutes before use. 200ul of this cell suspension was added 
to plasmid DNA to be transformed and left on ice for one 
hour. After heat shocking (2 minutes at 42°C) the cells were 
returned to ice for a further 15 minutes. An equal volume of
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L-broth was added and the cells were incubated for 1 hour at 
37°C to allow for expression of the plasmid resistance genes. 
Recovery for ampicillin selection is not necessary.
2.20 DNA PROBES
pDPOOl: Class I HLA (Sood et al. 1981) partial (1400bp) cDNA 
clone HLA-B7 allele in the Pstl site of pBR322. 
pmS3: Actin incomplete (900bp) cDNA clone for mouse skeletal
muscle actin (Leader et al. 1986) in the Pstl site of pBR322.
2.21 LARGE SCALE PREPARATION OF PLASMID
The following protocol is a modification of the 
method developed by Birnboim and Doly, 1979.
This particular method is based on the differences 
between the large linear chromosome and the closed circular 
covalent plasmid DNA, and uses the differential precipitation 
and selective alkaline denaturation of each.
500ml cultures of stationary phase cells were 
harvested by centrifugation (12000g, 5 minutes at 4°C). The 
pellet was resuspended in 8ml Quick Mix (GTE) containing 
lOmg/ml lysozyme and mixed very gently on ice for 5 minutes. 
16ml (freshly made) NaOH/SDS were added, gently mixed and 
left on ice for a further 5 minutes. 12ml cold 5M Na Acetate 
pH4.8 were added gently and the mixture was left on ice for 5 
minutes. The mixture was transferred to 50ml plastic Oak 
Ridge centrifuge tubes and centrifuged twice to precipitate a 
white floccular pellet (cell debris and most of the 
chromosomal DNA) at 32000g, for 15 minutes at 4°C. The 
supernatant was equilibrated to room temperature and 0.6 
volumes isopropanol was added. This was left to stand for 15 
minutes. A JA-20 rotor was prewarmed (so no salts were 
precipitated which contaminate the pellet) and centrifuged at 
39200g, for 30 minutes. The supernatant was poured off and 
the pellet flushed with 5ml 70% ethanol before vacuum drying. 
The pellet was resuspended in 8ml TE pH8 at 37°C if necessary 
and lg CsCl per 1ml of solution was added. For every 10ml of 
this salt/DNA solution, 0.8ml lOmg/ml ethidium bromide was 
added. The final density was checked and adjusted to 1.56-
1.60g/ml. The gradients were centrifuged in a Beckman Ti70 
fixed angle rotor at 200,000g for 16 hours at 20°C. Two 
bands were visible, a lower supercoiled plasmid band and an 
upper chromosomal band and relaxed plasmid DNA band. The
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lower band was obtained using a 5ml syringe and the ethidium 
bromide was removed by repeated extractions with water 
saturated iso-amyl alcohol. The salts were dialysed with 
repeated 500ml TE pH8 changes at 4°C.
Quick Mix (GTE): 50mM Glucose
25mM Tris.Cl (pH8) 
lOmM EDTA 
add lysozyme fresh (lOmg/ml)
NaOH: 0.2M NaOH
1% SDS
make up fresh 
5M K-Acetate pH4.8: 60ml 5M K-Acetate
11.5ml glacial acetic acid 
28.5ml H20
2.22 PHENOL/CHLOROFORM EXTRACTION
Proteins and lipids were removed from nucleic acid 
samples by extraction with buffer-saturated phenol, 
phenol:chloroform (1:1, v/v) and chloroform. Each extraction 
was centrifuged for 5 minutes to partition the organic and 
aqueous phase. Residual chloroform was removed by ether 
extraction, and in turn, this waw removed by either 
incubating for a brief period at 55°C or ethanol 
precipitation.
2.23 ETHANOL PRECIPITATION
One tenth volume of 3M Na-Acetate pH5.2 and 2.5 
volumes of -20°C ethanol were added to the nucleic acid 
solution and stored at -20°C for at least 1 hour. Nucleic 
acids were pelleted by micro-centrifugation for 15-30 minutes 
depending upon the concentration of the sample and are washed 
with cold 70% ethanol. After re-centrifugation, the pellet 
was vacuum dried briefly and resuspended in the appropriate 
buffer or water.
2.24 RESTRICTION OF DNA
Restriction endonuclease digests of DNA were 
routinely carried out in the appropriate buffers specified 
below.
lOx Low Salt Buffer: lOOmM Tris-Cl pH7.5
lOOmM MgCl2 
lOmM DTT
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lOx Medium Salt Buffer: lOOmM Tris-Cl pH7.5
50mM NaCl 
lOOmM MgCl2 
lOmM DTT
lOx High Salt Buffer: 500mM Tris-Cl pH7.5
1M NaCl 
lOOmM MgCl2 
lOmM DTT
lOx Sma I Buffer: lOOmM Tris-Cl pH8
200mM KCl 
lOOmM MgCl2 
lOmM DTT
The following KGB buffer can be used sequentially 
for different enzymes and was extremely useful when ligating 
fragments after their’ restriction. Both potassium and 
glutamate are effective buffering ions and most restriction 
endonucleases, polymerases and ligases show broad K-Gluc 
concentration optima and all enzymes function in lxKGB 
(McClelland et al. 1988).
lOx KGB: 1M K-Glutamate
250mM Tris-acetate pH7.6, 
lOmM Mg-Acetate 
500ug/ml BSA
5mM 2-mercaptoethanol.
2.25 ENZYMES AND STANDARD BUFFERS USED IN THIS STUDY TO
SYNTHESIZE, MODIFY AND RADIOACTIVELY LABEL NUCLEIC ACIDS 
DNA Dependent DNA Polymerases
E. coli DNA Polymerase I - all DNA polymerases add
deoxyribonucleotides to the 3'-hydroxyl terminus of a primed 
double-stranded DNA molecule - synthesis is exclusively in a 
5' to 3 1 direction with respect to the synthesized strand.
Many DNA polymerases have 3 1 to 5' exonuclease activity
inherently associated with polymerase activity, though this 
is influenced by the concentration of free dNTP's. Some DNA 
polymerases e.g. E. coli DNA Polymerase I, also have an 
associated 5 1 to 3 1 exonuclease activity which degrades
double-stranded DNA from a free 5' hydroxyl end. The large 
fragment of E. coli DNA Polymerase I which has been modified
so that it does not retain the 5 1 to 3 1 exonuclease activity
is known as the Klenow fragment. The Klenow fragment has
been used to label 3 1 ends of DNA molecules and in random
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oligonucleotide primed synthesis. E. coli DNA Polymerase I 
has been used in the synthesis of second strand of cDNA. 
lOx E. coli DNA Polymerase I or klenow fragment buffer:
0.5M Tris.Cl, pH 7.5 
0.1M MgCl2 
lOmM DTT 
0.5mg/ml BSA
T4 DNA Polymerase has a very active single- and double­
stranded 3' to 5' exonuclease activity (though lacks 5* to 3' 
exonuclease activity). This enzyme has been used in this 
study to convert the ends of cDNA to blunt ended structures. 
lOx T4 DNA Polymerase buffer 
0.5M Tris.Cl, pH8 
50mM MgCl2 
50mM DTT 
0.5mg/ml BSA 
Template-Independent DNA Polymerases
Terminal Deoxynucleotidyltransferase (terminal transferase)
This enzyme catalyzes the incorporation of deoxynucleotides 
to the 3 ’-hydroxyl termini of DNA (releasing inorganic 
phosphate). A template is not required.
This enzyme would have been used in the strategy 
which has been described in Chapter 7. 
lOx Terminal Transferase buffer
1M sodium cacodylate, pH7 
lOmM CoCl2 
ImM DTT 
0.5mg/ml BSA 
RNA-Dependent DNA Polymerases
Avian myeloblastosis virus (AMV) reverse transcriptase was
used in this work to reverse transcribe mRNA into first 
strand cDNA. Typically derived from retroviruses the reverse 
transcriptases use a primer on RNA to extend the 
complementary DNA strand. 
lOx Reverse Transcriptase buffer 
0.5M Tris.Cl pH8 
50mM MgCl2 
50mM DTT 
0.5M KCl 
0.5mg/ml BSA 
Phosphatases and Kinases
Calf Intestinal Phosphatase (CIP) catalyzes the hydrolysis of
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5'-phosphate residues of DNA, RNA and ribo and 
deoxyribonucleoside triphosphates, leaving 5 1-hydroxyl 
termini. CIP was used in this study for the 
dephosphorylation of M13 linear DNA to prevent self-ligation 
during subcloning. 
lOx CIP buffer
0. 2M Tris.Cl, pH8 
lOmM MgCl2 
lOmM ZnCl2 
0.5mg/ml BSA
T4 Polynucleotide Kinase catalyzes the transfer of the 
terminal (gamma) phosphate of ATP to the 5'-hydroxyl termini 
of DNA and RNA. This reaction is very efficient and was used \ 
to label 5 1 ends of the dephosphorylated oligonucleotide used 
for primer extension experiments. 
lOx Kinase buffer
0.5M Tris.Cl, pH7.5 
0.1M MgCl2 
50mM DTT 
0.5mg/ml BSA 
DNA Liaases
T4 DNA Ligase catalyzes the repair of single strand nicks in 
duplex DNA and joins duplex DNA restriction fragments having 
either blunt or cohesive ends. It uses ATP as a cofactor. 
This enzyme was used for cloning cDNA into lambda gtlO and 
for subcloning the cDNA clones into M13mpl8. 
lOx T4 DNA Ligase buffer
0.5M Tris.Cl, pH7.5 
0.1M MgCl2 
0.1M DTT 
0.5mg/ml BSA
2.26 RANDOM PRIME LABELLING
This method follows the procedure outlined in 
Feinberg and Vogelstein, 1983. The restricted DNA fragment 
was cut from a low melting point gel after sufficient 
separation so as to reduce contamination from other bands. 
Excess gel was removed and the fragment weighed (lug of gel 
slice has an equivalent volume of lul) before heating the 
sample to 65°C. At least five equivalent volumes of either 
dH20 or TE were added. The concentration of the final 
solution was adjusted to lng/ul for convenience. It was
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important to know the amount of DNA in the band isolated. 
The random prime labelling was set up as follows - 
Aul dH20
Bui DNA solution (lOng)
Cul [alpha-32P] dCTP (usually 40uCi) 
lOul "reaction mix" excluding dCTP’s 
2ul BSA
lul Klenow fragment of DNA polymerase I (5 units).
50ul total
A+B+C = 37ul.
"reaction mix" 250mM Tris-HCl
25mM MgCl2
50mM 2 mercaptoethanol 
50uM dATP, dGTP and dTTP 
1M Hepes pH6.6 
1.5mg/ml hexadeoxyribonucleotides
The labelling mixture was incubated 0/N or for 5 
hours at room temperature. Unincorporated nucleotides were 
removed using a sephadex G-50-150 column and Amersham column 
buffer. The probe was denatured by boiling for ten minutes.
2.27 SEPARATION OF mRNA FROM TOTAL RNA USING OLIGO-dT 
CELLULOSE AFFINITY MATRIX
Polyadenylated mRNA can be separated from other RNA 
species using oligo-thymidylic (dT) cellulose (BRL) which is 
a stable affinity matrix specifically designed for this
purpose (Aviv and Leder, 1972). Oligo (dT) cellulose
typically has a poly rA binding capacity of 50 O.D. units/g 
under appropriate high concentration ionic conditions at room 
temperature. Low ionic buffers used at an elevated
temperature (37°C) are sufficient to effect elution of mRNA 
by disrupting hydrogen bonds formed between oligo (dT) and 
the poly A tail of mRNA.
A 5ml plastic syringe, 1 inch soft tubing, 0.5cm 
syringe volume of glass wool and 0.5cm3 sephadex G-50-150
beads were treated with dimethyl-dichloro silane solution 
(repelcote) and baked overnight.
An appropriate but generous (0.4g) amount of dried 
oligo (dT) cellulose powder was suspended in Binding Buffer 
(BB) over a period of 1 hour and poured into the syringe
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(fixed upside down by clamping). A clip was used to regulate 
the flow by attaching it to the soft tubing which was in turn 
attached to the end of the syringe.
Wash the column with 30 volumes Elution Buffer (EB) 
and equilibrate with 30 volumes BB.
An equal volume of 2xBB was added to the RNA sample 
(typically 0.5-lmg) which was heat denatured at 70°C for 1 
minute and rapidly chilled on iced water. After 
equilibration to room temperature the sample was applied to 
the column at a rate of lml/minute. The column was washed 
with BB until no U.V. absorbing material eluted from the 
column. BB was used for the blank standard. The mRNA was
eluted with EB at 37°C using spectrophotometry to locate the 
mRNA-containing fractions. EB was used as the blank 
standard. The fractions were pooled and precipitated 
overnight with 0.1 volumes 4M NaCl and 2 volumes ethanol at - 
20°C.
After microcentrifugation for 30 minutes, the 
pellet was washed with 80% ethanol, vacuum dried briefly and 
resuspended the pellet in sterile RNase free water and frozen 
immediately at -70°C. It was advisable to precipitate using 
a potassium salt if the mRNA was required for cell-free 
translation.
Binding Buffer (BB): 0.5M NaCl
(make up 2x) lOmM Hepes pH7.5
ImM EDTA 
0.1% Sarcosine 
Elution Buffer (EB): lOmM Hepes pH7.5
ImM EDTA
2.28 IN VITRO TRANSLATION
mRNA can be translated in a cell-free system
Pelham and Jackson (1976). Translation of mRNA is carried 
out in the presence of luCi/ul L-[^S]-methionine (NEN) using 
a rabbit reticulocyte lysate obtained from Amersham 
International pic. mRNA is added to the lysate (the lysate 
should comprise 80% of the total volume) with label and
incubated at 30°C for 90 minutes. Half the volume of protein
gel electrophoresis buffer (30% glycerol, 6% SDS, 15% 2
mercaptoethanol, 150mM Tris HCl pH6.7, 0.05% bromophenol
blue) was added and the samples were boiled for 2 minutes
before loading on a 10% SDS-PAGE gel.
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2.29 PREPARATION OF cDNA
The preparation of double stranded cDNA from mRNA 
is based on the method outlined in Gubler and Hoffman, 1983. 
Biological materials, chemicals and various buffers were 
obtained from Amersham International pic. The composition of 
some buffers and solutions are undisclosed. It is important 
to add the components in the order specified. The synthesis 
procedure is divided into two parts.
The synthesis of the first strand cDNA was executed 
in a small 20ul volume whilst the second strand synthesis was 
performed in lOOul (necessary to adjust the buffer 
concentrations). The incorporation of [alpha-32P]dCTP during 
the synthesis of first and second strand cDNA enabled the 
estimation of the amount of cDNA made and its visualization 
using denaturing gel electrophoresis and subsequent 
autoradiography. Although the labelling is optional it is 
very advisable to monitor the reaction during the synthesis 
of both strands and therefore two separate reactions are 
usually set up. The cDNA from each can be pooled after 
analysis and treated singularly in the following steps.
First Strand Synthesis - First strand synthesis buffer 
(typically, lOOmM Tris-HCl pH8.3, 140mM KCl, 6mM MgCl2 , lOmM 
DTT) with sodium pyrophosphate, 20units human placental 
ribonuclease inhibitor, ImM dATP, ImM dGTP, ImM dTTP and 
0.5mM dCTP, 0 . lug/ul oligo-dT^ i 2-18 ) Pr:i-mer/ 20uCi [32P]dCTP 
(optional), lug mRNA, 20units (avian) reverse transcriptase 
and water upto a total volume 20ul. Incubate at 42°C for 40 
mins. lul (l/20th total volume) sample was removed for 
analysis and placed on ice.
Second Strand Synthesis - The following materials were 
added to the first strand synthesis mix on ice - second 
strand synthesis buffer (typically 50mM Tris.Cl pH8, lOmM 
MgCl2, lOmM DTT, 50ug/ml BSA) , 2-OuCi [32P]dCTP (optional), 
0.8units E. coli Ribonuclease H and 23units E. coli DNA 
Polymerase I with water upto lOOul. This was mixed gently 
and incubated sequentially at 12°C for 1 hour, 22°C for 1 
hour and 70°C for ten minutes. 2units of T4 DNA Polymerase 
(per ug of mRNA used) were added and the tube incubated at 
37°C for exactly ten minutes. The reaction was stopped by 
adding lOul 0.25M EDTA pH8 and lOul 10% SDS. 6ul (l/20th 
total volume) sample was removed for analysis.
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Purification of cDNA - Double stranded cDNA was 
extracted twice with an equal volume of phenol:chloroform 
(l:l;v/v) saturated with TE buffer. Two volumes of diethyl 
ether were added to the aqueous phase in order to remove 
traces of phenol:chloroform. An equal volume of 4M ammonium 
acetate was added to the remaining aqueous phase followed by 
twice the combined volume of ethanol. This was chilled on 
dry ice for 15 minutes and microcentrifuged for at least 30 
minutes. The supernatant was removed and resuspended in TE. 
After reprecipitation with ammonium acetate, the pellet was 
washed twice with -20°C ethanol. The pellet was dried, 
resuspended in TE buffer and stored frozen, frozen.
Analysis of cDNA synthesis products - After removing lul 
first strand synthesis (lss) reaction and 6ul second strand 
synthesis (2ds) reaction, the volumes were made upto 20ul 
with TE. lOul of each was used for analysis on alkaline 
agarose gels (see section 2.29). End-labelled DNA markers 
were used for sizing (e.g. lambda Pstl and phi X 174 Haelll).
Calculation of cDNA reaction yields - The remaining lOul of 
the samples removed for analysis were used for the 
calculation of cDNA synthesis yields. For each sample, 2ul 
was spotted onto the centre of each of five 2.4cm discs 
Whatman DE81 and left for 15 minutes to dry. Three of these 
were washed six times in 0.5M NaHPo^, (5 minutes per wash), 
twice in water (1 minute per wash) and twice in 95% ethanol 
(1 minute per wash). The filters were dried thoroughly. The 
two unwashed filters measured the total radioactivity in the 
sample, the three washed filters measured only the 
radioactivity incorporated into nucleic acid. The filter 
discs were counted by liquid scintillation, averages and % 
incorporation of radioactivity (precipitable counts/total 
counts x 100%) for first and second strand synthesis. The 
second strand synthesis % incorporation value (X) was used 
for the calculations outlined below. This value enabled the 
calculation of the amount of cDNA synthesized and hence the 
efficiency of the process.
Percentage of labelled [alpha-*^P]dNTP 
incorporated = X%
Amount of unlabelled dCTP in standard 
(20ul) first strand and (lOOul) second
strand mix* = lOnmoles
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Therefore assume amount of unlabelled 
dCTP incorporated
Total amount of dNTP1s incorporated 
Assume residue molecular weight of 
dNTP1s (lmole)
Therefore weight of cDNA synthesized 
4Ynmoles
Weight of input mRNA 
Therefore % yield of cDNA
X% of lOnmoles
Ynmoles
4Ynmoles
350g 
350ng x
Ang
Zng
A/Z x 100%
The amount of unlabelled dNTP's does not change 
significantly in the second strand mix.
For good preparations, 15-30% mRNA is transcribed 
into first strand cDNA and this is usually efficiently (90%) 
converted into double stranded cDNA.
2.30 ALKALINE AGAROSE GEL ELECTROPHORESIS 
Agarose gel solution 1.2%
Alkaline tank electrophoresis buffer 
Alkaline loading buffer
50mM NaCl 
ImM EDTA 
30mM NaOH 
ImM EDTA 
50mM NaOH 
ImM EDTA 
2.5% Ficoll 
0.025% bromocresol
This denaturing gel was used in order to electrophorese 
radioactive single stranded DNA. Electrophoresis was carried 
out at voltages upto 7.5v/cm until the dye had migrated one 
third of the length of the gel. At the end of the run the 
gel was soaked in 10% (tri-chloro acetic acid) TCA for 2x30 
minutes at room temperature. The gel was dried down onto 
Whatman 3MM paper and the position of the radioactive samples 
visualized by autoradiography using X-Omat S film.
2.31 CLONING cDNA INTO LAMBDA gtlO - cDNA LIBRARY
Lambda gtlO is an ideal vector for cloning and 
retrieving cDNA's (see Chapter 5). cDNA is normally cloned 
into the EcoRI site of lambda gtlO and so the following 
protocols describe the necessary preparation of the cDNA 
before cloning. Basically, any EcoRI sites that occur within
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the cDNA need to be methylated before the addition of blunt- 
ended EcoRI linkers.
The materials used were purchased from Amersham 
International pic - the composition of some of the buffers 
are undisclosed.
Methylation: lug cDNA (or control blunt ended DNA) 
was methylated in a final volume of 20ul containing s-
adenosyl-methionine, 8ug BSA in typically (50mM Tris HCl 
pH7.5, ImM EDTA, 5mM DTT) and 20units EcoRI methylase, 
incubated at 37°C for 1 hour and inactivated at 70°C for ten 
minutes.
Ligation of Linkers: lug methylated cDNA was
ligated to lug EcoRI linkers and 5 units T4 DNA ligase in a 
total volume of 30ul. This was incubated at 15°C overnight 
(20 hours). The ligase was heat inactivated at 70°C for ten 
minutes. For ligation buffer, see section 2.24.
EcoRI Restriction: The buffer was adjusted in
order to restrict DNA with EcoRI and made up to a final 
volume of lOOul (including lOOunits EcoRI). This was 
incubate at 37°C for 5 hours. EcoRI was heat denatured by 
incubating to 70°C for 10 minutes. After EcoRI digestion (to 
remove multiple ligated linkers) the excess linkers were 
removed using a sephacryl column. The linkered cDNA was be 
ligated into the arms of lambda gtlO.
Separation of EcoRI linkers: A sephacryl column
was equilibrated with STE buffer (lOOmM NaCl, lOmM Tris, ImM
EDTA, pH7.5) and allowed to empty until the meniscus arrived
at the top of the column bed. All of the lOOul sample was 
loaded and allowed to enter the column bed. The lOOul eluate 
was collected in tube 1 (of 10 1.5ul microcentrifuge
eppendorf tubes). 200ul STE was added and eluate collected 
in tube 2. These latter steps were repeated until 10 eluates 
had been collected. The radioactive cDNA was located by 
Cerenkov counting of total 33P dpm. The major two fractions 
which contributed to the cDNA peak were pooled. If samples 
were not radioactive they were run on an agarose gel. The 
cDNA elutes first from the column so it was important not to 
include fractions of the trailing edge since these contained 
progressively more linkers.
Ligation into lambda gtlO: The linkered and
methylated cDNA was ethanol precipitated by adding l/10th 
volume 3M NaAcetate pH5.2 and 2.5 volumes of cold ethanol,
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Left at -20°C for at least 2 hours and microcentrifuged for 
at least 30 minutes. The pellet was washed with 80% ethanol, 
vacuum dried and resuspended in 6ul dH20. The cDNA sample 
was divided into tubes with a volume ratio of 1:2:3 (e.g.
50ng:lOOng:150ng) and each was ligated into lug lambda gtlO 
arms using 2.5 units T4 DNA Ligase in appropriate buffer 
(typically 50mM Tris-HCl ph7.6, lOmM MgCl2 , 5% (w/v)
polyethylene glycol 8000, ImM ATP, ImM DTT) in a volume of 
lOul for 15 hours at 15°C. After ethanol precipitation each 
was carefully resuspended in 2.5ul TE buffer.
Packaging of lambda gtlO: The ligation reaction
was packaged using packaging reactions obtained from Amersham 
International pic following the protocol provided. 0.5ml SM 
buffer (see section 2.18) was added to each followed by lOul 
chloroform - mix very gently and store at 4°C.
2.32 PLATING OF PACKAGED PHAGE
Preparation of phage plating cells: In this case the 
appropriate cells (see Chapter 5) were E. coli L87 and NM514 
and were grown fresh from an overnight culture in L broth 
supplemented with 0.4% maltose until the O.D.6qq reached 0.5 
(2.5xl0®cells/ml). The culture was cooled on ice and 
centrifuged at 3000 rpm for 10 minutes at 4°C. The cells 
were resuspended in ice cold lOmM MgSO^ to a concentration of 
8xl07cells/ml and stored at 4°C.
Titration of recombinants: In order to assess the number 
of successfully packaged lambda bacteriophage a proportion 
of the "cDNA library” was plated out. 30 ul (out of a total 
500ul) was serially diluted on ice in 270ul SM buffer (102) 
until the 107th dilution. lOOul of each type of plating 
cells were aliquoted out for lOOul of each of the dilution 
series above in 5ml glass tubes (lOOul of each remained from 
the dilution series), incubated at 37°C for 15 minutes and 
4ml of liquid top agar was added at 45°C. The contents were 
poured onto prewarmed L-agar plates and after setting, the 
plates were incubated upside down at 37°C overnight. The 
number of plaques on those plates with upto 1000 plaques was 
counted The phage titre per ml was calculated by multiplying 
the numbers of plaques by the dilution number (see Chapter 
5.4 for calculations and explanations).
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2.33 PLAQUE LIFTS
After the appearance of plaques, the plates were 
removedfrom the incubator and chilled for 1 hour at 4°C. The 
plates were returned to room temperature and appropriately 
numbered and position marked filters were placed onto the 
plate surface. After 30 seconds, the filter was peeled off 
with blunt forceps in a controlled manner. Replica filters 
were taken and left on the plates longer by 30 seconds each 
time. The filters were laid plaque side up for 5 minutes on 
Whatman 3MM soaked in denaturing solution (1.5M NaCl, 0.5M 
NaOH) for 5 minutes and then transferred to neutralizing 
solution (3M Na-Acetate ph7, 1.5M NaCl) for a further 5 
minutes. The filters were blotted dry on Whatman 3MM for 30 
minutes and baked at 80°C for one hour.
2.34 SOUTHERN BLOTTING
After electrophoresis and photography, agarose gels 
were soaked in denaturing solution and subsequently in 
neutralizing solution each for 30 minutes. DNA was 
transferred to nylon membranes by capillary action due to 
migrating with 20xSSC from a reservoir through the gel and 
filter into layers of absorbent material (modified from 
Southern, 1975). After transfer overnight, the filter was 
air dried and baked for 1 hour at 80°C.
2.35 AQUEOUS PREHYBRIDIZATION AND HYBRIDIZATION CONDITIONS
The procedures which follow are adapted from 
Southern, 1975 and apply to DNA immobilized on filters either 
after plaque lifting or Southern blotting. The temperature 
at which hybridization occurs (usually 65°C) may have to be 
estimated empirically if the sequences to be detected are 
expected to have relatively low levels of homology to the 
probe being used.
Aqueous pre/hybridization solution
5x Denhardts
5x SSPE 
0.2% SDS
lOOug/ml salmon sperm DNA (non-homologous).
The Tm of hybridization can be estimated using the 
following formula.
Tm = 81.5 + 0.5(%G+C) + 16.6 log[Na+] - (600/L)
(0.6(%formamide)) - (%mismatch)
74
Hybridization was performed at Tm-25°C (often 55-65°C) 
depending on the probes used.
2.36 WASHING OF FILTERS AFTER HYBRIDIZATION
Firstly, filters (either Northern, plaque or 
Southern) -were washed 3x for 2 minutes at room temperature 
with a small volume of lxSSPE, 0.1%SDS to remove free probe.
The stringency of washes was increased by reducing 
the ionic concentration to O.lxSSPE, 0.1%SDS and by 
increasing the temperatures from 42°C, 55°C to 65°C. After 
washing filters, they were sealed damp in a plastic bag and 
autoradiographed using Kodak X-Omat S film for a variable 
length of time depending on the counts. 10 counts per second
was usually adequate for an overnight exposure. The 
stringency of washes was increased according to the number of 
counts retained on the filter. Depending on the nature of 
the experiment and the estimated/expected degree of sequence 
homology, it was often necessary to autoradiograph the 
filters overnight and wash at a higher stringency later. 
If the degree of sequence homology was expected to be low and 
if convenient, it was time-saving to do the experiment, in 
triplicate and wash at different stringencies.
2.37 PREPARATION OF LAMBDA DNA
Phage can be obtained from a plate lysate or a 
liquid culture lysate - the latter is preferable. The 
procedure can be scaled up for large preparations of this 
material.
A single plaque usually contains 106 phage. To 20ml 
exponentially growing culture ( O . D . ^ q q  = 8xl0®cells/ml) (a 
multiplicity of infection (m.o.i.) of 1/1000) single plaque 
was addeed and incubated overnight or until lysis occurred. 
The culture was transferred to a 20ml Oak Ridge centrifuge 
tube and the cell debris spun down at 10,000rpm for 10 
minutes. The supernatant was decanted into a new tube, DNase 
I and RNAase I were added to final concentrations of lug/ml 
and 2ug/ml respectively and incubates at room temperature for 
1 hour.
The concentration of the supernatant was adjusted 
to 1M NaCl and centrifuged at 20,000 rpm for 2.5 hours. The 
phage pellet (glassy in appearance) as resuspended in 2ml 
phage buffer, transferred to a Sarstedt tube and SDS added to
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a final concentration of 0.1%, with protease K to lOOug/ml. 
These were incubates at 65°C for 1 hour. The sample was 
extracted twice with phenol/chloroform as usual by slowly 
roll-mixing for twenty minutes and extracted with
chloroform/iso-amyl alcohol (24:l,v/v). 0.4 volumes 5M
Ammonium acetate and 1 volume isopropanol was added and the 
solution was left for 1 hour at 4°C before centrifuging in
the Centra 4X at maximum speed, 20 minutes. The supernatant
was removed and the DNA pellet washed with 70% ethanol before 
very briefly vacuum drying before resuspending in TE at 37°C.
2.38 PREPARATION OF SINGLE STRANDED AND REPLICATIVE FORM (RF) 
M13 DNA
Single strand and replicative forms of M13 DNA can 
be prepared at the same time.
20ml of an overnight culture of JM101 diluted 100- 
fold in 2xYT broth was infected with a single M13 plaque 
(stored in 0.5ml phage buffer, 4°C section 2.18) and 
incubated at 37°C with vigorous shaking for 5 hours. After 
centrifugation of JM101 cells in 50ml plastic Oak Ridge tubes 
at 10,000 rpm for 5 minutes at room temperature, the 
supernatant was transferred (containing the virus particles) 
to a fresh tube and centrifuged at 14,000 to remove any 
remaining cells and debris. The large cell pellet was used 
to prepare ds RF DNA by the boiling method described in 2.39 
This allowed the identification of recombinant clones by 
restriction enzyme analysis.
The viral supernatant was adjusted to 5% 
polyethylene glycol (PEG 6000) and 0. 5M NaCl.and after no 
more than ten minutes (since longer incubation periods 
precipitate free cellular chromosomal DNA) the pellet was 
centrifuged for 30 minutes at 14,000 at room temperature. 
All traces of supernatant were removed and the viral pellet 
resuspended in 700ul O.lxTE, transferred to a 1.5ml eppendorf 
tube and extracted twice with phenol:chloroform and once with 
chloroform. The interface was avoided by lOOul each time and 
the remaining 400ul aqueous phase was ethanol precipitated. 
The pellet was resuspended in 30ul water and frozen 
immediately. Aliquots were removed beforehand for 
observation on agarose gels.
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2.39 TRANSFECTION OF JM101 WITH M13
This followed the procedure described in section 
2.19 except that after heat-shock, the cells were incubated 
on ice for 15 minutes after which 200ul of fresh log phase 
JM101 culture was added. 5ml of molten soft-agar (pre-cooled 
to 45°C) which contained IPTG (150ug/ml) and X-Gal (300ug/ml) 
was mixed with the cells and plated out onto dried (2 hours) 
plates containing D&M minimal agar, vitamin Bl and glucose.
2.40 MINIPREPS OF PLASMID DNA
Plasmid mini-preps were performed according to the 
method of Holmes and Quigley (1981) which is outlined in 
Maniatis et al. 1983 pp336.
1.5ml of a stationary phase culture containing the 
plasmid of interest was harvested by centrifugation for 1 
minute in an eppendorf. The cells were quickly resuspended 
in 350ul STET buffer (8% sucrose, 0.5% Triton X-100, 50mM 
EDTA, lOmM Tris-Cl, pH8). 25ul freshly prepared lysozyme 
solution (lOmg/ml in lOmM Tris-Cl, pH8) was added and the 
mixture vortexed briefly. After boiling for 40 seconds the 
contents were centrifuged for 15 minutes at 4°C. The pellet 
was discarded using a toothpick and 40ul 2.5M Na-Acetate 
pH5.2 and 420ul isopropanol was added to the supernatant. 
After equilibration to room temperature the supernatant was 
centrifuged and the resulting pellet washed with 70% ethanol, 
re-centrifuged, and vacuum dried briefly. After resuspending 
in 20-50ul TE the DNA was suitable for various in- vitro 
manipulations. If necessary this preparation was phenol 
extracted and treated with 50ug/ml DNase-free RNase.
2.41 DNA SEQUENCING
Sequencing was performed using reagents supplied in 
the BRL M13 Sequencing System and according to the 
instructions provided in the "M13 Cloning/dideoxy sequencing 
Instruction Manual" with one exception. The working 
dideoxynucleotide concentrations were altered to:
O.lmM ddATP 
0.05mM ddCTP
0.5mM ddGTP 
ImM ddTTP
The routine concentrations of ddNTP's were doubled 
to ameliorate reading of the first few bases and diluted to
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ten-fold for reading upto 350 bases.
Also the Sequenase System Version 2.0 (United 
States Biochemical Corporation (USB)) was used according to 
the instructions supplied. Both systems were adapted for the 
incorporation of deoxyadenosine 5 1 - [alpha-THIO] triphosphate, 
[35S] (Dupont).
Samples were electrophoresed on 0.4mm, 5-8%
polyacrylamide/urea gels as described in the BRL manual. 
Instagel mix was deionised using analytical grade mixed bed 
resin beads (Bio Rad). Sequencing gels were run on a home­
made apparatus and the IBI Model STS 45 gel apparatus using a 
sharks tooth comb. After overnight polymerization, the gels 
were pre-run at a constant 110 W for 1 hour. After loading 
(multiple loadings) the samples were electrophoresed until 
the bromophenol blue dye-front reached the base of the gel 
(approximately 2 hours) or for upto 6 hours to extend the 
reaadable sequence. Wedge gels were also used to increase 
the number of readable bases for a single 2 hour run. It is 
important to realise that the concentration of polyacrylamide 
in the sequencing gel alters the rate of co-migration of both 
dyes with polynucleotides. For 8% gels, the rate of 
migration of bromophenol blue and xylene cyanol corresponds 
to 20 and 73 bases whereas for 5% gels, these values are 31 
and 130-140 bases respectively.
After electrophoresis, gels were fixed by soaking 
in 5% methanol/5% acetic acid for 15 minutes and transferred 
onto damp Whatman 3MM backing paper. The gel was dried under 
vacuum at 80°C for 1 hour. The dried gel was 
autoradiographed using Kodak X-omat S X-ray film.
2.42 SYNTHETIC OLIGONUCLEOTIDES 
Oligo-359: 5 1-GGTGGATCTCAGACGG-3' (16mer)
Complementary (antisense) to the intron of cDNA 
JW1 and JW5. Used initially for primer extension 
Oligo-386: 5 1-GGCTGTCTCTCCACCTCC-31 (18mer)
Complementary (antisense) to the 3'UT region of 
mRNA and cDNA JW1, JW4 and JW5.
Oligo-387: 5'-AGTGGGCTGGATGTCTCC-3' (18mer)
Complementary (sense) to the 3'UT region of cDNA 
JW1, JW4 and JW5.
01igo-400: 5'-GGTCGCAGCCAAACATCCTCTGG-3' (23mer)
Complementary (antisense) to alpha-2 domain (exon
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3), and used for primer extension.
Oligo-407: 5 1-GAGGTGCTGGGCCCTGG-31 (17mer)
Complementary (sense) to the alpha-3 domain (exon
4) and used in sequencing.
Oligo-SCREENING: 5 1-GGTCACGACCCCTCCCCATCCCCCA-31 (25mer)
Complementary (sense strand) to intron 2 of 
unspliced mRNA and used for screening extended recombinants 
(see chapter 6.6 for explanation of this).
Oligo-RSDF: 5 1-TAGAGGATCCCCGGGTCGCCCCGA-31 (24mer)
Complementary (sense) to intron 2 encompassing the 
Sma I site of the cDNA clones JW1 and JW5. Used to restrict 
single stranded DNA (see chapter 6.6 for explanation of 
this).
Oligo-SDF: 5'-GACTCTAGAGGATCCCCGGGG-31 (21mer)
"Bridgeing oligo". Complementary (sense) to M13 
polylinker (see chapter 6.6 for explanation of this).
2.43 32P-LABELLING OF OLIGONUCLEOTIDE PRIMERS
5 1-dephosphorylated synthetic oligonucleotides (to 
be used as primers) were gamma32P-phosphate labelled using T4 
polynucleotide kinase at 37°C for 30 minutes. 
Oligonucleotides stocks were adjusted to 50ng/ul in distilled 
water (and stored frozen).
Labelling reaction:
lOOuCi gamma32P-ATP lOul
50ng oligonucleotide lul
T4 polynucleotide kinase (10 units) lul
lOx oligo labelling buffer 1.3ul
13.3ul
lOx oligo labeling buffer: RNase free!
50mM Tris pH7.4 
lOmM MgCl2 
5mM DTT
0.ImM spermidine 
Afterwards, the kinase was heat inactivated at 65°C 
for 5 minutes. It was not absolutely necessary to remove 
free label although this could be done using ammonium 
acetate/ethanol precipitation.
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2.44 PRIMER EXTENSION
lOng (2ul) of the specific 32P-gamma labelled 
oligonucleotide primer was mixed with 5ug mRNA as outlined in 
section 2.28 (first strand cDNA synthesis). Incubate 40uCi
32P-dCTP if internal labeling of the synthesized strand
wasrequired. The addition of 0.8ug/ul actinomycin D (Sigma)
to mRNA before annealing this to the primer may prevent self 
hydrogen bonding. This creates looping out of mRNA and 
hinders primed extension.
The sample was incubated at 42°C for 90 minutes, 
ethanol precipitated as usual, and washed with 80% ethanol. 
After vacuum drying briefly the sample was resuspended in 2ul 
TE and 3ul formamide sequencing gel loading buffer (BRL
manual). A sequencing reaction (to size the synthesized
strands) and free oligonucleotide (to check labeling) was run 
alongside the sample on an 8% polyacrylamide/urea sequencing 
gel. Autoradiograph at -70°C overnight using Kodak X-Omat S 
film.
2.45 GENE CLEANING PROCEDURE.
After visualization of the DNA within the type I 
agarose gel on a long wave transilluminator (300-360nm), the 
band was excised. This was trimmed and added to 2-3 volumes 
of "Nal" solution (approximately 500ul) and heated to 55°C 
until the agarose had completely dissolved. 5ul of 
"Glassmilk" suspension was added quickly and the contents 
were placed on ice for 5 mins. After a 5 second 
microcentrifugation, the supernatant was discarded and the 
pellet washed in ice-cold "New" solution by resuspending, re­
spinning and discarding the supernatant. Any traces of "New" 
were removed using a micropipettor. The DNA was eluted from 
the glass beads by adding a volume of TE (pH8.0) and heating 
to 50°C. Spin for 10 second to pellet the glass beads and 
remove the supernatant. Repeat. Pool the supernatants and 
finally centrifuge to remove all traces of glass. The DNA 
can be ethanol precipitated but this is not necessary. The 
compositions of "Nal", "Glassmilk" and "New" were 
undisclosed.
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CHAPTER THREE.
CLASS I IMMUNOPRECIPITATION ANALYSIS OF THE CHORIOCARCINOMA 
CELL LINE JEG-3.
INTRODUCTION
3.1.1.
The introduction to this chapter gives a brief 
review of the literature landmarks at the start of the 
research period.
Sunderland et al. (1981a;b) illustrated that class 
I molecules were not expressed by villous syncytiotrophoblast 
but that extra-villous trophoblast forming the 
cytotrophoblast cell columns clearly exhibited class I 
molecules. Redman et al. (1984) subsequently discovered that 
these molecules consistently failed to bind antibodies 
specific for the foetal HLA-A and -B phenotype and suggested 
that MHC antigen expression may be restricted to HLA-C or 
some other unidentified class I antigen. Wells et al. (1984) 
noted differences in reactivity with W6/32 and 61D2 and it 
was suggested that class I molecules may have undergone 
alterations in immunogenicity.
On the basis of these results, the initial aim of 
the research set out was to isolate HLA class I homologous 
cDNA clones from a cytotrophobolast cDNA library in order to 
investigate the nature of the molecule(s) expressed. 
However, attempts to detect class I homologous sequences were 
unsuccessful. Subsequently, immunoprecipitation studies 
showed that the class I heavy chains of human chorionic 
cytotrophoblasts, a human choriocarcinoma cell line BeWo 
(Ellis et al. 1986) and also baboon syncytiotrophoblast 
(Stern et al. 1987), had lower molecular weights, 40kDa and 
41kDa respectively, than did the classical 45kDa molecules. 
The aim of the research focused on isolating such class I 
cDNA's from a choriocarcinoma library.
3.1.2 JEG-3 Choriocarcinoma Cell Line.
Current work in this area focuses on the precise 
nature of the stimulus and this necessitates good 
preparations of the cell type in question, namely the extra- 
villous cytotrophoblast. Since the latter are difficult to
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separate from uterine decidua and sustain in culture, a model 
choriocarcinoma (JEG-3) known to be derived from extra- 
villous cytotrophoblast was used in this study.
Hertz, (1959), developed an in vivo model of human 
choriocarcinoma by its hetero-transplantation into cortisone- 
conditioned hamster cheek pouches (WO strain). From this 
original material, Patillo and Gey, (1968), Kohler and 
Bridson, (1971) and Patillo et al. (1971), succeeded in
establishing in vitro growth of three separate clones, BeWo, 
JEG and Jar respectively. From eight subclones of JEG
cultured on fibroblast feeder layers, JEG-3 was found to 
produce the highest levels of the placental hormone human 
chorionic gonadotrophin (Kohler and Bridson, 1971). 
Hamilton et al. (1979) have shown that JEG-3 cells can be
induced to produce placental alkaline phosphatase by various 
biological chemicals including some corticosteroid hormones 
and sodium butyrate. Progesterone (also a placental 
hormone), is the major steroid synthesized by JEG-3 but there 
is no 17 beta-hydroxylase or 17-20 desmolase activity which 
is typical also of placental cells (Bahn et al. 1981). As 
well as this, the cells display a large number of high 
affinity EGF receptors. Takamizawa and Sekiya, (1984), 
reviewed the cell biology of choriocarcinoma. In culture,
mononuclear cells (cytotrophoblast like cells) with a 
prominent nucleus seem to be in excess over a relatively 
small number of giant multinuclear ones which are 
syncytiotrophoblast-like. Thus, the choriocarcinoma (JEG-3) 
is a highly malignant tumour and exhibits many of the 
steroidogenic capabilities and enzyme blocks of the normal 
placenta.
Even though class I expression is evident on some 
choriocarcinomas, both BeWo (Ellis et al. 1986) and JEG-3 
(P.L.Stern pers. comm.) cells have proven difficult to 
tissue-type.
3.1.3. Aims
The aim of the immunoprecipitation experiment 
carried out in section 3.2 was to investigate the nature of 
the class I molecules expressed on the JEG-3 choriocarcinoma 
cell line which is known to be weakly positive for HLA (Hunt 
et al. 1987). Section 1.2.6 of the introduction outlines 
similar work carried out previously in other laboratories in
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detail and will be referred to in the discussion of this 
chapter.
RESULTS
3.2. Immunoprecipitation Analysis of Surface Labelled JEG-3 
Cells.
Choriocarcinoma JEG-3 cells were grown in RPMI 
medium in large 75cm3 tissue culture flasks. (For very
nearly confluent growth, there are approximately 4x10^
cells/cm2). The expression of class I or class I-like
molecules was investigated by immunoprecipitation with two 
anti-class I monoclonal antibodies (W6/32 and 61D2) and anti- 
B2“microglobulin (BM.63)(Figure 3.2.1). JEG-3 cells were 
surface labelled by the 125-I-lactoperoxidase-glucose-oxidase 
technique and the immunoprecipitates were electrophoresed on 
a 10% SDS polyacrylamide gel (see sections 2.10 and 2.11).
W6/32, a monoclonal antibody directed towards a 
common framework determinant on class I heavy chains was
shown to immunoprecipitate two class I heavy chains of 45kDa 
and 41kDa; the latter molecule being the major component. 
The surface immunoprecipitation of these heavy chains with 
BM.63 demonstrated clearly that both molecules were 
associated with B 2 -microglobulin. The monoclonal antibody 
61D2 (directed against one other class I heavy chain 
determinant) precipitated the 45kDa molecule but did not 
react with the major 41kDa component.
DISCUSSION
3.3.
The immunoprecipitation results show that there are 
at least two class I molecules expressed on JEG-3 cells which 
differ in size. The pattern of the immunoprecipitation 
suggests that they differ in their ability to bind W6/32 and 
61D2. Similar results to the above have been obtained with 
BeWo cells (Stern et al. 1988), as might have been expected 
since both cell lines were derived from the same 
choriocarcinoma material. Although both JEG-3 and BeWo cell 
lines have previously been shown to be weakly positive for 
HLA a tissue type has been difficult to obtain. It might be 
expected that at least one of the molecules may be 
serologically recognized but the sparsity of sera and low 
levels of surface expression has probably prevented their
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1 2 3 4
45kDa
41kDa
12kDa
Figure 3.2.1 Class I Immunoprecipitation Analysis of 
Cells.
(1)-W6/32 anti-class I
(2)-BM.63 anti-B2~microglobulin
(3)-61D2 anti-class I
(4)-Normal Rabbit Serum
JEG-3
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specific typing.
Cloning and sequencing a number of class I cDNA clones 
would distinguish whether the class I proteins were derived 
from a common but alternatively spliced transcript (see
section 1.1.7), or whether they originated from two separate 
loci. It is possible that the 41kDa molecule is the result 
of alternative splicing of the mRNA coding for the 45kDa 
protein. However, to date, no one has shown that
alternatively spliced transcripts code for MHC proteins which 
exhibit modified/different or loss of function. It was 
thought that the difference in size of the two
immunoprecipitated molecules may have been due to differing 
degrees of glycosylation. Although both heavy chains in BeWo 
were found to be glycosylated, treatment with N-glycanase did 
not convert these molecules into a single smaller component 
(P.L.Stern, pers. comm.).
Interestingly, Ellis et al. (1986) did not 
immunoprecipitate a classical 45kDa heavy chain from either 
the BeWo choriocarcinoma or chorionic cytotrophoblast cell 
membranes and had therefore concluded that classical class I 
molecules (usually of 45kDa), were not expressed by these 
cell types. Thus, the results of the two experiments are
apparently qualitatively different. There is the possibility 
however, that the concentration of polyacrylamide (12%) used 
in the SDS gel (Ellis et al. 1986), may have been slightly 
too high and prevented the resolution of the two components. 
Subsequent studies by Stern et al. (1988) have confirmed the 
presence of the 45kDa molecule in BeWo cells. However, where 
the expression of the 45kDa molecule is concerned, one should 
not extrapolate the class I immunoprecipitation results for 
BeWo and JEG-3 cells to those of chorionic cytotrophoblasts. 
Further studies are necessary to confirm whether or not the 
45kDa heavy chain is present on chorionic cytotrophoblast 
membranes. The lack of 61D2 immunostaining on various 
trophoblast populations (Hsi et al. 1984; Wells et al. 1984; 
Earl et al. 1985) supports the immunoprecipitation data of 
Ellis et al. (1986) if one accepts that 61D2 normally reacts 
with classical MHC structures. However, the
immunoprecipitation data show at least a 5-fold (as assessed 
by eye) predominance of the 41kDa component and it could well 
be that the immunostaining studies using 61D2 were not 
sensitive enough to detect the low levels of the 45kDa cell
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surface protein. Indeed, the experiments of Hunt et al. 
(1987) agree with this suggestion, since only after gamma- 
interferon induction of JEG-3 cells could class I cell 
surface expression be detected clearly using 61D2, whereas 
W6/32 and BB7.5 detection of class I did not require further 
induction with gamma-interferon. These results will be 
referred to again with reference to additional collaborative 
data in the final discussion.
At this stage, it could be argued that only the 
choriocarcinoma cells express 45kDa molecules though clearly 
the situation needs clarifying. It is probably worth being 
reminded at this point that the class I molecules found on 
baboon syncytiotrophoblast are 41kDa (Stern et al. 1988), and 
those from mixed rat placental cells are found to be 41 and 
45kDa (Billington and Burrows, 1989).
If the two molecules indeed are different, then it 
would be reasonable to predict that they also have different 
functions but what these are and whether they are both 
absolutely required remains to be determined. Another 
interesting point is that the molecules are clearly expressed 
to very different levels and this may also be a requirement 
and be related to their individual functions. This latter 
point will be taken further in the final discussion.
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CHAPTER FOUR
PREPARATION AND ANALYSIS OF RNA FROM UNINDUCED AND GAMMA- 
INTERFERON TREATED CHORIOCARCINOMA CELLS.
INTRODUCTION
4.1.1
Preparations of JEG-3 RNA were analyzed for the 
presence of intact HLA mRNA since these samples were to be 
used in cDNA synthesis. The gamma-interferon induction 
profile of HLA mRNA was investigated since this might lead to 
an increased representation of the number of class I cDNA 
clones, and so increase the chance of obtaining such a clone. 
Work published recently also shows JEG-3 gamma-interferon 
induction profiles (Hunt.et al. 1987).
RESULTS
4.2. Preparation of RNA from uninduced and Gamma-interferon 
Treated JEG-3 cells and also from KNo cells.
Maniatis et al. (1982) estimates that the yield of 
total RNA from a single cell is 10_5ug. Depending upon the 
experiment, appropriate numbers of cells were grown (for very 
near confluency they are 40xl03cells/cm2). RNA was prepared 
from both uninduced and gamma-interferon (varying 
concentrations) treated JEG-3 cells, and also from a 
lymphoblastoid cell line KN£ (strongly HLA+ ).
The quantity of RNA was estimated by &260/2Q0 an(* 
checked on agarose gels as outlined below. Different amounts 
(l-10ug) of total RNA prepared from untreated JEG-3 cells 
were electrophoresed on a 1% non-denaturing agarose gel 
alongside Bglll/HincII digested pBR322 DNA markers (figure 
4.2.1). All samples showed intact RNA (not degraded) as 
illustrated by the presence of three sharp ribosomal RNA 
bands (28S, 18S rRNA and tRNA), and a background smear of
mRNA. The actual size of eukaryotic 28S and 18S rRNA is 3614 
bases and 2244 bases respectively, tRNA is 70 bases. The 
rRNA bands were visible indicating that the RNA was intact.
Unpublished data of Joan Hunt indicated that 
induction of class I with gamma-interferon was optimal at 
500-700U/ml and so these levels were covered in preliminary 
induction experiments. Initially, (first preparation) the 
concentration of gamma-interferon varied in culture from 0- 
700U/ml and in the second preparation ranged from 0-
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Figure 4.2.1 1% Agarose gel showing increasing amounts of
JEG-3 total RNA.
Tracks (1-6)-loaded respectively with 10,5,4,3,2 and lug 
total RNA, (7)-HindiII/Bglll pBR322 DNA markers.
8 8
10,000U/ml. These preparations used a different batch of
gamma-IFN which had been obtained on separate occasions (gift 
from Dr. Page, Wellcome Biotech). 5ug samples from each 
preparation were electrophoresed on a 1% agarose gel (see
figures 4.2.2 and 4.2.3 respectively). All samples showed 
very nearly equal loadings of intact RNA, although slight 
variation can just be discerned.
lOug JEG-3 RNA was electrophoresed on a formaldeyde 
northern gel and visualized by ethidium bromide staining in 
order to check their condition (figure 4.2.4). EcoRI/Hindlll 
Lambda DNA markers (denatured to single strands) were used 
although these are not strictly accurate for RNA. Both rRNA 
bands and a background smear of mRNA are visible.
4.3. Optimization of background levels of hybridization.
At first the background level of hybridization on 
Northern blots was too high and it became necessary to 
empirically optimize pre-/hybridization conditions. The 
level of HLA mRNA is known to be typically very low (less 
than 0.1% from my own studies presented in chapter 5 and 
other workers) and as such, did not help this situation. 
Non-specific background hybridization levels were reduced to 
a minimum by varying the concentration of some of the 
components of the solution in existing protocols. A 
formaldehyde gel (no RNA samples) was blotted with PAL
BiodyneTm nylon membrane as usual, cut into quarters and 
probed using the conditions outlined below (figure 4.3.1).
The salt concentration (5xSSPE) and that of formamide (50% 
v/v) were unaltered during the analysis whist other 
parameters were adjusted as follows:
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1 2 3 4 5 6 7
rRNA
1.3Kb
.89Kb
rRNA
tRNA
Figure 4.2.2 1% Agarose gel illustrating 5ug samples of
total RNA from the first preparation of uninduced and upto 
700U/ml Gamma-IFN treated JEG-3 cells.
Track (1-5)-700,500,350,200,lOOU/ml Gamma-IFN induced RNA 
respectively (6)-uninduced JEG-3 (7)-lambda Hindlll/EcoRI DNA 
markers.
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1 2 3 4 5 6 7 8 9 10 11 12 13
2 . 3Kb
1. 3Kb 
890bp 
560bp
Figure 4.2.3 1% Agarose gel illustrating 5ug samples of
total RNA from the second preparation of upto 10,000U/ml 
Gamma-IFN treated JEG-3 cells.
Tracks (l)-lambda Hindlll/EcoRI markers (2-12)-10,000, 
5000, 2000, 1000, 700, 500, 300, 150, 100, 50 and 25U/ml
Gamma-IFN induced samples (13)-uninduced JEG-3.
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1 2
23Kb
2 . 3Kb 
1.3Kb
rRNA
980bp
890bp
rRNA
Figure 4.2.4 Ethidium bromide stained JEG-3 total RNA on a 
Northern Formaldehyde gel.
Track (l)-10ug total JEG-3 RNA, (2)-lambda Hindlll/EcoRI DNA 
markers.
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Hybridization solution Comments
50% Formamide Conventional solution
5x SSPE
5x Denhardts
10% Dextran Sulphate
lOOug/ml salmon sperm DNA
50% Formamide
5x SSPE
5x Denhardts No Dextran Sulphate
lOOug/ml salmon sperm DNA
50% Formamide
5x SSPE
5x Denhardts No Dextran S04 or s/sperm
50% Formamide
5x SSPE
lOx Denhardts 2x Denhardts and s/sperm.
i—1a
stn3ooOJ salmon sperm No Dextran S04
As can be seen from figure 4.3.1 the conventional pre- 
/hybridization solution gave rise to the highest levels of 
background hybridization. The conditions used with filters 2 
and 4 proved to be the most effective in reducing background 
levels of hybridization and are fully described in section 
2.17. Indeed, the signal to noise ratio was much improved in 
subsequent Northern experiments.
4.4. Hybridization Analysis using h t .a  class I DNA Probes.
4.4.1. Dot Blot Hybridization.
Gamma-interferon induced JEG-3 (0-700U ml shown in 
figure 4.2.2) and KN2 total RNA (0.05ug-20ug) and mRNA 
samples (l-200ng) were dot blotted onto PAL BiodyneTm nylon 
membrane and hybridized to the 1.4Kb HLA-B7 cDNA probe 
(figure 4.4.1). The membrane included both positive (pDP 
1.4Kb 0.5ng-100ng with pBR322 4.3Kb 1.5ng-300ng) and negative 
(pBR322 1.5ng-300ng) control samples. The amounts of RNA
loaded onto the dot blot was controlled for by a comparison 
with the ethidium fluorescence of electrophoresed samples 
shown in figure 4.2.2 .(see below and discussion). A
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2 4
Figure 4.3.1 Northern background levels of radioactivity 
after using various hybridization conditions.
Blocks 1-4 show the hybridization background levels when 
using the solutions described in section 4.3.
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JEG-3 total RNA OU/ml
100
200
350
500
700
k n2
JEG-3 mRNA
Amounts of RNA (ug)
20 10 5 2 1 .5 .1 .05
• *
• • •
•  • •
Amounts of RNA (ug)
20 10 5 2 1 .5 .1 .05
# • • • • «
• •
200 100 50 20 10 5 2 1 (ng)
CONTROL DNA SAMPLES*
pBR322
pDPOOl
300 150 30 15
100 50 10
3 1.5 (ng)
• • • *
5 1 .5 (ng)
Figure 4.4.1 Dot Blot Arrangement of KN2 anc  ^ Gamma-IFN 
induced JEG-3 RNA samples hybridized with a 1.4Kb class I 
HLA-B7 cDNA probe. * - see text.
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comparison of equal amounts of each RNA from both uninduced 
and gamma-IFN treated JEG-3 samples indicates no obvious 
induction levels of HLA mRNA resulted from when any 
concentration of gamma-IFN is used for 30 hours.
4.4.2. Northern Hybridization.
lOug total RNA samples from KN2 and gamma- 
interferon induced (0-10,00011 ml shown in figure 4.2.3) JEG-3 
cells were electrophoresed on a Northern formaldehyde gel 
(figure 4.4.2) and after transfer, were hybridized to the 
1.4Kb HLA-B7 cDNA probe. The amounts of RNA loaded onto the 
dot blot was controlled for by a comparison with the ethidium 
fluorescence of electrophoresed samples shown in figure 4.2.3 
(see below and discussion).A duplicate filter was probed with 
pmS3, a 900bp incomplete actin cDNA probe (section 2.20) in 
order to normalize levels of RNA, since this is not induced 
by gamma-interferon. Unfortunately, the actin probe did not 
hybridize as clearly as expected and the Northern 
autoradiograph could not be photographed. This latter 
control was repeated and filters washed at reduced stringency 
but with the same results.
For definitive quantitation of class I mRNA levels, 
such controls are most important. The level of fluorescence 
of ethidium bromide staining of rRNA bands as an indication 
of the amounts of RNA loaded is a poor way of controlling the 
latter, especially since rRNA is not as readily degraded as 
mRNA.
Both the dot-blotting and Northern transfer 
experiments showed the presence of class I mRNA but that 
gamma-interferon did not appreciably increase these levels as 
assessed by hybridization with a class I HLA-B7 cDNA probe. 
There does appear to be some induction of transcripts when 
the concentration of gamma-interferon is increased to 50U/ml 
(track 5). This induction is variable upto l,000U/ml and is 
much reduced when the concentration of interferon is 
increased further. It is unwise to estimate the degree to 
which induction occurs since it is low. The amount of RNA in 
track 7 of figure 4.2.3 is slightly higher than the other 
samples and could account for the increased hybridization 
attained in track 8 (500U/ml) of figure 4.4.2. These
experiments were only preliminary and the collective data 
suggested no dramatic increase of class I mRNA levels after
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Figure 4.4.2 Northern Formaldehyde Gel of KN2 and Gamma-IFN 
induced JEG-3 RNA samples (shown in 4.2.3) probed with a 
1.4Kb class I HLA-B7 cDNA probe.
20ug total RNA samples. Tracks (1)-KN2, (2)-500U/ml Gamma-IFN
induced JEG-3 (large preparation), s/*ft3)-uninduced JEG-3, (4- 
14) -25, 50#‘°°150, 300, 500, 700, 1000, 2000, 5000, and 
10,000U/ml Gamma-IFN induced JEG-3, ^{ 15)-KN2f (16)-500U/ml 
Gamma-IFN induced JEG-3 (large preparation).
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gamma-interferon induction. Since class I mRNA was detected, 
attempts to clone the corresponding cDNA's were made 
immediately. Possible reasons for not obtaining induction 
are given in the final discussion. The positive control, 
KN2-LCL gave stronger signals.
Northern gels (figure 4.4.3) using Bglll/HincII 
restricted pBR322 end labelled radioactive markers showed the 
size of the mRNA to be approximately 1.6Kb. Figure 4.4.2, 
shows a slight difference in the mobility of the mRNA, with 
the JEG-3 band being slightly smaller than the KN2 band. The 
resolution generally attained on Northern gels is known to be 
relatively poor. To see whether the class I mRNA was the 
same or different size in KN2 and JEG-3 cells, RNA from each 
was electrophoresed as single and mixed samples and 
subsequently hybridized to the HLA-B7 probe (figure 4.4.4). 
Unfortunately the signal from the KN2 sample was relatively 
too strong and masked that of the JEG-3 sample. This 
Northern however, does show that single KN2 and JEG-3 total 
RNA samples migrate similarly. The reason for the difference 
in mobility of the two mRNA1s in figure 4.4.2 is not clear 
but it could have been due to differing salt concentrations 
in the samples.
4.5. Preparation of mRNA using Olicro-dT Cellulose Affinity 
Matrix.
Gamma-interferon induced (500U/ml) total JEG-3 RNA 
was used to prepare mRNA (section 2.27). Initially, this 
separation was attempted using Amersham’s messenger affinity 
paper (mAP), but this was relatively unsuccessful since the 
mRNA was not completely separated from the rRNA. In addition 
to this, the ethanol precipitated mRNA pellet was an orange 
colour (same as the paper) and this did not instill any 
confidence in this method! Oligo-dT cellulose affinity 
matrix gave much better results. lug JEG-3 mRNA (prepared 
using oligo-dT cellulose) was electrophoresed on a 1% agarose 
gel with 5ug total JEG-3 RNA from the original sample, and 
Hindlll/EcoRI digested lambda markers (figure 4.5.1). The 
mRNA appears as a background glow as expected and does not 
appear to be degraded or contaminated with rRNA bands. On a 
Northern gel (figure 4.5.2) this mRNA can be hybridized to 
the HLA-B7 cDNA probe. The mRNA was used for in vitro
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1 2  3 4
3.2Kb- 
2.3 Kb- 
1.8Kb-
1.1Kb-
1.6Kb
Figure 4.4.3 Northern Formaldehyde Gel of KN2 and Gamma-IFN 
induced JEG-3 RNA illustrating the size of the class I HLA 
mRNA expressed in both.
Tracks (l)-pBR322 Bglll markers, (2)-pBR322 HincII markers 
(3)-KN2 RNA, (4)-JEG-3 RNA.
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1 2  3 4 5 6 7 8 9 10 11 12 13
Figure 4.4.4 Northern Formaldehyde Gel of mixed RNA samples 
probed with a class I HLA-B7 cDNA probe. K=KN2 , J=JEG-3 
Tracks (1) - 20ug K.
(2,3,4)- 5ug J, 2.5ugK/2.5ugJ, 5ug K
(5,6,7)- 10ug J, 5ugK/5ugJ lOug K
(8,9,10)- 15ug J, 7.5ugK/7.5ugJ 15ug K
(11,12,13)- 20ug J, lOugK/lOugJ 20ug K
1 0 0
3 2 1
rRNA
rRNA
tRNA
2 . OKb 
1. 3Kb 
890bp 
560bp
Figure 4.5.1 Agarose gel electrophoresis of Gamma-IFN 
induced JEG-3 mRNA isolated by oligo-dT cellulose affinity 
matrix.
Track (l)-lambda Hindlll/EcoRI DNA markers, (2)-lug JEG-3 
mRNA, (3)-5ug JEG-3 total RNA.
1 0 1
12
3
4
5
6
Figure 4.5.2 Northern Formaldehyde Gel of mRNA from Gamma- 
IFN induced JEG-3 cells probed with a class I HLA-B7 cDNA 
probe.
Tracks (1-6)- 0.5, 0.25, 0.1, 0.065, 0.05, and 0.025ug mRNA.
1 0 2
translation analysis (see below) and for cDNA synthesis 
(chapter 5).
4.6. In vitro Translation of messenger and total RNA from 
JEG-3 cells.
Total RNA from untreated and gamma-interferon 
induced (500U/ml for 30 hours) JEG-3 cells and mRNA from 
induced cells was in vitro translated (figure 4.6.1) as 
described in section 2.28. The samples were exposed to X-ray 
film for only three days and consequently the signals are 
quite weak. During vacuum drying under heat, the gel cracked 
but it is clear that all samples have been translated since 
protein bands are visible upto the 92kDa protein marker. 
Discrete bands indicated that the mRNA samples were intact 
and had not been degraded. The H20 blank gave the expected 
results.
DISCUSSION
4.7.
Gamma-interferon is known to increase the levels of 
class I mRNA (reviewed by Rosa and Fellous, (1984) see also 
section 1.1.11. - Regulation of Class I Gene Expression by 
Immune Modulators). It was used in this study to increase 
the levels of class I mRNA species among the total mRNA 
population in order to elevate the chance of detecting the 
corresponding cDNA clone (to be described in chapter 5). 
Whether or not this lymphokine preferentially up or down 
regulated the expression of existing molecules on JEG-3 cells 
was not known at the time of the experiment and this point 
will be referred to in the final discussion, since
collaborative data completed later sheds light on the results 
obtained here.
Figure 4.2.1. illustrates very simply the
appearance of ethidium bromide stained RNA on an agarose gel 
and indicates that over a range of lug to lOug (previously 
assessed by spectrophotometry) one can assess the variability 
in the loading between samples and that the most visible 
range of variability is between 2-5ug. Figures 4.2.2 and
4.2.3 showed that the 5ug amounts of total RNA loaded were
comparable. The Dot Blot and Northern data (figures 4.4.1 
and 4.4.2 respectively) suggested that gamma-interferon did 
not appreciably increase the levels of class I mRNA and that
103
2 3 4 5 6 7 8 9 10 11
I
92K
69K
46K
# T I ■
3 OK
Figure 4.6.1 Autoradiograph of [ -methionine labelled in
vitro translated protein products of untreated and Gamma-IFN 
induced JEG-3 messenger and total RNA samples.
Track (l)-10n/Ci mw markers, (2)-water blank, (3,4,5,6)- 
0.005, 0.01, 0.05, 0.2ug mRNA from induced JEG-3 cells (7)-
lOnCi mw markers, (8,9)-0.5ug, lug 500U/ml Gamma-IFN total 
JEG-3 RNA, (10,11)-0.5ug, lug uninduced total JEG-3. The 
unlabeled middle two tracks were not used for technical 
reasons.
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there was no further induction in samples treated with more 
than 300U/ml. The hybridization signals were relatively weak 
and did not "blacken" the autoradiograph to saturation. The 
radioactivity of individual dots was not counted since there 
was no obvious induction and these results were therefore 
assessed by eye. Subsequent to this, an actin probe was 
acquired in order to properly control for the relative 
amounts of RNA, but unfortunately the levels of hybridization 
attained were extremely low and the signals were diffuse and 
a decent photograph could not be obtained. The signal was 
quite even across the samples. These quantitative data 
should be properly controlled for as explained earlier. 
Since the amounts of total RNA appear to be reasonably 
comparable on agarose gels, the levels of class I induction 
by gamma-interferon were assessed. Induction was not 
particularly apparent although it was quite clear that class 
I mRNA was present and these experiments were taken over by 
attempts to clone the corresponding cDNA.
Hunt et al. (1987) subsequently published very 
clear Northern data of a time course and induction profile of 
class I JEG-3 gamma-interferon induction. First of all, it 
is true to say of Hunts results that there is definite 
induction of transcripts upto lOOOU/ml and that over a period 
of 24hrs when using lOOOU/ml the transcripts do accumulate 
overall. However, the two sets of data are inconsistent in 
two samples from each. The two control samples show 
differing amounts of class I transcripts, as do the samples 
treated with lOOOU/ml for 24hrs. This could be due to a 
number of reasons (including different exposure times) which 
may or may not be a result of the following. Previous 
literature (Takamizawa and Sekiya, 1984) had reported 
syncytial elements present in the JEG-3 choriocarcinoma (see 
section 3.1.2), and it could be that the cells differentiate 
in in vitro culture (if they reach high density) as do normal 
cytotrophoblasts differentiate into syncytiotrophoblast. The 
latter are known not to express class I and so the effect of 
differentiation may effectively reduce the amounts of class I 
mRNA in a preparation.
Recently, a comparison of class I 
immunoprecipitation studies on BeWo cells before and after 
treatment with 2000U/ml gamma-interferon for 24 hours showed 
at most a three fold increase, and this was accompanied by
105
the appearance of a 51kDa immunoprecipitable component, the 
nature of which was unknown (Stern et al. 1988). Hunt et al. 
(1988) used the elaboration of renin to evaluate the 
viability of chorionic cytotrophoblasts in culture. Cultures 
exposed to interferon for 48hours resulted in a reduction in 
the amount of renin produced (reduced viability) especially 
under the influence of both 100 and lOOOU/ml interferon.
The conditions that were finally chosen to induce 
class I mRNA for the cDNA library were considered to be 
moderate: 500U/ml gamma-interferon for 30 hours.
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CHAPTER FIVE
SYNTHESIS. CLONING AND ISOLATION OF CLASS I cDNA CLONE 
DERIVED FROM GAMMA-INTERFERON INDUCED JEG-3 CHORIOCARCINOMA 
CELLS.
INTRODUCTION
5.1.
To isolate HLA class I cDNA clones from JEG-3 a cDNA 
library representing the mRNA population of these cells was 
constructed in lambda gtlO. The frequency at which the cDNA 
clones of a particular mRNA occur should be proportional to 
the abundance of that species in the population. Levels of 
class I mRNA are known to be very low (rare) and in order to 
isolate such a cDNA it was necessary to choose a vector which 
would allow efficient cloning and selection of a large number
of recombinants (at least 10^). The use of a lambda vector
in preference to a plasmid for the construction of a cDNA 
library takes advantage of the high efficiency and 
reproducibility of in vitro packaging of lambda DNA and the 
increased efficiency of nucleic acid screening of plaques 
over colonies.
Lambda gtlO (see section 2.6) is a good cloning vector 
for this purpose since it can accept DNA inserts up to 7.6Kb 
and its propagation on two different strains of E. coli also 
allows for an efficient biological selection system for 
recombinant phage.
Lambda gtlO contains a unique EcoRI restriction 
cloning site within the phage repressor gene (cl) into which 
the cDNA is inserted (see figure 5.1.1). The disruption of
cl forces the bacteriophage to follow the lytic pathway
(leads to cell lysis) and gives the effect of a clear plaque 
in the areas of infection. Lysogenic integration of lambda 
into the E. coli. chromosome results in the formation of a 
turbid plaque. The bacterial cell survives the lysogenic 
bacteriophage and does not produce phage particles. Both 
bacteriophage and host factors are involved in this process. 
Bacteriophage ell and cIII protein products negatively 
regulate the lytic process by positively regulating cl early 
transcription and hence any bacteriophage mutant in either 
the cl, ell or cIII genes follows the lytic pathway.
Parental lambda gtlO are cl+ and produce turbid 
plaques on wild type E. coli. and on the L87 strain used in
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Figure 5.1.1 Restriction endonuclease cleavage map 
Lambda gtlO. Hyunh et al. (1985).
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this study. Parental phage are also forced into the 
lysogenic pathway on high frequency lysogeny (hfl+ ) strains 
(NM514 used in this study). However, when cl“ bacteriophage 
are grown with wild type and L87 strains, lysogeny cannot 
occur and clear plaques result. Growing cl” bacteriophage on 
NM514 (Murray et al. 1977), adds a stringent biological 
selection since these phage replicate and lyse the cells 
efficiently.
RESULTS
5.2. Synthesis of cDNA.
Messenger RNA obtained from (500U/ml 30 hours) gamma- 
interferon induced JEG-3 cells was reverse transcribed into 
first strand cDNA as described in section 2.29. Double 
stranded cDNA was prepared using the RNase-H method of Gubler 
and Hoffmann, (1983) which involves the nicking of mRNA
strands in mRNA.cDNA hybrids followed by the synthesis of 
second strand cDNA using the mRNA fragments as primers for
DNA polymerase I. Globin mRNA (600bp) was used as a control.
The radioactive first and second strand cDNA products 
of cDNA synthesis were visualized by autoradiography after 
alkaline gel electrophoresis (see 2.30). cDNA samples were 
run alongside end-labelled DNA markers (lambda Pstl and
Haelll phiX174) and globin cDNA on an alkaline agarose gel 
(see figure 5.2.1). The alkaline agarose gel illustrated 
that radioactivity was being incorporated into both first and 
second strand cDNA and that the products ranged in size from 
below 300bp to 5Kb. Globin cDNA (600bp) was seen with two 
unexpected lower molecular weight fragments whose presence 
cannot be explained with very much certainty, but one 
possible explanation could be that reverse transcription was 
arrested at sites of secondary structure yielding shorter 
products. The molecular weight species (above 600bp) can 
only be explained by suggesting that globin mRNA 
(commercially acquired) was synthesized from a vector and 
that the synthesis carried on past the DNA clone or that in 
vivo splicing of pre-mRNA was incomplete.
The presence of a strong band of approximately 1.8Kb 
in JEG-3 cDNA may represent abundant mRNA species of this 
particular size - although this does not seem to be mirrored 
during the second strand synthesis. The latter statement 
cannot be fully supported since overexposure of this track
109
1 2  3 4  5 6  7 8 9
1.35Kb
1.08Kb
.87Kb
. 60Kb
.31Kb
5 Kb
4.5Kb
2.8Kb
2.4Kb
1.98Kb
1.7Kb
4 Globin
Figure 5.2.1 Alkaline agarose gel electrophoresis of
radioactive first and second strand labelled JEG-3 cDNA
products.
Track (l)-second strand labelled JEG-3 cDNA, (2)-first strand 
labelled JEG-3 cDNA, (3,4)-lambda Pstl markers, (5,6)-HaeIII 
Phi X 174 markers, (7)-second strand labelled globin cDNA 
(8)-first strand labelled globin cDNA, (9)-double stranded 
(labelled first and second strand) globin cDNA after ethanol 
precipitation.
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may reveal such a band.
The amount of cDNA synthesized (see section 2.29 for 
calculations) varied a great deal between the different mRNA 
preparations used throughout the study. This is probably due 
to the purity and quality of the mRNA if all other parameters 
are considered to be constant. The efficiency of reverse 
transcription varied between 10-20% whilst that of second 
strand synthesis varied between 60-75%. On average the 
amount of cDNA synthesized from lug mRNA was 200ng. This was 
stored frozen in water or as an ethanol precipitate at -70°C.
5.3. Cloning of JEG-3 cDNA into Lambda gtlO.
lug cDNA was used as starting material and in vitro 
manipulated for cloning as described in detail in section 
2.31. After methylation and separation of EcoRI linkers, 
0.5ug cDNA was removed after ethanol precipitation 
resuspended in 6ul water and divided into lul, 2ul and 3ul 
volumes. These three samples were individually ligated into 
lug EcoRI cut arms of lambda gtlO (see section 2.31). Two 
other ligations were prepared: 50ng EcoRI cut control DNA 
ligated into lug lambda gtlO arms and lug lambda gtlO arms 
self ligated with no other DNA present (see section 5.4 for 
explanation of these controls).
The ligation reactions were packaged in vitro (as was 
0.5ug uncut parental lambda gtlO) and subsequently plated out 
as described in section 2.32 and 5.4.
5.4. Titration of Lambda gtlO recombinants.
In effect, 2/50th of each preparation of the library 
has been used up in titrating recombinants and l/50th has 
been used in the dilution series (see section 2.32). 30ul 
phage solution was removed from a total of 500ul and serially 
diluted 10-fold into 270ul phage buffer. lOOul of each 
dilution was plated out onto both types of plating cells. 
Thus, 47/50th's of the library remained to be plated and 
screened.
After overnight incubation, the number of plaques was 
counted on both sets of plates whose phage were nearly 
confluent. If the phage are virtually confluent then these 
plates must be ignored since errors arise too easily when 
counting merged plaque forming units (pfu's). Likewise, 
ignore plates with too few plaques because the experimental
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error increases with the progression of the dilution series 
for a number of reasons.
The numbers of plaques obtained on each E. coli host 
were normalized for the 102 dilution series for subsequent 
calculations. The % of clear plaques in each in vitro 
packaged reaction was calculated by using the following;
% of clear0 plaques = no. of clear0 plaques appearing 
on NM514 / (no. of clear0 plaques + no. of turbid**
plaques appearing on L87) x 100%.
This has been done for the five ligations (tubes 2- 
6) that were set up in section 5.3 and also for the packaged 
parental lambda gtlO (tube 1). The raw data is presented 
below with an accompanying explanation of the controls.
Tube % clear0 plaques
Controls
1 - 0. 5ug lambda gtlO (parental) 0.38
2 - lug lambda gtlO arms (self-ligated) 0.8
3 - lug lambda gtlO arms + 50ng control DNA 12
Exoerimental
4 - lug lambda gtio arms + 50ng (lul) JEG-3 CDNA 1.4
5 - lug lambda gtlO arms + lOOng (2ul) JEG-3 cDNA 2.0
6 - lug lambda gtlO arms + 150ng (3ul) JEG-3 cDNA 2.0
6ul total volume
Calculate the total number of plaques (clear0 and
turbidt ) in tube 1. This figure reflects the efficiency of 
the in vitro packageing reaction and should be greater than 
2xl08pfu/ug. The % of clears in this tube gives an
indication of the degree of biological selection and mutated 
forms of lambda, and should be between 0.1-1%.
The number of plaques counted on (or normalized) to 
the 102 dilution (remember to add the figures obtained from 
both sets of plates) plate represents l/50th total number 
(strictly this is 0.9ul / 50 on 102 dilution plate but for 
our purposes such accuracy is not necessary). For tube 1,
only 0.5ug parental lambda gtlO was packaged and so therefore
the figure must be doubled.
Tube 1 - Total no. plaques = (4410^ + 17°) x 50ul x 2
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= 442700
= 4.4 x 105pfu/ug.
This figure is exceptionally low and may be because of 
problems in the particular packaging mix.
Repeat the calculation for tube 2 as for tube 1. This 
is an important control, since the titre gives a measure of 
the efficiency of ligation and should be approximately 
107pfu/ug.
Tube 2 - Total no. plaques = (1140000^ + 9200°) x 50ul
= 5746000 
= 5.7 x 107pfu/ug.
Two other numbers can be obtained by comparing the 
ratio of the titre on L87 and NM514. The arms selective 
ratio should always be >100 and is almost always lower than 
the parental DNA ratio (in tube 1).
In this case, the value for the arms selective ratio 
was 124 (or 0.8%, percentage of clears). This is an 
invariant property of the specific batch of lambda gtlO arms 
and the host cells taken together. It is directly applicable 
to tubes 3-6 since the same batch of lambda gtlO and the host 
cells were used. The L87 titre represents the total products 
of the ligation/packageing reaction which are mainly 
recreated parental lambda gtlO (in this experiment 99.2%). 
If this titre is divided by the arms selective ratio, a 
figure is obtained for the true background on NM514 if no 
recombinants have been formed (no insert DNA added to the 
ligation reaction). Subtracting the background figure from 
the actual titre obtained on NM514 cells in the cDNA reaction 
should give a reasonable count of the number of recombinants 
obtained and also the % of true recombinants out of the clear 
plaques. Obviously, if the same amount of lambda gtlO arms 
has been used in each cDNA ligation then values can be worked 
out more easily as percentages. The figures obtained here 
for the % of true recombinants are in agreement with 
empirical data described in section 5.6.
Tube 3 - Total no. of plaques = (369000t + 50900°) x 50ul 
50ng control insert = 20995000
= 2.1 x 107pfu/ug.
The percentage of clears is 12%, and the background (always
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taken from tube 2) is 0.8%. The percentage of true insert 
containing recombinants out of the total number of clears is: 
(12 - 0.8 / 12) x 100% = 93%
So the expected number of
true recombinants = 0.93 x 50900 x 50ul
= 2.4 x 106pfu/ug.
Tube 3 calculations should give an idea of the 
performance of the cloning procedure and should show 
definitive cloning of inserts. Success in cloning of this 
DNA (which can either be EcoRI linkered or EcoRI restricted 
DNA fragments) alongside failure of cloning experimental cDNA 
indicates that the latter could be the problem.
The same calculations have been completed on data from 
tubes 4, 5 and 6 where increasing amounts of JEG-3 cDNA (lul, 
2ul and 3ul = 500ng) were ligated into lug lambda gtlO arms. 
Figures have been adjusted for the 10^ dilution series on 
both E. coli. hosts.
Tube 4 - Total no. plaques = (37300^ + 560c ) x 50ul 
lul cDNA = 1893000
= 1.9 x 106pfu/ug.
The percentage of clears is 1.4% (background = 0.8%).
The percentage of true insert containing recombinants out of
a total number of clears is:
(1.4 - 0.8 / 1.4) x 100% = 43%
So the expected number
of recombinants is = 0.43 x 560 x 50ul
= 1.2 x 104 true recombinants.
Tube 5 - Total no. of plaques = (79200t + 1670c ) x 50ul
2ul cDNA = 404350
= 4 x 105pfu/ug.
The percentage of clears is 2.0% (background =0.8%).
The percentage of true insert containing recombinants out of
a total number of clears is:
(2 - 0.8 / 2) x 100% = 60%
So the expected number
of recombinants is = 0.60 x 1670 x 50ul
= 5 x 104 true recombinants.
Tube 6 - Total no. of plaques = (63300^ + 1320c ) x 50ul
3ul cDNA = 3231000
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= 3.2 x 106pfu/ug.
The percentage of true insert containing recombinants out of 
a total number of clears is:
(2 - 0.8 / 2) x 100% = 60%
So the expected number
of recombinants is = 0.66 x 1320 x 50ul
= 4 x 104 true recombinants.
Tubes 4, 5 and 6 were pooled together and so:
the total number of clears would be (560 + 1670 + 1320) x
50ul
= 177500 
= 1.8 x 105
The total number of true recombinants of the pooled library
should be approximately (1.2xl04 + 5xl04 + 4xl04)
= 1x10s
Thus, the percentage of true recombinants in the pooled 
library (tubes 4 + 5 + 6 )  will be approximately 57%.
5.5 Probing JEG-3 cDNA Library with cDNA to check for 
inserts.
In order to see if the cDNA library actually contained 
inserts, it was probed with radioactive labelled cDNA. The 
levels of hybridization were compared to the background 
hybridization levels on parental lambda gtlO.
A small proportion of the library was plated out at 
low density such that individual, medium sized plaques were 
well spaced out (less than 500 plaques per 100cm2 square 
plate). Parental lambda gtlO plaques were plated out to 
confluency. Duplicate plaque lifts were taken and probed 
with radioactively labelled reverse transcribed first strand 
cDNA using lug mRNA starting material as described in section 
2.28 but with two exceptions. Firstly, 40uCi [alpha-22P]- 
dCTP were used and secondly, no cold dCTP's were included in 
the synthesis. Unfortunately the probe made in this manner 
had too few counts to give a reasonable signal after 
autoradiography (data not shown). Subsequently, a 
preparation of cDNA was labelled using random 
hexadeoxynucleotide primers and synthesis with Klenow as 
described in section 2.26.
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The primary plaque lifts were washed at 65°C with
IxSSPE, 0.1%SDS while the secondary lifts were washed at
75°C. Figure 5.5.1 shows strong hybridization of the cDNA 
probe to some of the plaques on the experimental filter, with 
medium • and weak hybridization to others. The levels of
hybridization of the cDNA probe to parental lambda gtlO 
control filter lifts was very much lower (could not be 
photographed using the same exposure times) and could be 
compared to some of the plaques on the experimental filter. 
The exact frequency of insert containing plaques could not be 
estimated because of the differing levels of hybridization 
(as expected). This is a direct consequence of the nature of 
the mRNA population and hopefully its true representation as 
cDNA (whether as probe or that ligated into lambda gtlO). 
mRNA's that are quite rare in the population will not 
contribute greatly to the total signal of the probe and in 
addition to this, the probability of such a labelled species 
hybridizing to a plaque represented at low frequency will be 
much reduced. The relative hybridization signal achieved 
from a plaque on inspection might be an indication of how 
common this mRNA species is - indeed this could be a method 
of isolating more abundant mRNA's (using low levels of probe 
and limiting the time for hybridization). Filters washed at 
75°C had relatively low levels of hybridization and were not 
used in or necessary for the analysis (data not included).
The results appeared to be encouraging and 
consequently lambda DNA was prepared from six plaques which 
exhibited strong hybridization levels (lambdai_vi) and from 
two plaques with the lowest levels of hybridization levels 
(lambdavii and Viii) - see figure 5.5.1 for examples of such 
plaques.
5ug lambdai_viii DNA was EcoRI digested to see if an 
insert was present (figure 5.5.2a). An EcoRI digest should 
remove the insert from within the original EcoRI cloning site 
in the cl gene. Figure 5.5.2 shows that lambdaVj_ contains an 
insert of approximately 800bp.
Inserts will not be seen on agarose gels if they are 
too small even if large amounts of lambda DNA is restricted. 
A direct consequence of their relative small size will be a 
small amount of each (since they are restricted from lambda 
gtlO which is 43Kb). There is also the possibility that 
inserts may contain an internal restricion site and this
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Figure 5.5.1 Hybridization of random primed cDNA to lambda
gtlO JEG-3 cDNA library and a comparison with background
hybridization to purely parental lambda gtlO plaques.
***- Strong plaque hybridization to cDNA 
**- Medium " " "
*- Weak
- Background levels of hybridization to parental lambda 
gtlO (not visible using the exposure times for the 
above).
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6 . 5Kb 
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Figure 5.5.2 (a and b) Agarose gel electrophoresis of (a)- 
EcoRI and (b)-Hindi I I/Bgll I restricted Lajnbdaa_v^aa DNA 
samples.
a-Tracks (1,10) lambda Hindlll markers; (2-9)-lambda^_
viiiEcoRI.
b-Tracks (1) lambda PvuII markers, (8,11) lambda 
Hindlll/EcoRI markers; (2-7)-lambdai_viHindIII/BglII; (9,10)- 
lambdav:i_:j_ an^
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would hinder their visualization on gels for the reasons 
outlined above. In order to detect any of the possible 
remaining inserts, the samples could have either been 
Southern blotted and probed with cDNA or end-labelled after 
EcoRI restriction. Instead, the samples were restricted with 
Hindlll/Bglll which generates a 1.14Kb band encompassing the 
EcoRI cloning site (Figure 5.5.2b and 5.5.1). Providing that 
the inserts themselves do not contain one or both of these 
sites then the 1.14Kb band should show a reduced mobility on 
agarose gels.
The plaques (lambdavii a n 3  Viii^ which showed only 
very weak / background levels of hybridization (figure
5.5.1) appeared to have no inserts. Indeed, the lambda arms 
themselves do not appear to have been restricted and possible 
explanations for this might be the disruption of the EcoRI 
site during in vitro manipulation or a deletion of a small 
fragment encompassing the EcoRI site. All of the plaques 
(lambdai-vi) showed the presence of small inserts 
(approximately 150bp) within the 1.14Kb Hindlll/Bglll 
fragment. One puzzling aspect of these fragments is that 
they appear to be diffuse when compared to lambda DNA 
fragments of sizes greater and smaller than 1.14Kb.
5.6. Analysis of Random Picked cDNA Clones for the presence 
and size of inserts.
Lambda gtlO DNA was prepared from twenty-four random 
picked and well isolated plaques (lambdaA_x ). lug of each 
(and also lug of lambda gtlO - containing no insert) was 
EcoRI digested in KGB buffer and subsequently heated to 70°C 
for 10 minutes. The EcoRI cohesive ends generated were 
radioactively labelled by filling in with Klenow, [alpha- 
32P]-dATP, cold dCTP, dGTP and dTTP. The radioactive 
samples were electrophoresed on an agarose gel along with 
HindiII/EcoRI digested lambda DNA markers and photographed. 
The gel was TCA precipitated (section 2.30) and vacuum dried 
before autoradiography. Although each lambda preparation had 
been successfully restricted (presence of two lambda gtlO 
arms), the labelling reaction repeatedly did not work and so 
the samples were treated as follows. 5ug of each lambdaA_x 
were subsequently digested with Hindlll/Bglll as outlined in 
section 5.5, and electrophoresed on a 2% agarose gel (figure
5.6.1).
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Figure 5.6.1 Agarose gel electrophoresis of Hindlll/Bglll 
restriction digests of LambdaA_x DNA samples. Tracks (*) are 
Lambda Hindlll/EcoRI markers, tracks (-) are parental lambda 
gtlO DNA samples.
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Not all of the samples could be used in the analysis 
since some preparations were poor (samples P, X) and T did 
not restrict at all. Just to remove any confusion, the low 
levels of fluorescence in the control sample next to sample M 
is because of leakage from a hole in the gel well.
As can be seen from figure 5.6.1, the samples that 
appear to have inserts are B,D,E,F,G,H,I,J,K,L,M,Q,U,V and W. 
The percentage of insert containing recombinants is probably 
15/21 x 100% = 71%. Before the frequency of insert
containing recombinants is completed, certain points must be 
discussed. Firstly, it appears that in some samples (A and J 
are good examples) there is more than one 1.14Kb band and one 
explanation for this is contamination with other lambda 
phages. Although these plaques were not left to diffuse for 
any length of time and they were plated out at low density, 
it seems that the requirements to keep a plaque well isolated 
were underestimated. However, the relative intensity of 
these bands (within a certain limit) should largely 
discriminate between (1) more than one lambda phage in the 
preparation and (2) a large insert (multiple inserts) which 
contains either Hindlll or Bglll or both restriction sites. 
Thus, in sample A the band which shows greater fluorescence 
is likely to represent the actual sample, whereas the two 
other bands (one smaller, one larger) are more likely to be 
contaminating phage (situation 1). Sample J is more 
representative of situation 2 and shows four bands of equal 
intensity. The size of the insert here would be (1.7Kb +
1.1Kb + 1.3Kb + .98Kb) - [1.14Kb]) = approximately 4Kb. It
would be unwise to comment on the average size of the library 
inserts for the reasons above, but the fact that some samples 
do display inserts, even though there is variation, indicates 
that the cDNA library was worth screening. The average size 
of cDNA's obtained from commercial preparations is usually 
1Kb.
5.7. Screening the cDNA Library using a Class t ht,a-b 7 cDNA 
Probe.
The remaining proportion of the library was plated out 
at a density of approximately 10-11,000 clear pfu's per plate 
in two stages (plates labelled A-J and K-P) and plaque lifted 
as described in 2.33. The filter lifts were hybridized with 
a classical class I HLA-B7 cDNA probe as described in section
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2.34 at 55°C.
Six positive plaques lambdaj^-6 remained after 
primary, secondary and tertiary screening (see figure 5.7.1). 
The filters were autoradiographed between washing 
progressively with increasing stringencies. This aspect of 
the work will be discussed fully in the discussion in section
5.8. Lambda DNA was prepared from each.
EcoRI digests of each positive lambda clone showed 
the size of the inserts to be either approximately 1.2 or 
1.4Kb (figure 5.7.2). This gel was Southern blotted and 
probed with HLA-B7 (figure 5.7.3). All inserts hybridized 
clearly with the class I probe (upto O.lxSSPE 0.1%SDS at 
70°C). No hybridization was observed with a non-specific 
(negative control) pBR322 probe.
Lambdaj^ Clone______ Size (Kb)________1— screen 2— screen
plate of origin
1 1.4 A A, 3
2 1.2 G G, 1
3 1.2 N N, 1
4 1.2 N N,2
5 1.4 N N, 3
6 1.2 3 3,1
The clones lambdaj^ an(^  were analyzed primarily 
since these were obtained from the first round of screening 
(plates A-J). Since the clones were to be sequenced in M13 
(polylinker mpl8 and mpl9), polylinker compatible restriction 
enzyme were used in their restriction analysis as well as 
others.
Many restriction enzymes were used (single and double 
digests) to map l a m b d a ( 1 . 4 K b )  and after agarose 
electrophoresis followed by Southern transfer, the membrane 
was probed with the 1.4Kb HLA-B7 cDNA probe. The results of 
the mapping were confusing since the molecular weight of the 
fragments in some of the samples did not always sum up to 
1.4Kb. This data has not been included and an explanation of 
this will be given in section 6.8.
The single SstI (see figure 5.7.4) and PstI sites in 
all clones were useful in subcloning into M13 (see chapter 
6). The two longer clones l a m b d a an(^  (1.4Kb) seemed
to generate similar patterns of restriction as each other as
122
(a) (c)
•• A
•*
•» •
ji.
•* * •
^  4 • -
(b) (d)
Figure 5.7.1 Primary and secondary screening of Gamma-IFN 
induced JEG-3 lambda gtlO cDNA library, with a class I HLA-B7
cDNA probe.
Primary Screen
(a)-washed with lxSSPE, 0.1%SDS 55°C e.g. plate A
(b)- " " " "e.g. background
parental lambda
(c)- " " " 65°C
Secondary Screen
(d)-washed with O.lxSSPE, 0.1%SDS at 65°C.
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1 2 3 4 5 6 7 8
2.3Kb
2.0Kb
1.6Kb
1.3Kb
980bp
890bp
5 60bp
Figure 5.7.2 Agarose gel electrophoresis of six positive 
cDNA lambda gtlO clones showing a size range 1.2 - 1.4Kb. 
Tracks (1,8)-lambda Hindlll/EcoRI markers, (2-7)-EcoRI 
lambdaJW^_ ( cDNA
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1 • I
i
l
I
1.4Kb 1.2Kb
Figure 5.7.3 Southern hybridization of six positive 
cDNA clones (JW1-6) hybridized with HLA-B7 cDNA probe. 
Tracks (1-6)- EcoRI lambdajW1_g cDNA clones. N.B. Track 
a partial digest.
lambda 
3 is
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8 7 6  5 4 3  2 1
2 . 3Kb
1. 6Kb
1.3Kb
8 90bp
560bp
Figure 5.7.4 Sstl digest of lambda clones
illustrating similar restriction patterns.
Tracks (l/8)-lambda Hindlll/EcoRI markers (2-7) 
l a m b d a c D N A  clones .
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JW1-6
Sstl
did the four shorter clones lambdaj^2,3,4 and 6 (l«2Kb).
DISCUSSION.
5.8.
5The total number of clear pfu's plated out was 1.8x10 
of which 1x10^ were by comparison with control experiments 
calculated to be true recombinants (section 5.4). Six 
positive cDNA clones were obtained which indicates that the 
frequency of class I inserts is 1:16,666 or 0.006%. If one 
assumes the library has an insert frequency of 71% 
(determined empirically) as assessed in section 5.6 then the 
frequency of class I inserts is 1:21,300 or 0.005%.
The longest (1.4Kb) cDNA clone is obviously shorter
than the size of the mRNA detected on northern formaldehyde
gels (section 4.4.2.). Obviously, full length mRNA is 
required at the beginning of the cloning procedure. Using 
total RNA for cDNA cloning would eliminate the mRNA isolation 
step and hence reduce the chance of degradation. Ribosomal 
RNA could be removed after the synthesis of the second strand 
by treatment with DNAse free RNAse and preparations of cDNA 
could be pooled before ligating into lambda gtlO. The 
attempted cloning of the remainder of the class I cDNA 
molecule is described in section 6.6 although a different 
procedure from the above was employed.
After autoradiography of the library filters that were 
washed at 55°C with lxSSPE, 0.1%SDS, a high level of 
background was observed, and also on the primary plaque lifts 
of parental lambda gtlO (figure 5.7.1a;b). The filters had 
to be washed with increasing stringencies in order to remove 
the background levels of hybridization. The unfortunate
consequences of this will be discussed in the concluding 
discussion. Screening secondary plaque lifts of the second 
part of the cDNA library was found to give much lower
background hybridization levels and "cleaner11 results, and it 
is advisable to screen both sets of plaque lifts. The high 
background levels on primary lifts are almost certainly due 
to an excess of E .coli debris, DNA and possibly agarose. 
Such high backgrounds were not observed on filters that were 
probed with random primed cDNA buth this is probably because 
the filters were washed at 65°C first (the hybridization 
conditions were the same in both experiments).
127
CHAPTER SIX
SEQUENCING OF CLASS I HLA cDNA CLONES OBTAINED FROM A CDNA 
LIBRARY MADE FROM GAMMA-INTERFERON INDUCED JEG-3 CELLS.
INTRODUCTION
6.1.
Sequencing of DNA has undergone rapid improvement 
since introduction of the chain terminating DNA sequencing 
method (Sanger et al. 1977) and the construction of 
convenient single-stranded DNA cloning vectors (Messing,
1983).
Initially, the M13 BRL sequencing system was used 
until the components were finished and subsequent to this the 
USB Sequenase™ Version 2.0 sequencing system was purchased 
since it claimed to have improved qualities. In actual fact, 
there was no difference in the quality of the sequence 
produced, but the latter system was easier to use and 
required much less [alpha-35S]thio-dATP.
There are two main differences between both systems; 
the enzyme used and the timing of sequence termination. BRL 
uses the Klenow fragment of E. coli. DNA Polymerase I whilst 
USB uses Sequenase™ (Tabor and Richardson, 1987) which is a 
modification of bacteriophage T7 DNA Polymerase. The,,
synthesized strand is continuously labelled and terminated 
throughout the sequencing procedure in the BRL system, 
whereas in the USB protocol, the dideoxynucleotides are added 
further on in the reaction. A consequence of the latter is 
that the concentration of dideoxynucleotides need not to be 
primarily optimized in order to influence the average length 
of the synthesized strand (refer to section 2.41).
Properties of T7 DNA Polymerase include high 
processivity (ability of the polymerase to incorporate 
nucleotides continuously without dissociating from the 
template), low 3 1 to 5' exonuclease activity, high speed and 
the efficient use of nucleotide analogues important for DNA 
sequencing (ddNTP's, alph-thio dNTP's, dITP, 7-deaza dGTP and 
others).
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6.2. Preparation of Double-Stranded Replicative Form (RF) M13 
DNA.
The vector used for sequencing was M13. Single 
plaques of both M13mpl8 and M13mpl9 were obtained and grown 
in 250ml cultures. Replicative form (RF) double stranded DNA 
(to be used for sub-cloning) was prepared as described in 
section 2.21. These preparations were tested for their 
efficiency in transfecting JM101/JM109 as described in 2.19 
and 2.39. The efficiency of transfection of M13 DNA is 
typically lower than that described for plasmids (lxl05/ug as 
compared to lxl03/ug respectively) and also varies between JM 
strains of E. coli. as outlined in the BRL manual.
Stocks M13mpl8 300ug/ml
M13mpl9 160ug/ml
Initially, the transformation efficiency of each 
preparation was extremely low on JM101: lxl03pfu/ug. After 
phenol extraction and ethanol precipitation this was 
increased to 7.5xl04 pfu/ug. It is worthy to note here that 
if too much M13 is used to transfect JM101 no blue plaques 
appear on the plate. Instead, a green tinge can just be 
discerned. This can easily be mistaken for no transfectants 
at all. Reducing the amount of transfecting DNA sees the 
individual blue plaques re-appearing.
6.3. Subcloning of JW1-6 into M13mpl8 and M13mpl9.
All six class I cDNA clones were EcoRI excised from 
lOug lambda gtlO and electrophoresed on a tris-acetate-EDTA 
(TAE) agarose (type I) gel. The inserts (approx. 300ng) were 
cut out of the gel and purified using the gene-clean 
procedure described in section 2.45. After ethanol 
precipitation they were resuspended in ligation buffer and 
ligated into 500ng EcoRI digested M13 (in duplicate ligations 
the vector was treated with calf-intestinal phosphatase - see 
section 2.25). After transfection, clear plaques were picked 
and minipreps of M13 RF DNA were made (STET prep, section
2.40) and tested for the presence of inserts on an agarose
gel. Since there is an Sstl restriction site within each
clone and also in the M13 polylinker, an Sstl digest reveals
the orientation of the clone (in JW1 and JW5 but not the 
others). A large proportion of the clear plaques did not
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contain inserts, and it became much less time consuming and 
more efficient to filter lift the plaques and hybridize the 
cDNA clone to detect the true recombinants. Most of the 
recombinant clones obtained were in M13mpl8 and some were in 
both orientations. Because of this, M13mpl9 was not used any 
further.
6.4. Sequence Strategy.
JW1 was subcloned into the EcoRI site of M13mpl8 in 
both orientations, JWla and JWlb (see below and figure
6.4.1).
Orientation (a^ - antisense strand is located on 
the single +ve strand of M13 and the 5 1 end of the gene is 
nearest the sequencing primer. Consequently, the sense 
strand is synthesized during sequencing.
Orientation (b) - sense strand is located on the 
single +ve strand of M13 and the 3 1 end of the gene is 
nearest the sequencing primer. Consequently, the antisense 
strand is synthesized during sequencing.
JWlEcoRI,a/b (JW1 EcoRI fragment in orientation a
or b.)
Replicative forms of these recombinants were Sstl 
and Pstl digested in 2xKGB buffer and heated to 70°C for 10 
minutes. After cooling on ice, the buffer was adjusted to 
include ImM ATP and 5units of T4 DNA ligase in 0.5x KGB 
buffer. The ligations were incubated overnight and were used 
to transfect JM101 as usual. The reason for doing this was 
to delete out the region between the sites (the 5 1 or 3 1 end 
of the gene depending on its orientation) since both sites 
were present once in the polylinker and once in the cDNA.
JWlSstI,a/b (JW1 EcoRI/SstI fragment, these are 
formed from the Sstl deletion digest of the JWlEcoRI a/b 
clone).
JWlPstIfa/b (JW1 EcoRI/PstI fragment, these are formed 
from the Pstl deletion digest of the JWlEcoRI a/b clone.
JWlPvuII,a/b 300bp PvuII fragment from JW1.
An EcoRI/PvuII digest generated three restriction 
fragments of 600, 300 and 400 base pairs, whilst a PvuII 
digest generated only the 300 base pair fragment. This
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JW1 / E c o R I .a
5’
Smal Pstl PvuII Sstl PvuII
^ J W 1  / E c o R l / o
 JW1*Smal*
_______ :_______ ^  J W 1 / P s t l / a
____________ J W 1 / P v u l l / a
^ __________ ^ J W 1 / S s t l / a
______ ^  Ol igo 3 8 6
J W 1 / E c o R I . b
3’ 5’
Pstl PvuII Sstl'. PvuII Smal
JVV1 / E c o R I ------
Oligo 3 8 6
>
>
JW1 / P s t l / b
JW1 / P v u I I / b
>
>
JW1 / S s t l / b >
0  i i g o 4 0 7 >
Figure 6.4.1 Sequence strategy used in sequencing JW1,4 and
5. See section 6.4 foR details.
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central 300bp PvuII fragment was cloned into the Smal (blunt) 
site of the M13 polylinker (M13 contains 3 PvuII sites).
Other subclones were designated JWlSmaI,a and
it it
JWl Sma ,a and will be described in section 6.6 in detail.
Unfortunately, no other useful restriction sites were 
in any way compatible (nor any isoschizomers) with the 
M13mpl8 polylinker restriction sites and it was necessary to 
use synthetic oligonucleotides (386, 387 and 407, see section 
2.42) to sequence the remaining part of the clone (see figure
6.4.1).
6.5. Preparation and Sequencing of Single Stranded
Recombinant M13.
Single stranded M13 DNA containing inserts were 
prepared from subclones obtained at that stage and a sample 
of each (JWlEcoRI,a/c and JWlSstl,a/c) electrophoresed on an 
agarose gel in order to estimate the amount of DNA prepared 
since this varies between preparations (see figure 6.5.1.).
Sequencing reactions were electrophoresed on 5-8% wedge or 
uniform sequencing gels as described in the BRL Manual and in 
section 2.41.
The JWlEcoRI,a/c subclones were sequenced at the same
time as preparing the other subclones, and this initial 
information was analyzed. The first 250bp of sequence from 
the 5 1 and 3 1 ends of cDNA clone JWl were compared by eye to 
the published HLA-B7 cDNA sequence (Sood et al. 1985). The 
3' region (extending from the poly A tail) could be position 
matched (lined up) quite easily but that of the 5 1 region 
could not be. Being aware that the cDNA clone (1.4Kb) was 
incomplete (Northern data indicated a 1.6Kb mRNA) and now 
obviously lacking the 5' end, a strategy based around the 
5 1 sequence information was devised to obtain the remaining 
section of this cDNA (see section below).
6.6. Cloning Strategy to Obtain the Remaining 5 1 Part of the 
Class I cDNA.
This cloning strategy was based upon the method of 
Dale et al. (1985), and required knowledge of the orientation 
of the clone and preliminary 5 1 sequence. The method and 
strategy are represented in figure 6.6.1. The idea behind
132
1 2 3 4 5
Figure 6.5.1 Agarose gel electrophoresis of ssM13 DNA 
samples containing various subclones of JWl.
Tracks (1,2)-lambdaJWEcoRIa/c (3)-lambda Hindlll markers, 
(4,5)-lambdaJWSstIa/c.
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this was to hybridize the antisense single strand of the 
partial cDNA (cloned into M13mpl8 +ve strand) to its 
complementary mRNA and use this as a primer/template complex 
in order to extend the 5' end. The antisense strand of the 
cDNA must be cloned within the +ve phage single strand in 
order that it should hybridize to the homologous mRNA 
(sense). Single strand M13 phage DNA is circular and so this 
must be linearised at a point within the clone and preferably 
as near to the 5' end as possible. Linearization of the 
strand can be accomplished by the appropriate combination of 
a restriction site directed synthetic oligonucleotide (RSDF 
see below) and its compatible restriction endonuclease. 
Indeed, some restriction endonucleases are able to cleave 
single strand sequences (Bischofberger et al. 1987). If no 
convenient restriction sites are present, the endonuclease 
(FokI) can be used with a specific oligonucleotide to 
restrict a non-specific dsDNA sequence (Kim et al. 1984; 
Podhajsska and Sybalski, 1985). The use of FokI represents a 
more universal approach.
One practical consideration, is the removal of the 
EcoRI site from the 5 1 end of the cDNA clone (which has 
arisen from the addition of EcoRI linkers to the cDNA before 
cloning). It is most unlikely that this site will be present 
here (unless methylation during cDNA preparation was 
unsuccessful). Fortunately, a Smal site within the 
polylinker and a single Smal site 40bp into the 5' end of the 
cDNA enabled the deletion of the EcoRI site and the formation 
of the Smal modified clone, JWlSmaI,a from JWlEcoRI,a (see 
figure 6.6.1). The deletion of the Smal fragment obviously 
retained a 5' most Smal site to which a restriction site 
directed fragment (RSDF) or oligonucleotide could be made. 
This was used as a means of linearizing the modified, single 
stranded cloned. The deletion of the Smal fragment to form 
the modified clone and the knowledge of the cDNA sequence 
within it enabled the design of the screening oligo (see 
section 2.42). This was used to detect extended 
recombinants, since the blue/white selection is no longer 
useful.
Obviously there are problems associated with extending 
sequences which belong to a polymorphic multigene family, 
since hybrid alleles could be generated. A number of clones 
would be required to confirm results.
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JWl,EcoRI,a.
Ml 3
< -
Deletion of the Smal fragment from RF JWl,EcoRI,a (to 
remove the EcoRI site, see figure 6.6.3). Religate and 
transfect. Select for the subclone by T-tracking and 
sequencing (see figure 6.6.2).
polylinker
— K ------- <
a m m o
JWlEcoRI,a
carboxyl 
 >
HindiII Smal RI 
-J________I_l_
Smal»
A  A
Smal deletion
Sstl
Antisense
JWl,Smal(Modified Clone). Prepare ssM13 DNA and anneal 
Smal oligo. Linearize by restriction with Smal.
JWlSmal (Modified Clone) 
Hindlll Smal Sstl
 |_________I 1 TTTTTT
5 ' 3 1
Smal oligo
M13 single +ve strand
Figure 6.6.1 Outline of the cloning strategy to obtain 
the remaining 5 1 part of the JWl Class I cDNA. This was 
based around the method of Dale et al. (1985).
JWl,Smal (Modified Clone).
Hybridize the linearized single stranded form or JWl,Smal to 
JEG-3 mRNA.
^   mRNA
 _ _ _ _ _    AAAAAAAAAA 3 ’
TTTTTT
3'
Synthesize cDNA using reverse transcriptase (XXX). Terminal
transferase using deoxycytidine(C). Hybridize the annealing 
(bridgeing) oligo-RSDF.
Annealing oligo
V
5 1XXXXXXXXXGGGGGGG 3'
  1------ 1 CCCCCCC
C 5'
c X \
X \
X '■
X
X - 
X.
M13 single strand form
1
! Transform
Select recombinants by hybridization with 
screening oligo.
Figure 6.6.1 contd.
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During the preparation of the modified clone, two
other different "spurious" deletion clones were obtained, and 
the sequences are shown in figure 6.6.2. The possible sites 
for the spurious Smal restriction seem to be different and 
are represented in figure 6.6.3. The first of these clones 
(JWl Smal ) was useful in completing the sequence of JWl, 
since it allowed progress through to the Pstl site.
6.7. Nucleotide Sequence Comparison of JWl. JW4 and JW5.
The complete sequence of both strands of JWl was
obtained and that for JW4 and JW5 was completed by
overlapping information obtained from alternative strands. 
Overlapping sequence data within the coding region (as far as 
they extend) of clones JWl, 4 and 5 suggest that all are
derived from the same allele (see figure 6.7.1.). Primarily, 
before any sequence data had been obtained a simple diagram 
was drawn (shown below) from the Sstl restriction pattern 
(figure 5.7.4) with reference to this site (although there 
was no evidence to suggest that this site was in the same 
position in all of the clones because of the possibility of 
there being two or more genes/alleles expressed. The size 
(bp) was estimated from mobility on agarose gels.
~850bp Sstl ~550bp
5'-- *---------- (polyA15) 3 1 JWl and JW5
—  --------- *-------------(polyA>10o) JW2,3,4 and 6
~600bp Sstl ~600bp
Sequence alignments have confirmed that this is how 
the clones JWl, JW4 and JW5 overlap.
Clones JWl and JW5 were found to be identical in both 
sequence and length (1418bp) and extended forward from the 
polyadenylation tail (15bp). This was very unusual since 
these clones were independently picked and they originated 
from different plates (refer to end of section 5.7).
JW4 was shorter than JWl, beginning at nucleotide 268 
(see figure 6.7.1) and having a much longer polyadenylation 
tail (>100bp assumed partly from the Sstl digest). JW6 which 
gives the same Sstl restriction pattern as JW4 was found to 
have a >100bp polyadenylation tail on sequencing gels. JWl
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Clone 1 
ACGT
Clone 2 
JWlSmal,a JWl*SmaI* 
ACGT ACGT
Figure 6.6.2 Sequence Autoradograph of Smal deletion 
subclones.
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The strand represented below is the sense strand which is 
synthesized during sequencing of JW^EcoR^a anc^  so
corresponds to the 5 ’most part of the cDNA.
M13 polylinker --------------HLA JWl cDNA clone
Smal EcoRI Smal *SmaI?*
atcCCCGGGtaccgaqctcGAATCCcqq cggCCCGGGtcg------ gagccCCAGT
atcCCCGGGtcg -gagccCCAGT Smal deletion clone!
This Smal deletion clone (see figure 6.6.1) was 
created solely for the purpose of obtaining the remaining 5 1 
end of the existing cDNA clone. It represents the starting 
material for the cloning strategy outlined in section 6.6.2.
However, two different spurious Smal deletions were 
obtained unexpectedly, the first of which enabled sequencing 
of the 5 1 region of the clone.
1:
atcCCCGGGtaccgaqctcGAATCCcqq cggCCCGGGtcg------ gagccCCAGT
atcCCCAGT JWl*SmaI* useful for completing the sequence. 
2:
atcCCCGGGtaccgaqctcGAATCCcqq cggCCCGGGtcg------ gagccCAGT
atcCCCGGGtaccgagctcGAATTCcgg cggCCCCAGTCAC
Figure 6.6.3. Smal deletion subclone of JWl - JWl Smal used 
in the cloning strategy described in section 6.6. Two
further "spurious" subclones are outlined.
and JW4 differed in the 3 1 untranslated region by a 7 base 
pair deletion (AATCCGC) 5 1 to the polyadenylation site in JW4 
(see figure 6.7.1. and 6.7.2). Only one common
polyadenylation signal could be identified. The significance 
of a different polyadenylation site in clones JWl and JW4 is 
not known. Cianneti et al. (1989) reported an alternative 
polyadenylation site in the HLA-A2 gene which probably 
resulted from the use of a less efficient polyadenylation 
signal located 100 base pairs 5 1 to the canonical one. 
Multiple polyadenylation sites and signals have been reported 
for several other genes and are known to contribute to the 
overall regulation of gene expression (reviewed by Birnstiel 
et al. 1985).
6.8. Comparison of JWl and FT.a-a r -b and -C locus nucleotide 
sequences.
Computer alignments of the sequences of JWl compared 
to HLA-A, -B and -C genomic and cDNA revealed that the first 
221 bp of the 5' region were in fact part of intron 2 (figure
6.8.1). Thus JW4 began 47 base pairs into the alpha-2 
domain. JWl and JW5 were thought to be cDNA products of 
polyadenylated nuclear precursor mRNA. The frequency of 
incompletely spliced mRNA's (two out of six clones) is 
unusually high. The presence of intron 2 sequence explains 
the confusion in restriction mapping outlined in section 5.7. 
Primarily, restriction digests of the HLA-B7 cDNA were 
Southern blotted and hybridized to JWl insert probe since the 
restriction map of the former was known. Some of these 
results were confusing. Obviously, no sequences hybridized 
to intron 2 and the restriction digests that separated the 
latter from the alpha-2 domain sequence could not be 
understood fully. Similar concurrent work (where HLA-B7 cDNA 
was radiolabelled and hybridized to a series of restriction 
digests of JWl) was equally confusing and for this reason 
none of the data was included in section 5.7. This work was 
to be repeated using self (JWl) hybridization of the lambda 
clones, however, initial sequence information indicating the 
presence of intron 2 excluded the need for this data. As a 
consequence of this, the strategy developed to clone the 
remaining 5 1 of the gene (outlined in section 6.6) was 
abandoned although it has been represented diagramatically
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Figure 6.7.1 Complete Sequence of JWl, 4 and 5. The
first 221bp of JWl are intron 2 followed thereafter by 
coding sequence. Note that Jw4 begins at position 268 
and differs from JWl and JW5 by a 7bp deletion 5* to the 
polyadenylation site. Restriction sites used in 
subcloning are underlined and the oligonucleotides used 
in completing the sequence are marked in 1 . The exon
boundaries are marked with a note of the protein domain 
that follows (refer to figure 1.1.4c).
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5 ’ Intron 2 Sma I
1 CGGTCACGAC CCCTCCCCAT CCCCCACGGA CGGCCCGGGT CGCCCCGAGT
51 CTCCCCGTCT GAGATCCACC CCGAGGCTGC GGAACCCGCC CAGACCCTCG
101 ACCGGAGAGA GCCCCAGTCA CCTTTACCCG GTTTCATTTT CAGTTTAGGC
151 CAAAATCCCC GCGGGTTGGT CGGGACTGGG GCGGGGCTCG GGGGACCGGG
I—
201 CTGACCACGG GGGCGGGGCA GfGGTCTCACA CCCTCCAGAG GATGTTTGGC
^  oligo 4oo......................
251 TGCGACCTGG GGCCGGACGG GCGCCTCCTC CGCGGGTATA ACCAGTTCGC
301 CTACGACGGC AAGGATTACA TCGCCCTGAA CGAGGATCTG CGCTCCTGGA
351 CCGCCGCGGA CACGGCGGCT CAGATCACCC AGCGCAAGTG GGAGGCGGCC
401 CGTGAGGCGG AGCAGCGGAG AGCCTACCTG GAGGGCACGT GCGTGGAGTG
451 GCTCCGCAGA TACCTGGAGA ACGGGAAGGA GACGC^GCAG CGCGCGG,AA<^2
501 ACCCAAAGAC ACACGTGACC CACCATCCCG TCTCTGACCA TGAGGCCACC
551 CTGAGGTGCT GGGCCCTGGG CTTCTACCCT GCGGAGATGA CACTGACCTG
601 GCAGTGGGAT GGGGAGGACC AAACTCAGGA CACCGAGCTT GTGGAGACCA
651 GGCCAGCAGG AGATGGAACC TTCCAGAAGT GGGCA^CTGT GGTGGTGCCT
701 TCTGGAGAAG AGCAGAGATA CACGTGCCAT GTTCAGCACG AGGGGCTGCC
751 GGAGCCCCTC ACCCTGAGAT GGAIAGfecGTC TTCCCAGCCC ACCATCCCCA
801 TCGTGGGCAT CGTTGCTGGC CTGGCTGTCC TGGCTGTCCT AGCTGTCCTA
Sstl _ 3pl
851 GGAGCTATGG TGGCTGTTGT GATGTGTAGG AGGAAGAGCT CAGGTGGAAA
901 AGGAGGGAGC TGCTCTCAGG CTGCGfcC^G CAACAGTGCC CAGGGCTCTG
951 ATGAGTCTCT CATCGCTTGT AAAdcC^TGAG ACAG^TGCCT GTGTGGGACT
stop
1001 GAGATGCAGG ATTTCTTCAC ACCTCTCCTT TGTGACTTCA AGAGCCTCTG
1051 GCATCTCTTT CTGCAAAGGC ATCTGAATGT GTCTGCGTTC CTGTTAGCAT
1101 AATGTGAGGA GGTGGAGAGA CAGCCCACCC CCGTGTCCAC CGTGACCCCT
 6figo586 ^
1151 GTCCCCACAC TGACCTGTGT TCCCTCCCCG ATCATCTTTC CTGTTCCAGA
1201 GAAGTGGGCT_ GGATG_TCTCC ATCTCTGTCT CAACTTCATG GTGCGCTGAG
oiigo 387
125 1 CTGCAACTTC TTACTTCCCT AATGAAGTTA AGAACCTGAA TATAAATTTG
1301 TTTTCTCAAA TATTTGCTAT GAAGGGTTGA TGGATTAATT AAATAAGTCA
1351 ATTCCTGGAA GTTGAGAGAG CAlAATAAA)GA CCTGAGAACC TTCCAGAATC 
1401 CGCAAAAAAA AAAAAAAA 3 ’
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JWl
ACGT
JW4
ACGT
Figure 6.7.2 Sequence autoradiograph illustrating the 
presence and absence of 7 base pairs (AATCCGC) in the 3' UT 
region of clones JWl and JW4 respectively.
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—
E  -
T
h
G
G
G
A
C
G
G
G|
G
- intron2-exon3 (alpha-2)
Figure 6.8.1 Sequence autoradiograph of the 
boundary of clones JWl and JW5.
intron2/exon3
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because both the Sma subclone, JWlSmaI,a and a spurious Sma 
subclone, JWl*SmaI* from this strategy were very useful in 
completing the sequence of JWl.
It is important to mention at this point that further 
attempts were being made to clone the remaining 5 1 end of the 
cDNA since all the sequence data was complete. However, 
Ellis and co-workers in Oxford had submitted a paper which 
described the full length sequence of a class I cDNA clone 
obtained from a BeWo cDNA library. The sequence of JWl as 
far as it extended seemed to be (see discussion) identical to 
that of BeWo C.l described in this recent publication (Ellis 
et al. 1989). This is indeed not surprising since BeWo and 
JEG-3 seem to be derived from the same choriocarcinoma, see 
section 3.1.1.
The information below has been derived from the 
sequence comparison (using the GCG Sequence Analysis Software 
Package) of the coding and 3 1UT regions of JWl and HLA-A3 
(Strachan et al. 1984), HLA-B7 (Sood et al. 1985), HLA-Cwl; 
HLA-Cw2 (Gussow et al. 1987), HLA-Cw3 (Sodoyer et al. 1984) 
and HLA-Cw4 mRNA (Davidson et al. 1985) which were obtained 
from the GenBank and EMBL databases. A comparison of JWl or 
BeWo C.l with HLA-A, -B and -C locus sequences clearly shows 
that they are both more homologous with sequences derived 
from the HLA-C locus (see figure 6.8.2 and Ellis et al. 
(1989), respectively).
A detailed comparison of nucleotide substitutions in 
the coding region, shows that JWl differs from Cwl-4 in five 
positions (393, 418, 844, 904, 991, these numbers do not
correspond to the positions in the actual genomic sequence) 
where the latter are in full agreement, and in two positions 
(374, 425) where a Cwl-4 consensus cannot be derived. At
eight positions (465, 492, 545, 565, 566, 611, 736, 912) when 
a consensus cannot be derived, the corresponding nucleotide 
of JWl is always the same as one other sequence. The % 
homology between the exonic coding sequences of JWl with HLA- 
A3, HLA-B7 and four C-locus (Cwl-4) is illustrated in figures 
6.8.3 and 6.8.4. These figures give a detailed summary of 
where these differences lie with an exact account of the 
number of nucleotides used in the calculations.
Overall, the four alleles Cwl-4 are 98.5% homologous 
to each other, while JWl is 99.6% homologous to a C-locus 
consensus! This figure however is obviously biased because
145
Cw3ex 
Cw2ex 
Cwlex 
HIa-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Hla-B7 
HI a-A3
Cw4rna
Cw3ex
Cw2ex
Cwlex
Hla-B7
Hla-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
H1a-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
H1a-B7 
HI a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
H 1a-B7 
H 1a-A3
1 signal peptide
ATGCGGGTCA TGGCGCCCCG 
ATGCGGGTCA TGGCGCCCCG 
ATGCGGGTCA TGGCGCCCCG 
A TGGCGCCCCG 
A TGGCGCCCCG
51
GGCCCTGACC 
GGCCCTGACC 
GGCCCTGACC 
GGC..TGACC 
GGCCCTGACC
101
ACACCGCCGT
GCACCGCTGT
ACACCGCTGT
TCACATCCGT
ACACATCCGT
TCACATCCGT
151
GGCTACGTGG
GGCTACGTGG
GGCTACGTGG
GGCTACGTGG
GGCTACGTGG
GGCTACGTGG
201
TCCGAGAGGG
TCCGAGAGGG
TCCAAGAGGG
TCCGAGAGGG
TCCGAGAGAG
CCAGAGGATG
251
ATTGGGACCG
ATTGGGACCG
ATTGGGACCG
ATTGGGACCG
ATTGGGACCG
ATTGGGACCA
GAGACCTGGG
GAGACCTGGG
GAGACCTGGG
GAGACCTGGG
CAGACCTGGG
GTCCCGGCCC
GTCCCGGCCC
GTCCCGGCCC
GTCCCGGCCT
GTCCCGGCCC
GTCCCGGCCC
ACGACACGCA
ACGACACGCA
ACGACACGCA
ACGACACGCA
ACGACACCCA
ACGACACGCA
GAGCCGCGGG
GAGCCGAGGG
GAGCCGCGGG
GAGCCGCGGG
GAGCCGCGGG
GAGCCGCGGG
GGAGACACAG
GGAGACACAG
GGAGACACAG
GGAGACACAG
GAACACACAG
GGAGACACGG
GACCCTCATC
AACCCTCATC
AACCCTCATC
AACCGTCCTC
AACCCTCCTC
1
T .•.GCTC 
CCG.^.GCTC 
CCT.•.GCTC 
CCT.•.GCTC 
CGG.•.GCTC 
CGG.#.GCTC
GGCGCCGGAG
GGACGCGGGG
AGCCGCGGAG
GGCCGCGGAG
NNNNNNGGGG
GGCCGCGGGG
GTTCGTGCGG
GTTCGTGCGG
GTTCGTGCGG
GTTCGTGCGG
GTTCGTGAGG
GTTCGTGCGG
CGCCGTGGGT
CGCCGTGGGT
GCCGCTGGGT
CGCCGTGGGT
CGCCGTGGAT
CGCCGTGGAT
AAGTACAAGC
AAGTACAAGC
AAGTACAAGC
AAGTACAAGC
ATCTACAAGG
AATGTGAAGG
CTGCTGCTCT
CTGCTGCTCT
CTGCTGCTCT
CTGCTGCTCT
CTGCTACTCT
CCACTCCATG
CCACTCCATG
CCACTCCATG
CCACTCCATG
CCACTCCATG
CCACTCCATG
AGCCCCGCTT 
AGCCCCACTT 
AGCCCCACTT 
AGCCCCGCTT 
AGCCCCG.CT 
AGCCCCGCTT
TTCGACAGCG
TTCGACAGCG
TTCGACAGCG
TTCGACAGCG
TTCGACAGCG
TTCGACAGCG
GGAGCAGGAG
GGAGCGGAAG
GGAGCAGGAG
GGAGCAGGAG
AGAGCAGGAG
AGAGCAGGAG
GCCAGGCACA
CCCAGGCACA
GCCAGGCACA
GCCAGGCACA
CCCAAGCACA
CCCAGTCACA
50
CGGGAGCCCT 
CGGGAGCCCT 
CGGGAGCCCT 
CGGGG.CCCT 
CGGGGGCCCT
100
AGGTATTTCG
AGGTATTTCT
AGGTATTTCT
AAGTATTTCT
AGGTATTTCT
AGGTATTTCT
150
CATCTCAGTG
CATCGCCGTG
CATCGCAGTG
CATCTCAGTG
CATCTCAGTG
CATCGCCGTG
200
ACGCCGCGAG
ACGACGAGAG
ACGCCGCGAG
ACGCCGCGAG
ACGCCGCGAG
ACGCCGCGAG
250
GGGCCGGAGT
GGGCCGGAGT
GGGCCGGAGT
GGGCCGGAGT
GGGCCGGAGT
GGGCCGGAGT
300
GGCTGACCGA
GACTGACCGA
GACTGACCGA
GACTGACCGA
GACTGACCGA
GACTGACCGA
Figure 6.8.2. Exon and 3 1UT Sequence Comparison of JWl with 
HLA-A3 (Strachan et al. 1984); HLA-B7 (Sood et al. 1985);
HLA-Cwl and HLA-Cw2 (Gussow et al. 1987); HLA-Cw3 (Sodoyer et 
al. 1984) and HLA-Cw4mRNA (Davidson et al. 1985).
The exons boundaries are marked by (.•.) with a note of the 
protein domain that follows (refer to figure 1.1.4c).
146
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
Hla-B7 
HI a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
H1a-B7 
HI a-A3
Cw4rna
Cw3ex
Cw2ex
Cwlex
Jwlex
Hla-B7
H1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
Hla-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jw1 ex 
H 1a-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
Jw1 ex 
H 1a-B7 
HI a-A3
Cw4 rna 
Cw3ex 
Cw2ex 
Cw1 ex 
Jw1 ex 
Hla-B7 
H 1a-A3
301
GTGAGCCTGC
GTGAGCCTGC
GTGAACCTGC
GTGAGCCTGC
GAGAGCCTGC
GTGGACCTGG
351^-2
GTCTCACACC
GTCTCACATC
GTCTCACACC
GTCTCACACC
GTCTCACACC
GTCTCACACC
TTCTCACACC
GGAACCTGCG
GGAACCTGCG
GGAAACTGCG
GGAACCTGCG
GGAACCTGCG
GGACCCTGCG
CTCCAGAGGA
ATCCAGAGGA
CTCCAGAGGA
CTCCAGTGGA
CTCCAGAGGA
CTTCAGAGCA
ATCCAGATAA
CGGCTACTAC
CGGCTACTAC
CGGCTACTAC
CGGCTACTAC
CGGCTACTAC
CGGCTACTAC
♦
TGTCTGGCTG
TGTATGGCTG
TGTACGGCTG
TGTGTGGCTG
TGTTTGGCTG
TGTACGGTTG
TGTATGGCTG
AACCAGAGCG
AACCAGAGCG
AACCAGAGCG
AACCAGAGCG
AACCAGAGCG
AACCAGAGCG
CGACCTGGGG
CGACGTGGGG
CGACCTGGGG
CGACCTGGGG
CGACCTGGGG
CGACGTGGGG
CGACGTGGGG
350
AGGACG.•.G 
AGGCCG.•.G 
AGGCCG.•.G 
AGGCCG.•.G 
. •. G 
AGGCTG.•.G 
AGGCCG.#.G
+  400
CCCGACGGGC 
CCCGACGGGC 
CCCGACGGGC 
CCCGACGGGC 
CCGGACGGGC 
CCGGACGGGC 
TCGGACGGGC
401
GCCTCCTCCG
GCCTCCTCCG
GCCTCCTCCG
GCCTCCTCCG
GCCTCCTCCG
GCCTCCTCCG
GCTTCCTCCG
CGGGT AT GAC 
CGGGTATGAC 
CGGGTATGAC 
CGGGTATGAC 
CGGGTATAAC 
CGGGCATGAC 
CGGGTACCGG
CAGTACGCCT
CAGCACGCCT
CAGTCCGCCT
CAGTACGCCT
CAGTTCGCCT
CAGTACGCCT
CAGGACGCCT
ACGACGGCAA
ACGACGGCAA
ACGACGGCAA
ACGACGGCAA
ACGACGGCAA
ACGACGGCAA
ACGACGGCAA
450
GGATTACATC
GGATTACATC
GGATTACATC
GGATTACATC
GGATTACATC
GGATTACATC
GGATTACATC
451
GCCCTGAACG
GCCCTGAACG
GCCCTGAACG
GCCCTGAACG
GCCCTGAACG
GCCCTGAACG
GCCCTGAACG
♦
AGGACCTGCG
AGGATCTGCG
AGGACCTGCG
AGGACCTGCG
AGGATCTGCG
AGGACCTGCG
AGGACCTGCG
CTCCTGGACC
CTCCTGGACC
CTCCTGGACC
CTCCTGGACC
CTCCTGGACC
CTCCTGGACC
CTCTTGGACC
GCGGCGGACA
GCCGCGAACA
GCCGCGGACA
GCCGCGGACA
GCCGCGGACA
GCCGCGGACA
GCGGCGGACA
+  500
CCGCGGCTCA 
CGGCGGCTCA 
CAGCGGCTCA 
CCGCGGCTCA 
CGGCGGCTCA 
CGGCTGCGCA 
TGGCGGCTCA
501
GATCACCCAG
GATCACCCAG
GATCACCCAG
GATCACCCAG
GATCACCCAG
GATCACCCAG
GATCACCAAG
551
CCTACCTGGA 
CCTACTTGGA 
CCTACCTGGA 
CCTACCTGGA 
CCTACCTGGA 
CCTACCUGGA 
CCT ACC I K.i(j A
601
GGGAAGGAGA
GGGAAGGAGA
GGGAAGGAGA
GGGAAGGAGA
GGGAAGGAGA
GGGAAGGACA
GGGAAGGAGA
CGCAAGT GGG 
CGCAAGT GGG 
CGCAAGTGGG 
CGCAAGTGGG 
CGCAAGTGGG 
CGCAAGTGGG 
CGCAAGTGGG
GGGACTGTGC 
GGGCCTGTGC 
GGGCGAGTGC 
GGGCACGTGC 
GGGCACGTGC 
GGGCGAGTGC 
T GGCACGT GC
O
CGCTGCAGCG 
CGCTGCAGGG 
AGCTGCAGCG 
GCCTGCAGCG 
CGCTGCAGCG 
AGCTGGAGCG 
CGCTGC___
AGGCGGCCCG
AGGCGGCCCG
AGGCGGCCCG
AGGCGGCCCG
AGGCGGCCCG
AGGCGGCCCG
AGGCGGCCCA
GTGGAGTGGC
GTGGAGTGGC
GTGGAGTGGC
GTGGAGTGGC
GTGGAGTGGC
GTGGAGTGGC
GTGGAGTGGC
^ - 3
C G C A ..©.AA 
CGCGG. •. AA 
CGCGG.•.AA 
CGCGG.#.AA 
CGCGG.#.AA 
CGCTG.#.AC 
..... •. AC
TGCGGCGGAG
TGAGGCGGAG
TGAGGCGGAG
TGAGGCGGAG
TGAGGCGGAG
TGAGGCGGAG
TGAGGCGGAG
TCCGCAGATA
TCCGCAGATA
TCCGCAGATA
TCCGCAGATA
TCCGCAGATA
TCCGAAGATA
TCCGCAGATA
9  550
CAGCTGAGAG 
CAGCTGAGAG 
CAGTGGAGAG 
CAGCGGAGAG 
CAGCGGAGAG 
CAGCGGAGAG 
CAGTTGAGAG
600
CCTGGAGAAC
CCTGAAGAAT
CCTGGAGAAC
CCTGGAGAAC
CCTGGAGAAC
CCTGGAGAAC
CCTGGAGAAC
CCCCCAAAGA
CACCCAAAGA
CACCCAAAGA
CACCCAAAGA
CACCCAAAGA
CCCCCTAAGA
CCCCCCAAGA
650
CACACGTGAC
CACACGTGAC
CACACGTGAC
CACACGTGAC
CACACGTGAC
CACACGTGAC
CACATATGAC
147
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
HIa-B7 
H1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
Hla-B7 
HIa-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jw1 ex 
Hla-B7 
HI a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
H1a-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
H 1a-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
Jw1 ex 
H 1a-B7 
H I a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
Jw1 ex 
H 1a-B7 
Hla-A3
651
CCACCACCCC
CCACCATCCC
CCACCATCCC
CCACCATCCC
CCACCATCCC
CCACCACCCC
CCACCACCCC
701
GCTTCTACCC
GCTTCTACCC
GCTTCTACCC
GCTTCTACCC
GCTTCTACCC
GTTTCTATCC
GCTTCTACCC
CTCTCTGACC
GTCTCTGACC
GTCTCTGACC
GTCTCTGACC
GTCTCTGACC
ATCTCTGACC
ATCTCTGACC
TGCGGAGATC
TGCGGAGATC
TACGGAGATC
TGCGGAGATC
TGCGGAGATC
TGCGGAGATC
TGCGGAGATC
ATGAGGCCAC
ATGAGGCCAC
ATGAGGCCAC
ATGAGGCCAC
ATGAGGCCAC
ATGAGGCCAC
ATGAGGCCAC
ACACTGACCT
ACACTGACCT
ACACTGACCT
ACACTGACCT
ACACTGACCT
ACACTGACCT
ACACTGACCT
CCTGAGGTGC
CCTGAGGTGC
CCTGAGGTGC
CCTGAGGTGC
CCTGAGGTGC
CCTGAGGTGC
CCTGAGGTGC
GGCAGCGGGA
GGCAGTGGGA
GGCAGCGGGA
GGCAGTGGGA
GGCAGTGGGA
GGCAGCGGGA
GGCAGCGGGA
700
TGGGCCCTGG
TGGGCCCTGG
TGGGCCCTGG
TGGGCCCTGG
TGGGCCCTGG
TGGGCCCTTG
TGGGCCCTGG
750
TGGGGAGGAC
TGGGGAGGAC
TGGCGAGGAC
TGGGGAGGAC
TGGGGAGGAC
TGGCGAGGAC
TGGGGAGGAC
751
CAGACCCAGG
CAAACTCAGG
CAAACTCAGG
CAAACTCAGG
CAAACTCAGG
CAAACTCAGG
CAGACCCAGG
ACACCGAGCT
ACACTGAGCT
ACACCGAGCT
ACACCGAGCT
ACACCGAGCT
ACACTGAGCT
ACACGGAGCT
TGTGGAGACC
TGTGGAGACC
TGTGGAGACC
TGTGGAGACC
TGTGGAGACC
TGTGGAGACC
CGTGGAGACC
AGGCCAGCAG
AGGCCAGCAG
AGGCCAGCAG
AGGCCAGCAG
AGGCCAGCAG
AGACCAGCAG
AGGCCTGCAG
800
GAGATGGAAC
GAGATGGAAC
GAGATGGAAC
GAGATGGAAC
GAGATGGAAC
GAGATAGAAC
GGGATGGAAC
801
CTTCCAGAAG
CTTCCAGAAG
CTTCCAGAAG
CTTCCAGAAG
CTTCCAGAAG
CTTCCAGAAT
CTTCCAGAAG
TGGGCAGCTG
TGGGCAGCTG
TGGGCAGCTG
TGGGCAGCTG
TGGGCAGCTG
TCGGCAGCTG
TGGGCGGCTG
TGGTGGTGCC
TGGTGGTGCC
TGGTGGTGCC
TGATGGTGCC
TGGTGGTGCC
TGGTGGTGCC
TGGTGGTGCC
TTCTGGACAA
TTCTGGAGAA
TTCTGGAGAA
TTCTGGAGAA
TTCTGGAGAA
ATCTGGAGAA
TTCTGGAGAG
850
GAGCAGAGAT
GAGCAGAGAT
GAGCAGAGAT
GAGCAGAGAT
GAGCAGAGAT
GAGCAGAGAT
GAGCAGAGAT
851
ACACGTGCCA
ACACGTGCCA
ACACGTGCCA
ACACGTGCCA
ACACGTGCCA
ACACATGCCA
ACACCTGCCA
90 1a . Ini 
TGGG.©.AGC 
TGGG.® .AGC 
TGGG.©.AGC 
TGGG.©.AGC 
TGGA.©.AGC 
TGGG.©.AGC 
1GGG.©.AGC
951
TGGCCTGGCT
TGGCCTGGCT
TGGCCTGGCT
TGGCCTGGCT
TGGCCTGGCT
TCGCCCGGCT
TGGCCTGGTT
TATGCAGCAC
TGTGCAGCAC
TGTGCAGCAC
TGTGCAGCAC
TGTTCAGCAC
TGTACAGCAT
TGTGCAGCAT
C?TCTTCCCA 
CGTCTTCCCA 
CATCTTCCCA 
CGTCTTCCCA 
CGTCTTCCCA 
CGTCTTCCCA 
T GT CTTCCCA
GTCCTGGTT G 
GTCCTGGCTG 
GTCCTGGCTG 
GTCCTGGCTG 
GTCCTGGCTG 
GTCCTAGCAG 
CTCCTTGGAG
GAGGGGCTGC
GAGGGGCTGC
GAGGGGCTGC
GAGGGGCTGC
GAGGGGCTGC
GAGGGGCTGC
GAGGGTCTGC
GCCCACCATC
GCCCACCATC
GCCCACCATC
GCCCACCATC
GCCCACCATC
GTCCACCGTC
GCCCACCATC
TCCTAGCTGT
TCCTAGCTGT
TCCTAGCTGT
TCCTAGCTGT
TCCTAGCTGT
TTGTGGTCAT
CTGTGATCAC
AAGAGCCCCT
CGGAGCCCCT
CGGAGCCCCT
CGGAGCCCCT
CGGAGCCCCT
CGAAGCCACT
CCAAGCCCCT
CCCATCATGG
CCCATCGTGG
CCCATCGTGG
CCCATCGTGG
CCCATCGTGG
CCCATCGTTG
CCCATCGTGG
CCTTGGAGCT
CCTAGGAGCT
CCTAGGAGCT
CCTAGGAGCT
CCTAGGAGCT
CGGAGCTGTG
TGGAGCTGTG
900
CACCCTGAGC
CACCCTGAGA
CACCCTGAGA
CACCCTGAGA
CACCCTGAGA
CACCCTGGGA
CACCCTGAGA
950
GCATCGTTGC
GCATCGTTGC
GCATCGTTGC
GCATCGTTGC
GCATCGTTGC
GCATTGTTGC
GCATCATTGC
GTGGTCACCG 
GTGGTGGCTG 
GTGGTGGCTG 
GTGGTGGCTG 
ATGGTGGCTG 
GTCGCTGCT. 
GTCGCTGCC.
Cw4rna 
Cw3ex 
Cw2ex 
Cwiex 
Jwlex 
H1a-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
Hla-B7 
HIa-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
HIa-B7 
HIa-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jwlex 
HIa-B7 
Hla-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cwlex 
Jw1 ex 
H 1a-B7 
H1a-A3
Cw4rfia 
Cw3ex 
Cw2ex 
Cwlex 
Jw 1 ex 
H1a-B7 
H 1a-A3
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
Jw1 ex 
H1a-B7 
H 1a-A3
1001
CTATGATGTG 
TTGTGATGTG 
TTGTGATGTG 
TTGTGATGTG 
TTGTGATGTG 
..GTGATGTG 
..GTGATGTG
TAGGAGGAAG
TAGGAGGAAG
TAGGAGGAAG
TAGGAGGAAG
TAGGAGGAAG
TAGGAGGAAG
GAGGAGGAAG
AGCTCAG.#. 
AGCTCAG.•. 
AGCTCAG.•. 
AGCTCAG.#. 
AGCTCAG.#. 
AGTTCAG.#. 
AGCTCAG.#.
C1
GTGGAAAAGG
GTGGAAAAGG
GTGGAAAAGG
GTGGAAAAGG
GTGGAAAAGG
GTGGAAAAGG
gtAGAAAAGG
1050
AGGGAGCTGC
AGGGAGCTGC
AGGGAGCTGC
AGGGAGCTGC
AGGGAGCTGC
AGGGAGTTAC
AGGGAGTTAC
1051
TCTCAGGCTG
TCTCAGGCTG
TCTCAGGCTG
TCTCAGGCTG
TCTCAGGCTG
TCTCAAGCTG
ACTCAGGCTG
1101 *
CATCACTTGT
CATCGCTTGT
CATCGCTTGT
CATCGCTTGT
CATCGCTTGT
CACAGCTTGA
CACAGCTTGT
CGT
CGT
CGT
CGT
CGT
CGT
CAA
C2
•.GCAG 
•.CCAG 
#.CCAG 
#.CCAG 
•.CCAG 
•.GCAG 
#.GCAG
C3
AAAG.#.CC. 
AAAG.#.CC. 
AAAG.#.CC. 
AAAG.#.CC. 
AAAG.•.CC. 
AAAG.#.CC. 
AAAG.•.TG.
CAACAGTGCC
CAACAGTGCC
CAACAGTGCC
CAACAGTGCC
CAACAGTGCC
CGACAGTGCC
TGACAGTGCC
CAGGGCTCTG
CAGGGCTCTG
CAGGGCTCTG
CAGGGCTCTG
CAGGGCTCTG
CAGGGCTCTG
CAGGGCTCTG
stop 3 ?UT 
•.TGA.•.GA CAGCTGCCT. 
#.TGA.#.GA CAGCTGCCT. 
#.TGA.#.GA CAGCTGCCT. 
•.TGA.#.GA CAGCTGCCT. 
•.TGA.•.GA CAGCTGCCT. 
•.TGA.•.GA CAGCTGTCTT 
#.TGA.#.GA CAGCTGCCTT
1 100 
ATGAGTCTCT 
ATGAGTCTCT 
ATGAGTCTCT 
ATGAGTCTCT 
ATGAGTCTCT 
ATGTGTCTCT 
ATGTGTCCCT
1150 
GTGTGGGACT 
GTGTGGGACT 
GTGTGGGACT 
GTGTGGGACT 
GTGTGGGACT 
GTGAGGGACT 
GTGTGGGACT
1151
GAGATGCAGG
GAGATGCAGG
GAGATGCAGG
GAGATGCAGG
GAGATGCAGG
GAGATGCAGG
GAGAGGCAAG
A .TTTCTTCA 
A.TTTCTTCA 
A.TTTCCTCA 
A.TTTCCTCA 
A.TTTCTTCA 
A.TTTCTTCA 
AGTTTGTTCC
CACCTCTCC. 
CACCTCTCC. 
CACCTCTCC. 
CACCTCTCC. 
CACCTCTCC. 
CGCCTCCCC. 
TGCCCTTCCC
TTTGTGACTT
TTTGTGACTT
TTTGTGACTT
TTTGTGACTT
TTTGTGACTT
TTTGTGACTT
TTTGTGACTT
1200 
CAAGAGCCTC 
CAAGAGCCTC 
CAAGAGCCTC 
CAAGAGCCTC 
CAAGAGCCTC 
CAAGAGCCTC 
GAAGAACC.C
1201
TGGCATCTCT 
TGGCATCTCT 
TGGCATCTCT 
TGGCATCTCT 
TGGCATCTCT 
TGGACTCT.T 
T .GACTTTGT
1251
ATAATGTGAG
ATAATGTGAG
ATAATGTGAG
ATAATGTGAG
ATAATGTGAG
ATAATGTGAG
ATAATGTGAG
TTCTGCAAAG
TTCTGCAAAG
TTCTACAAAG
TTCTGCAAAG
TTCTGCAAAG
TTCTGCAAAG
TTCTGCAAAG
GAGGTGGAGA 
GAGGTGGAGA 
GAGGTGGAGA 
GAGGTGGAGA 
GAGGTGGAGA 
GAGGTGGAGA 
GAGGT GGGGA
GCACCTGAAT
GCATCTGAAT
GCATCTGAAT
GCATCTGAAT
GCATCTGAAT
GCACCTGAAT
GCACCTGCAT
GAC.AGCCCA 
GAC.AGCCCA 
GACCAGCCCA 
GAC.AGCCCA 
GAC.AGCCCA 
GAC.AGCCCA 
GACCACCCCA
GTGTCTGCGT
GTGTCTGCGT
GTGTCTGCGT
GTGTCTGCGT
GTGTCTGCGT
GTGTCTGCGT
GTGTCTGTGT
CCCCCGTGTC 
CCCCC.TGTC 
CCCCCGTGTC 
CCCCCGTGTC 
CCCCCGTGTC 
CCCTTGTGTC 
CCCCCAT GT C
1250
TCCTGTTAGC
TCCTGTTAGC
CCCTGTTAGC
TCCTGTTAGC
TCCTGTTAGC
CCCTGTTAGC
TCGTGTAGGC
1300 
CACCGTGACC 
CACCGT GACC 
CACCGTGACC 
CAC.GT GACC 
CACCGTGACC 
CACTGTGACC 
CACCATGACC
1 301
CCTGTCCCCA 
CCTGTCCCCA 
CCTGTCCCCA 
CCTGTCCCCA 
CCTGTCCCCA 
CCTGTTCCCA 
C .TCTTCCCA
CACTGACCTG
CACTGACCTG
CACTGACCTG
CACTGACCTG
CACTGACCTG
TGCTGACCTG
CGCTGACCTG
TGTTCCCTCC
TGTTCCCTCC
TGTTCCCTCC
TGTTCCCTCC
TGTTCCCTCC
TGTTTCCTCC
TGCTCCCTCC
CCGATCATCT
CCGATCATCT
CCGATCATCT
CCGATCATCT
CCGATCATCT
CCAGTCATCT
CCAATCATCT
1 350 
TTCCTGTTCC 
TTCCTGTTCC 
TTCCTGTTCC 
TTCCTGTTCC 
TTCCTGTTCC 
TTCTTGTTCC 
TTCCTGTTCC
149
Cw4rna 
Cw3ex 
Cw2ex 
Cw1 ex 
Jw1 ex 
H1a-B7 
HI a-A3
1351
AGAGAGGTGG
AGAGAAGTGG
AGAGAAGTGG
AGAGAAGTGG
AGAGAAGTGG
AGAGAGGTGG
AGAGAGGTGG
GGCTGGA.TG 
G.CTGGA.TG 
G.CTGGA.TG 
G.CTGGA.TG 
G.CTGGA.TG 
GGCTGGA.TG 
GGCTGAGGTG
TCTCCATCTC
TCTCCATCTC
TCTCCATCTC
TCTCCATCTC
TCTCCATCTC
TCTCCATCTC
TCTCCATCTC
TGTCTCAAAT
TGTCTCAACT
TGTCTCAACT
TGTCTCAACT
TGTCTCAACT
TGTCTCAACT
TGTCTCAACT
:a
14Q
TCATGGTGC 
TCATGGTGCG 
TTA.CGTGTA 
TCATGGTGCG 
TCATGGTGCG 
TTA.CGTGCA 
TCATGGTGCA
1401 ^  1450
Cw4rna CTGAGCTGCA ACTTCTTACT TCCCTAATGA AGTTAAGAAC CTGAATATAA
Cw3ex CTGAGCTGCA ACTTCTTACT TCCCTAATGA AGTTAGGAAC CTGAATATAA
Cw2ex CTGAGCTGCA ACTTCTT... .CCCTACTGA AAATAGGAAT CTGAATATAA
Cwlex CTGACGTGCA ACTTCTTACT TCCCTAATGA AGTTAAGAAC CTGAATATAA
Jwlex CTGAGCTGCA ACTTCTTACT TCCCTAATGA AGTTAAGAAC CTGAATATAA
H1a-B7 C .GAGCTGCA ACTTCTTACT TCCCTACTGA AAATAAGAAT C.GAATATAA
HI a-A3 CTGAGCTGTA ACTTCTTCCT TCCCTATTAA AATTAGAACC TT.AGTATAA
1451 1500
Cw4rna ATTTGTGTTC TCAAATATTT GCTATGAAGC GTTGATGGAT TAATTAAATA
Cw3ex ATTTGTTTTC TCAAATATTT GCTATGAAGG GTTGATGGAT TAATTAAATA
Cw2ex ATTTGTTTTC TCAAATATTT GCTATGAGAG GTTGATGGAT TAATTAAATA
Cwlex ATTTGTTTTC TCAAATATTT GCTATGAAGG GTTGATGGAT TAATTAAATA
Jwlex ATTTGTTTTC TCAAATATTT GCTATGAAGG GTTGATGGAT TAATTAAATA
H1a-B7 ATTTGTTTTC TCAAATATTT GCTATGAGAG GTTGATGGAT TAATTAAATA
H1a-A3 ATTTACTTTC TCAAATTCTT GCCATGAGAG GTTGATGAGT TAATTAAAGG
1501 1550
Cw4rna AGTCAATTCC TAAAAAC
Cw3ex AGTCAATTCC TGGAAGTTGA GAGAGCAAAT AAAGACC... ..TGAGAAGC
Cw2ex AGTCAATTCC TGGAAGTTGA GAGAGCAAAT AAAGACC... ...GAGAACC
Cw1 ex AGTCAATTCC TGGAAGTTGA GAGAGCAAAT AAAGACC... ..TGAGAACC
Jw1 ex AGTCAATTCC TGGAAGTTGA GAGAGCAAAT AAAGACC... ..TGAGAACC
H1a-B7 AGTCAATTCC TGGAATTTGA GAGAGCAAAT AAAGACC... ..TGAGAACC
HI a-A3 AGAAGATTCC TAAAATTTGA GAGACAAAAT AAATGGAAGA CATGAGAACC
1551 1600
Cw3ex TTTCCAGAAT CCGCATGTTC TCTGTGGCTG AGTCTGTTGC AGGTGGGGGT
Cw2ex TT.CCAGAAT CCGC
Cw1 ex TT.CCAGAAT CCGC
Jw1 ex TT.CCAGAAT CCGCAAAAAA AAAAAAAAA
H1a-B7 . . .CCAG
H1a-A3 TT.CCAGAGT CCACGTGTTT CTTGTGCTGA TTTGTTGCAG GGGAGGAGAG
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the likely variable alpha-1 domain can not be included in the 
analysis. The data has been presented per exon in a 
tabulated form for this reason. All C-locus sequences are 
extremely homologous over the transmembrane and cytoplasmic 
domains, indeed there is complete identity with Cwl, Cw2 and 
Cw3 in exons 6-8 which includes the HLA-C locus specific 
region (Strachan et al. 1986 and Smeaton et al. 1987).
In the non-coding region, there are three positions 
(1167, 1400, 1436) where a consensus cannot be derived, but
the nucleotides of JWl agree with one or more nucleotides of 
Cwl-4.
Comparisons of JWl (C-locus) with HLA-A3 and HLA-B7 
and of HLA-A3/HLA-B7 are shown in figure 6.8.4. The 
percentage homologies are typical of interlocus comparisons 
made elsewhere (Sodoyer et al. 1985; Strachan et al. 1984).
Intron 2 of JWl was nearly full length and over 221bp 
differed at six positions (>97% homology) when compared to
other HLA-C-locus intron 2 sequences (see figure 6.8.5). 
Where Cwl-3 are in full agreement, JWl differs at positions 
26, 83 and 250. In two of these positions (74, 205) the
nucleotide of JWl was the same as another sequence which also 
differed from the consensus. The nucleotide of JWl at
position 228 is different from the other sequences which are 
not in agreement. The % homology of intron 2 when compared 
to intron 2 of HLA-Aw24, HLA-B27, HLA-6.0 and HLA-E is 76.2%, 
82.4%, 73% and 84% respectively.
6.9. Comparison of JWl and HT.A-r amino acid sequences.
A comparison of the amino acid sequences from the 
alpha-1, -2 and -3 domains of class I HLA-A, -B and -C
molecules shows an overall conservation of 183/273 residues. 
There are only six locus-specific residues (HLA-A 138Met and 
189^et/ HLA—B 239j^g., HLA—C 52y^l/ ^-®^Glu ^^®Glu^* though
at no one position are all three loci different (reviewed by 
Parham et al. 1988). Initially, the comparison of few 
sequences enabled the identification of locus specific 
sequences however, this is becoming increasingly difficult 
since the publication of new alleles often abolishes this 
specificity. As single residues predominate at most 
positions, a consensus sequence can be deduced. Individual 
molecules from the three loci are seen to differ from the
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Figure 6.8.5. Nucleotide sequence comparison of JWl 
Intron 2 with those from HLA-Aw24 (N'Guyen et al. 1984), 
HLA-B27 (Weiss et al. 1985), HLA-Cwl and HLA-Cw2 (Gussow 
et al. 1987) and HLA-Cw3 (Sodoyer et al. 1984). JWl 
intron 2 is 221bp and begins at position 27 in this 
comparison. The positions where JWl differs from those 
sequences of HLA-Cwl-3 are marked in blue. See section 
6.8 for a description of these differences.
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Hla-Aw24 
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Hla-Cw1 
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HI a-6 
Hla-E
H1a-Aw24 
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HIa-Aw24 
H1a-B27 
Hla-Cw3 
H1a-Cw2 
H1a-Cw1 
Intronjwl 
Hla-6 
Hla-E
H 1 a-Aw2a 
H 1 a-B2 7 
H1a-Cw3 
H1a-Cw2 
H1a-Cw1 
Intronjwl 
Hla-6 
Hla-E
1
GTGAGTG.AC 
GTGAGTG.AC 
GTGAGTGGAC 
GTGAGTG.AC 
GTGAGTG.AC
GTGAGTA.AC 
GTGAGTG.AC
CCCGGCCCGG
CCCGGCCCGG
CCCGGCCCGG
CCCGGCCCGG
CCCGGCCCGG
TCCGGCCCAG 
CCCGGCC.AG
GGCGCAGGTC 
G.CGCAGGTC 
GGCGCAGGTC 
GC.GCAGGTC 
GGCGCAGGTC 
CGGTC 
GGAGCAGATC 
G .AGCAGGTC
ACGACCC.T. 
ACGAC...TC 
ACGACCCCTC 
ACGACCCCTC 
ACGACCCCTC 
ACGACCCCTC 
ACGACCCCCA 
ACGACCCCTC
50
 CATCCC
CC..CATCCC 
CT..CATCCC 
CC..CATCCC 
CT..CATCCC 
CC..CATCCC 
CCTCCATGCC 
CC..CATCCC
51
CCACGGAGGG
CCACGTACGG
CCACGGACGG
CCACGGACGG
CCACGGACGG
CCACGGACGG
CCACGGACGG
CCACGGACGG
CCGGGGCGCC
CCCGGGTCGC
CCCGGGTCGC
CCCGGGTCGC
CCCGGGTCGC
CCCGGGTCGC
CCCGGGTACT
CGCGGGTCCC
CACAGGCTCC
CCCGAGTCTC
CCCAAGTCTC
CCCGAGTCTC
CCCAAGTCTC
CCCGAGTCTC
CCCGAGTCTC
CTCGAATCTT
GGGGCCT.AG 
CGGGTCCGAG 
CCGGTCTGAG 
CGGGTCTGAG 
CCGGTCTGAG 
CCCGTCTGAG 
CGGGTCTGGG 
CGGGTCCCAG
100
ATCCACCCC.
ATCCGCCCCC
ATCCACCCCG
ATCCACCCCG
ATCCACCCCG
ATCCACCCCG
ATCCACCCCG
ATTCACCCCA
101
GAAGCCGCGG
GAGGCCGCGG
AGGCTGCGGA
AGGCTGCGGA
AGGCTGCGGA
AGGCTGCGGA
AGGCCGCGGG
AGGCTGCGGA
GACCCCG..A 
GACCCGCCCA
ACCCG A
ACCCGCCC.A 
ACCCGCCC.A 
ACCCGCCC.A 
ACCCGCCC.A 
ACCCGCCC.A
GACCCTTGCC
GACCCTCGAC
GACCCTCGAC
GACCCTCGAC
GACCCTCGAC
GACCCTCGAC
GACCCTCTAC
GACCCTAGAC
CTGGGAGAGG 
CGGCGAGAG. 
CGGAGAGAGC 
CGGAGAGAGC 
CGGAGAGAGC 
CGGAGAGAGC 
CTGGGAGAAC 
CGGGGAGAGT
150
CCCAGGCGCC 
CCCAGGCGCG 
CCCAGTCACC 
CCCAGTCACC 
CCCAGTCACC 
CCCAGTCACC 
CCCAAGGCGC 
CTCAGGC.GC
151
.TTAACCCGG 
.TTTACCCGG 
.TTTACCCGG 
.TTTACCCGG 
.TTTACCCGG 
.TTTACCCGG
CTTTA....
CTTTACCCGG
TTTCATTTTC
TTTCATTTTC
TTTCATTTTC
TTTCATTTTC
TTTCATTTTC
TTTCATTTTC
TT.CTTTTTC
AGTTTAGGCC
AGTTGAGGCC
AGTTTAGGCC
AGTTTAGGCC
AGTTTAGGCC
AGTTTAGGCC
........CC
AGTTTAGGCC
AAAAATCCCC 
AAAA.TCCCC 
AAAA.TCCCC 
AAAA.TCCCC 
AAAA.TCCCC 
AAAA.TCCCC 
AAAA.TCCCC 
AAAA.TGCCC
200
CCGGGTTGGT 
GCGG.TTGGT 
GCGGGTTGGT 
GCGGGTTGGT 
GCCGGTTGGT 
GCGGGTTGGT 
GCGGGTGGGT 
ACAGGGTGGT
201 ^  
CGGGGC.CGG 
CGGGGC.GGG 
CGGGGC.GGG 
CGGGGCTGGG 
CGGGACTGGG 
CGGGACTGGG 
CCGGGCGAGG 
GGCGACGGGG
GCGGGGCTCG
GCGGGGCTCG
GCGGGGCTCG
GCGGGGCTCG
GCGGGGCTCG
GCGGGGCTCG
GCGAGGCTCG
GCGGGGCTTG
GGGGACT.GG 
GGGGGACGGG 
GGGGAC.GGG 
GGGGAC..GG 
GGGGAC.GGG 
GGGGAC.CGG 
GTGGGC.GGG 
GTGGGC.GGG
GCTGACCGCG
GCTGACCGCG
GCTGACCGCG
GCTGACCACG
GCTGACCACG
GCTGACCACG
GCTGACCGAG
ACTGACTAA.
25^
GGGTCGGGGC 
GGGGCGGGTC 
GGGGCGGG.C 
GGGGCGGGGC 
GGGGCGGGGC 
GGGGCGGGG. 
GGGGTGGGGC 
GGGGCGGGGC
251
CAG
CAG
CAG
CAG
CAG
CAG
CAG
CAG
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Figure 6.9.1 Amino acid sequence comparison of JW1 (from 
the beginning of the alpha-2 domain) with ten class I 
sequences from different loci. HLA-A3 (Strachan et al.
1984), HLA-A2ex28 (Roller et al. 1985 ), HLA-B7 (Sood et 
al. 1985), HLA-B27 (Weiss et al. 1985), HLA-Cwl and HLA- 
Cw2 (Gussow et al. 1987), HLA-Cw3 (Sodoyer et al. 1984),
HLA-Cw4mRNA (Davidson et al. 1985), HLA-6.0 (Geraghty et 
al. 1987) and HLA-E (Shimizu et al. 1988). The 
"Parhcons" represents the consensus sequence derived from 
a comparison of 39 class I sequences (Parham et al.
1988). The hypervariable positions are marked X. The 
row "Structure" represents the conformation of the 
corresponding polypeptide regions, "A" is alpha helix, 
"B" is beta-pleated sheet and "T" represents a turn. The 
row "Pclocspec" shows the positions of the three HLA-C 
locus specific residues (see section 6.9 for details). 
The residues where JW1 differs from C-locus sequences 
have been marked
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MAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG
MR YFFTSVSRPG RGEPRFIAVG 
MLVMAPRTVL LLLSGPW.LT ETWAGSHSMR YFYTSVSRPX XGEPRFISVG 
MRVTAPRTLL LLLWGAVALT ETWAGSHSMR YFHTSVSRPG RGEPRFITVG
CSHSMR YFDTAVSRPG AGEPRFISVG 
MRVMAPRTLI LLLSGALALT ETWAGSHSMR YFCTAVSRPG RGEPHFIAVG 
MRVMAPRTLI LLLSGALALT ETWACSHSMR YFYTAVSRPS RGEPHFIAVG 
MRVMAPRTLI LLLSGALALT ETWACSHSMK YFFTSVSRPG RGEPRFISVG 
MVVMAPRTLF LLLSGALTLT ETWAGSHSMR YFSAAVSRPG RGEPAFIAMG 
MVDGTLLLLL SEALALTQTW AGSHSLKYFH TSVSRPGRGE PRFISVGYVD
GSHSMR YFYTSVSRPG RGEPRFIAVG
X...............X. .
TBBBBB BBBBBBBBTT TTTBBBBBBB
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YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV 
YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDGETRK VKAHSQTHRV 
YVDDTQFVRF DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE 
YVDDTLFVRF DSDAASPREE PRAPWIEQEG PEYWDRETQI CKAKAQTDRE 
YVDDTQFVRF DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQADRV 
YVDDTQFVRF DSDDESPRGE PRAPWVERKG PEYWDRETQK YKPQAQTDRV 
YVDDTQFVRF DSDAASPRGE PRGRWVEQEG PEYWDRETQK YKRQAQTDRV 
YVDDTQFVRF DSDAASPRGE PRAPWVEQEG PEYWDRETQK YKRQAQTDRV 
YVDDTQFVRF DSDSACPRME PRAPWVEEQG PEYWEEETRN TKAHAQTDRM 
DTQFVRFDND AASPRMVPRA PWMEQEGSEY WDRETRSARD TAQIFRVNLR 
YVDDTQFVRF DSDAASPRME PRAPWIEQEG PEYWDRETQI VKAQSQTDRE
  ............ X.................. X. .XX X.XXX. .X.X
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DLGTLRGYYN QSEAGSHTIQ IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL 
DLGTLRGYYN QSEAGSHTVQ RMYGCDVGSD WRFLRGYHQY AYDGKDYIAL 
SLRNLRGYYN QSEAGSHTLQ SMYGCDVGPD GRLLRGHDQY AYDGKDYIAL 
DLRTLLRYYN QSEAGSHTLQ NMYGCDVGPD GRLLRGYHQD AYDGKDYIAL 
SLRNLRGYYN QSEDGSHTLQ RMSGCDLGPD GRLLRGYDQS AYDGKDYIAL 
SLRNLRGYYN QSEAGSHIIQ RMYGCDVGPD GRLLRGYDQH AYDGKDYIAL 
NLRKLRGYYN QSEAGSHTLQ RMYGCDLGPD GRLLRGYDQS AYDGKDYIAL 
SLRNLRGYYN QSEAGSHTLQ WMCGCDLGPD GRLLRGYDQY AYDGKDYIAL
SHTLQ RMFGCDLGPD GRLLRGYNQF AYDGKDYIAL 
NLQTLRGYYN QSEASSHTLQ WMIGCDLGSD GRLLRGYEQY AYDGKDYLAL 
TLRRYYNQSE AGSHTLQWMH GCELGPDRRF LRGYEQFAYD GKDYLTLNED 
SLRTLRGYYN QSEAGSHTLQ RMYGCDVGPD GRLLRGYHQY AYDGKDYIAL
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127
NEDLRSWTAA
KEDLRSWTAA
NEDLRSWTAA
NEDLSSWTAA
NEDLRSWTAA
NEDLRSWTAA
NEDLRSWTAA
NEDLRSWTAA
NEDLRSWTAA
NEDLRSWTAA
LRSWTAVDTA
NEDLRSWTAA
DMAAQITKRK
DMAAQTTKHK
DTAAQITQRK
DTAAQITQRK
DTAAQITQRK
NTAAQITQRK
DTAAQITQRK
DTAAQITQRK
DTAAQITQRK
DTAAQISKRK
AQISEQKSND
DTAAQITQRK
WEAAHEAEQL
WEAAHVAEQL
WEAAREAEQR
WEAARVAEQL
WEAARAAEQL
WEAAREAEQL
WEAAREAEQW
WEAAREAEQR
WEAAREAEQR
CEAANVAEQR
ASEAEHQRAY
WEAARVAEQL
RAYLDGTCVE 
RAYLEGTCVE 
RAYLEGECVE 
RAYLEGECVE 
RAY LEGLCVE 
RAYLEGLCVE 
RAYLEGECVE 
RAYLEGTCVE 
RAYLEGTCVE 
RAYLEGTCVE 
LEDTCVEWLH 
RAYLEGTCVE
..... X
AAAAATAAAA
1 76
WLRRYLENGK 
WLRRYLENGK 
WLRRYLENGK 
WLRRYLENGK 
WLRRYLENGK 
WLRRY LKNGK 
WLRRYLENGK 
WLRRYLENGK 
WLRRYLENGK 
WLHRYLKNGK 
KYLEKGKETL 
WLRRYLENGK
AAAAAAATAA
. .  ............................ X
BTTTTBBBBB TAAAAAAAAA AATTTAAAAA
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ETL. . .'HPPK
ETLQRTDAPK
DKLERADPPK
ETLQRADPPK
ETLQRAEPPK
ETLQGAEHPK
EKLQRAEHPK
ESLQRAEHPK
ETLQRAEHPK
EMLQRADPPK
LHLEPPKTHV
ETLQRADPPK
AAAATTTTTB
..... E. . .
THMTHHPISD 
THMTHHAVSD 
THVTHHPISD 
THVTHHPISD 
THVTHHPLSD 
THVTHHPVSD 
THVTHHPVSD 
THVTHHPVSD 
THVTHHPVSD 
THVTHHPVFD 
TH...HPISD 
THVTHHPISD 
BBBBBTTTTT
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
HEATLRCWAL
YEATLRCWAL
HEATLRCWAL
HEATLRCWAL
TTBBBBBBBB
GFYPAEITLT 
SFYPAEITLT 
GFYPAEITLT 
GFYPAEITLT 
GFYPAEITLT 
GFYPAEITLT 
GFYPTEITLT 
GFYPAEITLT 
GFYPAEITLT 
GFYPAEIILT 
GFYPAEITLT 
GFYPAEITLT 
TTTTTTTBBB
226
WQRDGEDQTQ
WQRDGEDQTQ
WQRDGEDQTQ
WQRDGEDQTQ
WQRDGEDQTQ
WQWDGEDQTQ
WQRDGEDQTQ
WQWDGEDQTQ
WQWDGEDQTQ
WQWDGEDQTQ
WQQDGEGHTQ
WQRDGEDQTQ
BTTTTTTTTT
227
DTELVETRPA
DTELVETRPA
DTELVETRPA
DTELVETRPA
DTELVETRPA
DTELVETRPA
DTELVETRPA
DTELVETRPA
DTELVETRPA
DVELVETRPA
DTELVETRPA
DTELVETRPA
TTBBBBBBBB
GDGTFQKWAA
GDGTFQKWAA
GDRTFQKSAA
GDRTFQKWAA
GDGTFQKWAA
GDGTFQKWAA
GDGTFQKWAA
GDGTFQKWAA
GDGTFQKWAA
GDGTFQKWAA
GDGTFQKWAA
GDRTFQKWAA
TTTTBBBBBB
VVVPSGEEQR
VVVPSGQEQR
VVVPSGEEQR
VVVPSGEEQR
VVVPSGQEQR
VVVPSGEEQR
VVVPSGEEQR
VMVPSGEEQR
VVVPSGEEQR
VVVPSGEEQR
VVVPSGEEQR
VVVPSGEEQR
BBBTTTTTTT
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHMQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
YTCHVQHEGL
BBBBBBTTTT
2(76
PKPLTLRWEL
PKPLTLRWEP
PKPLTLGWEP
PKPLTLRWEP
QEPLTLSWEP
PEPLTLRWEP
PEPLTLRWEP
PEPLTLRWEP
PEPLTLRWKP
PEPLMLRWKQ
PEPVTLRWKP
PKPLTLRWEP
TBBBBB
.E
HLA-A3
277
SSQPTIPIVG
HLA-A2 SSQPTIPIVG
HLA-B7 SSQSTVPIVG
HLA-B27 SSQSTVPIVG
HLA-Cw4mR SSQPTIPIMG
HLA-CW3 SSQPTIPIVG
HLA-CW2 SSQPTIPIVG
HLA-Cwl SSQPTIPIVG
JW1 SSQPTIPIVG
HLA-6 SSLPTIPIMG
HLA-E ASQPTIPIVG
Parhmcons SSQPTIPIVG
HLA-A3
3l2 7
KQ*......
HLA-A2 ASSDSAQGSD
HLA-B7 ACSDSAQGSD
HLA-B27 ACSDSAQGSD
HLA-Cw4mR ACSNSAQGSD
HLA-CW3 ASSNSAQGSD
HLA-CW2 ASSNSAQGSD
HLA-Cwl ASSNSAQGSD
JW1 ASSNSAQGSD
HLA-E EWSDSAQGS.
Parhmcons ASSNSAQGSD
IIA.GLVLLG A ..VITGAVV 
IIA.GLVLFG A..VITGAVV 
IVARPAVLAV V..VI.GAVV 
IVA.GLAVLA VV.VI.GAVV 
IVA.GLAVLV VLAVL.GAVV 
IVA.GLAVLA VLAVL.GAVV 
IVA.GLAVLA VLAVL.GAVV 
IVA.GLAVLA VLAVL.GAVV 
IVA.GLAVLA VLAVL.GAMV 
IVAAGLVVLA VV...TGAAV 
IIA.GLVLLG SV.VS.GAVV 
IVA.GLAVLA VLAVL.GAVV
C3
VSLTACKV*.
VSLTA*....
VSLTA*. . . .
ESLITCKA*
ESLIACKA*
ESLIACKA*
ESLIACKA*
ESLIACKA*.
ESHSL*
ESLIACKA*
 _>C1 326
AAVMWRRKSS IEKRRELHSGC 
AAVMWRRKSS DRKGGSYSQA 
AAVMCRRKSS GGKGGSYSQA 
AAVMCRRKSS GGKGGSYSQA 
TAMMCRRKSS GGKGGSCSQA 
AVVMCRRKSS GGKGGSCSQA 
AVVMCRRKSS GGKGGSCSQA 
AVVMCRRKSS GGKGGSCSQA 
AVVMCRRKSS GGKGGSCSQA 
AAVLWRKKSS D* 
AAVIWRKKSS GGKGGSYSKA 
AVVMCRRKSS GGKGGSCSQA
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consensus by 7 - 26 residues.
Since the nucleotide sequence of JW1 (limited as far 
as the alpha-2 domain) more closely resembled sequences of 
members of the HLA-C locus, a more detailed comparison of the 
amino acid alignment was made (see figure 6.9.1.). JW1 does 
not specify any A- or B-locus specific residues but codes for 
glutamic acid residues at positions 183 and 268. JW1 does 
not extend as far as residue 52, but BeWo C.l has a valine 
locus specific residue at this position. In exon 5, which 
codes for the transmembrane region, there is a degree of HLA- 
A, -B and -C interlocus amino acid divergence over positions 
292-300. In this region, JW1 codes for amino acids which are 
specific only for HLA-C derived molecules. When the amino 
acid sequences of Cwl-4 are in full agreement, JW1 differs 
from the consensus at only 3/242 positions. At position 114 a 
change from aspartic acid to asparagine occurs in the beta- 
pleated sheet portion of the alpha-2 domain. This has 
previously been designated a hypervariable residue. The 
other substitutions normally common to A, B and C locus 
products, (Glu to Lys-275, Val to Met-303) both occur within 
the transmembrane region. At positions 99 and 116, JW1 codes 
for an amino acid that is different from all other C-locus 
amino acids although there is no consensus at these 
positions. BeWo C.l is predicted to code for a 45kDa 
protein. From the complete amino acid sequence of BeWo C.l, 
Ellis et al.(1989), suggested that a substitution for 
tryptophan at position 14 (in the alpha-1 domain) from the 
highly conserved arginine may bring about a conformational- 
change, or alter a recognition site.
The extent to which the amino acid sequence of JW1 
(not including the signal peptide or alpha-1 domain) differs 
from other class I polypeptides is shown in figure 6.9.2.
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Allele No. of different 
amino acids
No. of residues % Homology 
considered
HLA-A2
HLA-A3
44
48
250
231
82.4 
79.3
HLA-B7
HLA-B27
34
27
247
247
87.2
89.1
HLA-Cwl
HLA-CW2
HLA-CW3
HLA-Cw4mRNA
HLA-CW6
HLA-CW7
HLA-Cwll
HLA-CX52
7
10
12
21
10
16
9
9
251
251
251
251
251
251
251
251
97.2
96.1
95.3 
91.7
96.1
93.4
96.4
96.4
Figure 6.9.2. Table of Amino Acid Homologies between JW1 
(not including the signal peptide or the alpha-1 domain) and 
various class I polypeptides. The homology between JW1 and 
HLA-C derived molecules is higher than that when compared to 
HLA-A and HLA-B. HLA-A 2 (Roller et al. 1985); HLA-A3 
(Strachan et al. 1984); HLA-B7 (Sood et al. 1987); HLA-B27 
(Weiss et al. 1985); HLA-Cwl and HLA-Cw2 (Gussow et al. 
1987); HLA-Cw3 (Sodoyer et al. 1984); HLA-Cw4mRNA (Davidson 
et al. 1985); HLA-Cw6 (Mizuno et al. 1989); HLA-Cw7 (Pohla et 
al. 1989); HLA-Cx52 (Takata et al. 1988).
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6.10 Discussion.
The initial aim of the research was to clone and 
characterize a class I molecule that was most certainly 
present on some subpopulations of extravillous trophoblast. 
At this time, our knowledge extended only to the fact that 
the molecule did not cross react with antibodies which were 
specific for the foetal HLA-A or HLA-B phenotype. Since 
anti-HLA-C antibodies were not available, the assumptions 
made were simply that the molecule expressed was either 
derived from the HLA-C locus or from some other locus.
Subsequent work illustrating the lack of reactivity of 
61D2 with the trophoblast class I molecule suggested 
tentatively that it may be a "different" or slightly modified 
form of class I . Class I immunoprecipitation studies of 
chorionic cytotrophoblasts and BeWo choriocarcinoma revealed 
for the first time that the molecule expressed was a 40kDa 
heavy chain associated with B2~M (Ellis et al. 1986).
cDNA libraries of JEG-3 (this work) and amplified cDNA 
libraries of BeWo (Ellis, Oxford) were prepared solely for 
the purpose of obtaining class I cDNA clones corresponding to 
the 40kDa molecule (although data presented in chapter 3 
shows the expression of 45kDa and 41kDa molecules). A number 
of class I clones have been obtained from JEG-3 (JW1-6) and 
also from BeWo.
Comparisons between the exonic nucleotide and amino 
acid sequence of JW1 and other HLA sequences undoubtedly 
placed this cDNA amongst the HLA-C locus alleles. High 
homology (97.7%) of intron 2 when compared to a consensus C- 
locus intron 2 added strength to this observation. A formal 
designation would however require the full length cDNA clone. 
The coding sequence of JW1 (although incomplete) seems to be 
identical to that of BeWo C.l and since JEG-3 and BeWo cell 
lines are derived from the same choriocarcinoma material, 
these cDNA's might be expected to be derived from the same 
gene. The sequence of JW1 has been assumed to be identical 
to that of the published BeWo C.l sequence. The sequence of 
BeWo C.l has not been written out in the publication but has 
been represented by dashes (-) indicating its identity to 
HLA-Cwl. A comparison of the HLA-Cwl sequence in the Ellis 
et al. (1989) publication with that obtained from the data 
base for this analysis (figure 6.8.1) indicates that this
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sequence has been differently represented in the coding
region both at the nucleotide (see positions 541 and 1109 in
figure 6.8.1) and amino acid (see position 167 in figure 
6.9.1) level. The translation of BeWo C.l is identical to 
that of JW1 which supports possible typing errors in the 
nucleotide sequence.
Ellis et al. (1989), predicted that BeWo C.l encoded a 
45kDa heavy chain and this was surprising at the time, since 
previous immunoprecipitation and IEF analyses indicated only 
the presence of a 40kDa molecule (Ellis et al, 1986). No
transcriptional start signals were found in JW1 intron 2 
which could have ultimately accounted for the translation of 
the smaller 40kDa protein product. The translational stop 
codon (TGA) if in frame would prevent the synthesis of a 
class I polypeptide. However, concurrent to the sequencing 
of JW1 and BeWo C.l, anti-class I immunoprecipitation studies 
on BeWo cells showed without a doubt that two class I 
molecules of 45kDa and 41kDa were expressed and that the
latter was more abundant (Stern et al. 1988). Similar 
results (chapter 3) have been seen with JEG-3 cells. The 
presence of the larger 45kDa component could account for the 
predicted amino acid sequence of BeWo C.l.
As mentioned in section 6.6, there may be a source of 
confusion when extending sequences which belong to a 
polymorphic multigene family, since hybrid alleles could be 
generated. The strategy shown in section 6.6 was adopted 
because IEF data indicated the presence of a single 40kDa 
component. This points out the difficulties encountered 
when researching a multigene family. Progress can be 
hampered by the limited resolution of the technology 
employed. A number of clones would be required to assess the 
situation.
At this point speculations of the origin of the two 
molecules included 1: that two separate genes were being 
expressed, 2: or that a common pre-mRNA was alternatively
spliced leading to the translation of two differently sized 
molecules. The molecules are not glycosylation variants 
(P.L.Stern pers. comm.). Since the smaller component was 
41kDa, it was thought that it might be a homologue of a Q 
region gene in the mouse and that it could be inserted into 
the membrane via a phosphatidyl inositol anchor (Low et al. 
1986) as is the Qa-2 product of the Q-7 gene (Stroynowski et
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al. 1987).
It might have been expected that the size of their 
respective mRNA's be different. The Northern hybridization 
results in chapter 4 show a single molecular weight class I 
mRNA (species) although it must be said that the resolving 
power of formaldehyde gel electrophoresis is not as high as 
that for non-denaturing gels. Class I mRNA's generally have 
3'UT regions that are approximately 450 bases long which 
means that a reduction (if this occurs) within the 1Kb coding 
region of approximately 150 bases mRNA (equivalent to 4kDa) 
would be difficult to resolve. Although the difference 
between approximately 1Kb (coding region) and 850 bases 
(reduced coding region) may be electrophoretically resolved, 
the presence of the 3'UT region and polyadenylation tail 
(totalling approximately 1.6Kb) prevents such resolution. In 
addition to this there would be a degree of mRNA degradation 
during purification. As was also pointed out in section 2.15 
the inclusion of formaldehyde in the gel and its diffusion 
out during the running period, might affect electrophoretic 
resolving power under these denaturing conditions.
Since BeWo C.l (and possibly JW1) is predicted to code 
for a 45kDa molecule, then it seems very likely that it 
corresponds to the minor 45kDa component immunoprecipitated 
from BeWo cells. Eight cDNA clones obtained from the 
amplified BeWo cDNA library (Ellis et al. 1989) and at least 
three from that of JEG-3 are identical in sequence which 
suggests that only one allele at the C-locus is being 
transcribed unless the cell line is homozygous at this locus. 
One other explanation for this might be that choriocarcinomas 
are usually derived from hydatidiform moles (diploid) which 
are often of a homozygous androgenetic origin (reviewed 
Bagshawe and Lawler, 1982; Lawler and Fisher, 1987a,b). Thus 
the possibility remains that both HLA-C alleles may be 
expressed in normal trophoblast.
The 41kDa molecule appears to be approximately in a 
five fold excess after immunoprecipitation. This can not 
(or would be unlikely) be due to the relative affinities of 
W6/32 for either, since the same results were obtained when 
using BM.63 (anti-B2-M). One might be tempted to suggest 
that the levels of mRNA representing each would be in these 
relative proportions whether alternative splicing had 
occurred or not - however, nothing is known about the
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absolute or relative turnover rates of either mRNA's or their 
heavy chains. Pulse chase experiments would resolve such a 
situation at the protein level. Measurements on mRNA 
stability would be much more complicated and would require 
specific probes (which obviously are not available yet!).
The inconsistency between obtaining only C-like 
sequences which may code for 45kDa molecules and a 
predominance of the immunoprecipitable 41kDa component is 
surprising. One would have expected the cDNA clones 
corresponding to the 41kDa molecule to have been represented 
in both the JEG-3 cDNA library (this work) and the BeWo cDNA 
library (Ellis et al. 1989). Classical class I probes are 
normally expected to hybridize to most class I sequences 
under relaxed stringency conditions, since the alpha-3 
domains are highly conserved within the class I gene family, 
indeed, the C-locus cDNA clones were isolated using an HLA-B7 
cDNA probe. One explanation might be that these transcripts 
have a short polyadenylated tail and would therefore not be 
favourably selected during oligo-dT chromatography and oligo- 
dT primed cDNA synthesis.
A further and more likely explanation for not 
obtaining a sequence corresponding to the 41kDa molecule is 
that the stringency of washing after hybridization was too 
high. Preliminary filter washes were carried out at 55°C 
with lxSSPE, 0.1%SDS, but after autoradiography, high 
background levels forced the temperature of subsequent washes 
to be raised (see figure 5.7.1a;b). If the sequences coding 
for the 41kDa molecule have reduced homologies, then
hybridization of HLA-B7 would be much reduced on elevating 
the washing temperatures. Hybridization of the HLA-B7 probe 
to the HLA-C-like clones that were obtained persisted to 65°C 
with O.lxSSPE, 0.1%SDS. Further screening of the second half 
of the library using secondary filter lifts did actually 
result in a much lower background and filters were washed at 
a lower stringency. The clones obtained from this screen 
(JW4 and JW5) were HLA-C derived. The higher levels of
background hybridization on primary filter lifts was probably
due to an excess of E. coli. chromosome, protein and agarose 
fragments which would not be in such great quantities on
secondary filter lifts
Neverless, the HLA-C-like clones that have been 
obtained deserve careful consideration.
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In general, C-locus products are expressed at much 
lower levels than HLA-A or HLA-B locus antigens which is 
probably why there is a lack of specific typing sera (Gussow 
et al. 1987; Mizuno et al. 1989). However, if the total 
number of C-locus alleles is much reduced when compared to 
HLA-A and HLA-B then it will be relatively more difficult to 
accrue specific sera between individuals for use in typing. 
Indeed, there are only eleven serologically defined alleles 
(in Ellis et al. 1989). The promoter sequences found 
upstream of the HLA-Cw3 gene are also different to those 
found at HLA-A and HLA-B loci (Sodoyer et al. 1985). If the 
efficiencies of these respective promoters are different then 
this may explain the lower levels of HLA-C products at least 
at the transcriptional level. Thus, if the above proposal 
is correct then it is very surprising that the clones 
obtained are all from the HLA-C locus. This implies that 
their expression may be governed by different regulatory 
factors and that they may have an altered and important role 
in immunity when compared to HLA-A and HLA-B locus products. 
The absence of clones derived from the HLA-A and HLA-B loci 
is consistent with earlier serological studies (Redman et al. 
1984). Both BeWo and JEG-3 cells could not be tissue typed 
(Ellis et al. 1986 and P.L.Stern pers. comm.).
Several recent reports have illustrated some 
interesting features associated with C-locus antigens. Guild 
et al. (1983) reported the conserved Tyr3^  (substituted for 
Cys in C-locus products) to be the site of phosphorylation by 
tyrosine kinases, although the significance of 
phosphorylation is as yet unknown. IEF gels have shown that 
multiple sized products (upto five) are produced upon 
transfection of Cwl, Cw2 genomic and Cw6 cDNA clones (Gussow 
et al. 1987; Mizuno et al. 1989) which is in contrast to HLA- 
A and HLA-B gene single sized products. The differential 
focusing is probably due to multiple post-translational 
modifications (possibly tissue specific) in the extracellular 
domains and Mizuno et al. (1989) have suggested that it is 
possible that these may confer an altered function on the 
molecule. Ellis et al. (1989) had previously completed IEF 
studies of BeWo class I products and although the 40kDa 
component was electrophoretically non-polymorphic the 45kDa 
which probably corresponds to BeWo C.l was not detected. 
Ellis is now undertaking similar studies to those of Gussow
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and Mizuno with the BeWo C.l cDNA clone. The overall data 
suggests the possibility of a distinct functional role for 
HLA-C antigens. Dill et al. (1988) demonstrated that the 
transgenic HLA-Cw3 allele functioned as an immunologically 
competent MHC restriction element.
There is no evidence to date that HLA-C antigens are 
present on placenta (unless one extrapolates the 
choriocarcinoma immunoprecipitation experiments). However, 
the inability to type for HLA-A and HLA-B (and also HLA-C but 
with only few sera) suggests that the 45kDa molecule 
expressed at the surface is more likely to be HLA-C. It must 
also be remembered that the cloning experiments have been 
carried out on choriocarcinomas and not on normal 
trophoblasts expressing class I. If the HLA-C antigens are 
expressed as classical class I molecules, then they may be 
capable of presenting antigens to the maternal immune system 
and those derived from the paternal haplotype might act as 
allogeneic stimuli (if these differ from the maternal 
haplotype). Ellis et al. (1989) suggested that one or more 
amino acid substitutions in BeWo C.l may bring about a 
conformational change or alter a recognition site and that 
this may account for the antibody binding pattern between 
W6/32 and 61D2. Even though this may be true, the 
immunoprecipitation studies in chapter 3 and those of Stern 
et al. (1988), largely disprove the latter possibility 
concerning the patterns of antibody binding. A change in the 
conformation of the recognition site may impair antigen 
presentation or recognition by T cells. Furthermore, Ellis 
et al. (1989) propose that if HLA-C can be shown to be 
expressed at higher levels than HLA-A or HLA-B, or in their 
absence, this might point towards a specialized role for HLA- 
C antigens - which may or may not be involved in the 
maintenance of pregnancy.
Finally, the question which still remains to be 
answered is "What is the origin, nature and function of the 
41kDa molecule?" This question will be addressed in the 
final discussion.
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FINAL DISCUSSION
Since class I antigens are known to evoke allograft 
rejection, their expression on some extra-villous 
trophoblasts (which are genetically semi-allogeneic) has 
raised the question of the nature of the antigen(s) and the 
immunological relationship between the mother and foetus. 
The existence of the trophoblast barrier and hence lack of a 
vascular connection limits the transfer of maternal cells 
into the foetus (and vice versa) to a very large extent 
(Hunziker et al. 1984). There are cases where the traffic of 
foetal cells (e.g. blood) provokes the maternal immune system 
to produce antibodies (reviewed Jones and Need, 1988). These 
antibodies pass through the placenta via Fc-gamma receptors 
and cause deleterious effects on target cells; such an 
example of this is the anti-Rh(D) response. The 
syncytiotrophoblast constitutes most of this barrier and its 
lack of class I expression (or any other antigens that may 
provoke a response) is important in avoiding sensitization of 
the mother to foetal/placental antigens (Sunderland et al. 
1981a) and thus it is thought to contribute to the success of 
pregnancy.
Maternal alloantibodies against foetal class I and 
II MHC antigens have been found frequently during normal 
human pregnancy demonstrating that these antigens are not 
completely hidden from the competent maternal immune system. 
These alloantibodies (perhaps blocking antibodies) have been 
found in first pregnancies and can be eluted from placentas. 
Therefore it appears that their formation is not dependent on 
antigen exposure during delivery and in this respect differs 
from rhesus isoimmunization. Billington and Burrows (1989) 
also detected alloantibodies in pregnant sera directed 
against rat classical class I MHC structures but were unable 
to observe a concomitant cell-mediated immune response to 
these antigens. Thus, the molecules (possible alloantigens) 
expressed at the interface have been proposed to function as 
"absorbing material" for any antibodies that are accidentally 
generated. The production of antibodies might arise by 
leakage between the interface, and their binding activity may 
be directed towards both classical and modified structures. 
Depletion of these antibodies by trophoblast antigens would 
reduce the severity of any adverse response made towards
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foetal antigens. Any cell-mediated response may be overcome 
by the intrinsic properties of the trophoblast cells. The 
immunogenicity of any antigens will obviously influence the 
maternal response and thus it is of prime importance to
establish the nature of the molecule(s) involved.
Pregnancy is not normally disrupted by pre­
immunization against paternal or third party antigens 
(Chaouat et al. 1984b), indeed some types of recurrent 
spontaneous abortion have been treated successfully in this 
way - presumably from the development of a "protective"
immune response (Mowbray, 1985). However, abortion can be 
induced in mice by maternal immunization with tumour cells
and it is thought that the response elicited is directed
towards cross-reacting foetal (onco-foetal) antigens 
(Tartakovsky, 1987). The mechanism whereby immunization
confers a beneficial effect is not very well understood, but 
it is thought to require appropriate recognition of some 
antigens. One candidate though to be involved in this are 
the trophoblast-leucocyte common (TLX) antigens which are 
expressed on all populations of peripheral blood lymphocytes 
and foetal trophoblasts (Bulmer and Johnson, 1985) and may be 
encoded on chromosome 1 (Stern et al. 1986). There is the
possibility that trophoblast lymphocyte cross-reactive
L
antigens (Faulk et al. 1978; McIntyre et al. 1983,* Bulmer and 
Johnson, 1985) stimulate the production of maternal antibody 
in normal pregnancy, but there is conflicting data on the 
nature of the responses to these antigens (reviewed 
Billington, 1989).
It has been difficult to ascertain whether 
trophoblasts are susceptible to cellular and humoral immune 
effectors. Recent work has shown that class I positive mouse 
trophoblasts were lysed by specific alloantibody but not by 
allospecific cytotoxic lymphocytes (Drake and Head, 1989; 
Zuckerman and Head, 1987). The basis of. this 
insusceptibility is unknown but it will obviously be 
beneficial if trophoblasts are implicitly resistant to a 
maternal immune attack.
Certain studies have shown that maternal lymphocyte 
populations arrive in the decidua and suppress the induction 
of a response towards foetal antigens (Bulmer and Sunderland, 
1984; Kabawat et al. 1985). Immunosuppressive activity has 
been detected in extracts of decidua and trophoblast
(Golander et al. 1981), in the supernatants of some human 
pre-implantation embryos (Daya and Clark, 1986), in mouse 
mid-term placental supernatants (Chaouat et al. 1986) and in 
human syncytiotrophoblast plasma membranes (Degenne et al. 
1986). If immunosuppression is important in the maintenance 
of pregnancy, then it must act locally since retroplacental 
blood inhibits lymphocyte activation whereas peripheral blood 
does not (Redman et al. 1986).
Sunderland et al. (1981b;c) showed that class I
molecules were not expressed by villous syncytiotrophoblast 
but that extra-villous trophoblast forming the 
cytotrophoblast cell columns clearly stained positive. 
Generally, class I antigens are restricted to those forms of 
trophoblast outside the major maternal-foetal exchange area 
in mature placentae. Obviously, the easiest solution to 
escaping immunological recognition would be the complete 
absence of class I antigens from all trophoblasts (as is the 
case for class II molecules, reviewed Redman, 1983). Thus, 
their low level of expression on some forms of extra-villous 
trophoblasts implies that they may have an important 
function. This restricted expression may have implications 
in the immune interactions during pregnancy and may influence 
the physiological function of this organ in growth and 
differentiation.
Some earlier studies have documented parental and 
thus foetal sharing of classical HLA alleles and have 
attempted to describe the significance of this in terms of 
pregnancy failure (Bolis et al. 1984; Komlos et al. 1977;
Ober et al. 1983;1987; Unander and Olding, 1983). Given that 
recent studies have now described the expression of 
apparently non-classical class I molecules, the significance 
of such results should be reassessed.
The class I molecules expressed on extra-villous 
trophoblast consistently failed to bind antibodies specific 
for the foetal HLA-A and -B phenotype and 61D2 (Redman et al. 
1984, Wells et al. 1984) suggesting that MHC antigen 
expression may be restricted to HLA-C or some other 
unidentified class I antigen. Similar results were observed 
in both early, mature and molar pregnancies (Fisher and 
Lawler, 1984; Sunderland et al. 1985).
The nature of the molecules expressed on 
extravillous trophoblast will hopefully be resolved to a
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certain extent after their corresponding cDNA's are obtained. 
By comparing their amino acid sequences to other known 
classical and non-classical molecules, it is hoped that any 
real differences may be discerned. These may indicate a 
structural change which may in turn modify or completely 
change their function. Such comparisons may be informative 
in indicating whether these molecules are able to present 
antigen (do they have a discernible antigen binding site?) 
although this would have to be formally proven using in vitro 
assays. As has been suggested, they both may have a role in 
re-directing a potentially harmful immune response directed 
towards the foetus by acting as blocking molecules in a sort 
of "buffering zone" and so preventing any immune response 
from reaching the foetus.
The work presented in this thesis describes the 
characterization of class I molecules expressed on a form of 
extra-villous trophoblast. Pure preparations of class I 
positive trophoblasts are required to study such molecules, 
but since they are difficult to separate from uterine decidua 
and sustain in culture, a choriocarcinoma cell line (JEG-3) 
derived from extra-villous cytotrophoblast was used (Kohler 
and Bridson, 1971). Class I expression was initially 
investigated by immunoprecipitation followed by the use of 
recombinant DNA techniques in order to clone the genes 
expressed. The high level of sequence conservation within 
the MHC class I gene family has made it difficult to identify 
products of a given class I locus independent of other 
sequences. Thus a cDNA library representing only the genes 
specifically expressed by trophoblasts was constructed.
Class I immunoprecipitation data had already proven 
that the BeWo choriocarcinoma and chorionic cytotrophoblast 
cell membranes expressed a 40kDa molecule and Ellis et al.
(1986) had therefore concluded that classical class I 
molecules were not expressed by these cells. 
Immunoprecipitation studies on JEG-3 cells (chapter 3) using 
W6/32 showed that two class I heavy chains of molecular 
weight 45kDa and 41kDa were expressed. Both were associated 
with B 2 ~microglobulin 12kDa, and the 41kDa polypeptide was 
the major component, being in a five fold excess. Notably, 
61D2 did not cross react with, and therefore did not 
immunoprecipitate the 41kDa component. Similar results were 
obtained with BeWo cells (Stern et al. 1988) as expected
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since both cell lines were probably derived from the same 
choriocarcinoma material (Hertz et al. 1959).
So in addition to the 40-41kDa (hereafter referred 
to as 41kDa) component, the more recent data suggests that a 
classical 45kDa molecule can be detected by 61D2. If the 
immunoprecipitation results of the JEG-3 choriocarcinoma are 
extrapolated to normal class I positive extravillous 
trophoblasts then it is very likely that the 61D2 
immunostaining experiments of Redman et al. (1984) and Wells 
et al. (1984) and the IEF experiments of Ellis et al. (1986) 
were limiting in their sensitivity and consequently did not 
detect the low levels of the 45kDa component. It is also 
likely that the high percentage (12%) polyacrylamide SDS gel 
prevented Ellis et al. (1986) from resolving these two 
different molecular weight species, or that exposure to 
autoradiographic film was too short to detect the minor 45kDa 
polypeptide. Indeed, the subsequent cloning of a complete 
HLA-C class I molecule (BeWo C.l from BeWo choriocarcinoma 
predicted to encode a 45kDa polypeptide), also lends support 
to this interpretation (Ellis et al. 1989). Further 
confirmatory studies are necessary to determine whether or 
not the larger polypeptide is indeed present on human 
chorionic cytotrophoblast membranes. This seems likely 
since Billington and Burrows, (1989) have recently 
immunoprecipitated both 41kDa and 45kDa polypeptides from rat 
placenta and have evidence for the presence of paternally 
encoded class I antigens on rat spongiotrophoblast 
(counterpart of human cytotrophoblast) and endovascular 
trophoblast.
The collective data suggests that there are two 
class I products expressed on trophoblast. These 
polypeptides could be derived from two different genes. 
However, if only one gene is transcribed then there is the 
possibility that the two different molecular weight heavy 
chains could represent the products of a common but 
alternatively spliced mRNA or they could be the result of 
differential glycosylation. Since one of the components is 
40kDa, it may represent a human analogue of a Q region gene 
product. Furthermore, the Q7 gene product (Qa-2) is known to 
be inserted into the cell membrane via a phosphatidyl 
inositol anchor (Stroynowski et al. 1987; Low et al. 1986; 
see also section 1.1.7). N-glycanase treatment of BeWo class
I heavy chains has excluded the possibility of these two
molecules being glycosylation variants (P.L.Stern unpublished 
results), and phospholipase C treatment of JEG-3 class I 
molecules shows that they are not inserted into the membrane 
via a phosphatidyl inositol anchor (Rinke de Wit pers.
comm.).
Screening the JEG-3 gamma-interferon cDNA library
yielded six independent class I positive clones, JW1-6. 
Sequence data of three of the cDNA clones JW1, 4 and 5 
suggest that they are all derived from the same allele at the 
HLA-C locus. JW1 intron-2 allowed the assignment of the 
sequence to the HLA-C locus. The JW1 exonic sequence as far 
as it extends seems to be (see chapter 6) identical to that
of the complete BeWo C.l cDNA (Ellis et al. 1989). JW1
intron 2 does not contain a translational start codon which 
could re-direct the synthesis to a 41kDa heavy chain. Two of 
the six clones contained intron 2 which was quite unexpected. 
Interestingly, studies by Matsuura et al. (1987) show that 
incompletely spliced (containing intron 1 and 2) Tla
transcripts are present at higher levels in leukaemia cells 
than in thymocytes.
The immunoprecipitation data taken together with
the nucleotide sequence indicate that the 45kDa component may
be coded for by BeWo C.l and possibly by JW1. Eight cDNA
clones obtained from BeWo (Ellis et al. 1989) and at least 
three (of six) from JEG-3 are identical in sequence which 
implies that only one allele at the C-locus is being 
transcribed. Unless the cell line is homozygous at this
locus, one other explanation for this might be that 
choriocarcinomas are usually derived from hydatidiform moles 
(diploid) which are often androgenetic in origin (Bagshawe 
and Lawler, 1982; Lawler et al. 1987a,b). Thus the
possibility remains that both HLA-C alleles may be expressed 
in normal trophoblast. The data of Ellis et al. (1989) and 
this work has largely ruled out alternative splicing as the 
mechanism generating two molecules of different molecular 
weight. Thus three of the four proposals of the origin of
both components have largely been ruled out. The remaining 
possiblity that two separate genes code for these two 
molecules becomes much more likely and evidence for this is 
given below.
The absence of clones derived from the HLA-A and
17 9
HLA-B loci is consistent with earlier serological studies 
(Redman et al. 1984), indeed, both BeWo and JEG-3 cells could 
not be tissue typed (Ellis et al. 1986 and P.L.Stern pers. 
comm.). In general, C-locus products are thought to be 
expressed at much lower levels than A- or B-locus antigens 
which is probably why there is a lack of specific typing sera 
(Gussow et al. 1987; Sodoyer et al. 1984). The lack of 
typing sera may not be necessarily due to their low levels of 
expression, but may be a result of their relatively low 
polymorphism, since the chance of generating a serum to a 
molecule that is less polymorphic is relatively much lower. 
Thus it was quite unexpected that only HLA-C clones were 
obtained although this had always been a possibility. Why 
there should be a reversal in the expression of HLA-A, HLA-B 
with HLA-C is itself intriguing and may imply that HLA-C has 
a different function. However, Dill et al. (1988) have shown 
that the one allele tested (Cw3) was able to act as a 
restriction element. The function of the class I antigen(s) 
expressed by extravillous trophoblast remains obscure to 
date. There is no firm evidence to date that HLA-C antigens 
are present on placenta and obviously further studies need to 
be done. If the HLA-C locus derived molecules function as 
classical class I antigens then the paternal haplotype might 
act as an allogeneic stimulus (if this differs from the
maternal haplotype).
Some of the characteristics of HLA-C locus genes 
and products have been described in chapter 6. One further 
point about HLA-C locus derived genes has been made by Ronne 
et al. (1985). The intron sequences of eleven class I genes 
(human, mouse and rabbit) were used to ascertain the 
evolutionary relationships between each although only one 
allele (HLA-Cw3) at the C-locus was used. Ronne used a 
dendrogram to show that the HLA-C genes were as divergent 
from other class I genes as H-2 was from Qa-2,3. As
mentioned before, the polymorphism at the HLA-C locus seems 
to be relatively lower than that at HLA-A and HLA-B loci. 
This is consistent with the proposal of Pohla et al. (1989) 
who suggest that the HLA-C locus evolved much more recently.
Having obtained cDNA's that seem to encode a 45kDa
molecule, the origin and nature of the 41kDa component still 
remains obscure.
Much more progress has been made in cloning and
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sequencing the mouse MHC and various "non-classical" Q and TL 
genes (see section 1.1.5) have been found to be considerably 
less polymorphic than H-2K, D and L class I classical 
sequences. However, the function of these non-classical 
antigens is largely unknown but their limited expression in 
some somatic cells (Q10 in the liver, Tla in thymocytes and 
T-cell leukaemias) suggests that they may have specialized 
roles in immunity e.g. in lymphoid differentiation (Mellor et 
al. 1986). Some relatively invariant human class I-like
molecules HT (Gazit et al. 1980a;b), HA (Fauchet et al. 
1986) and TCA (van Leeuwen et al. 1986) have been detected 
serologically (see section 1.1.6) and the genes corresponding 
to these polypeptides are currently being cloned. TCA 
molecules are not expressed on JEG-3 cells (Rinke de Wit. 
pers. comm.) or on BeWo cells (Stern et al. 1988).
One particularly active area of MHC research 
involves cloning all members of the human class I gene 
family. Shimizu et al. (1988), cloned three genomic class I 
genes from a T lymphoblastoid cell line; HLA-5.4 (Shimizu et 
al 1988), HLA-6.0 (Geraghty et al. 1987) and HLA-E (Roller et 
al. 1988). All three associate with B2-microglobulin and 
code for 40, 38.5 and 41kDa molecules respectively. The 
function of these products and the level of polymorphism at 
these loci is unknown but the latter is thought to be low 
since no sera are known to have been generated. HLA-E and 
HLA-6.0 genes show some unusual features in their nucleotide 
sequence and at the amino acid sequence level are clearly 
different from classical HLA-A, -B and -C antigens (see 
figure 6.9.1). Geraghty et al. (1987) suggested that HLA-6.0 
may be a structural homologue of a murine class I Q gene 
since its cytoplasmic region is predicted to be considerably 
shorter than expected and its COOH terminus is most similar 
to that of the Q7 gene. In addition to this, the HLA-6.0 
promoter region very much resembles those of the mouse Q 
genes. The lower molecular weight (41kDa) of one of the 
trophoblast class I molecules may signify that it is encoded 
by a human analogue of the murine Q genes, which also yield 
similar sized class I molecules. (Lew et al. 1986).
Hybridization with an HLA-E specific probe showed 
that trancripts homologous to HLA-E were not expressed by 
JEG-3 cells (Rinke de Wit pers. comm.). Using an HLA-6.0 
specific probe, work in collaboration with with T. Rinke de
Wit (Leiden) and P.L.Stern (Manchester) showed that 
homologous transcripts were expressed in JEG-3 cells (Ward et 
al. 1990). The HLA-6.0 specific probe hybridized to a 1.6Kb 
transcript which was present in both JEG-3 and EBV 
transformed lymphoblastoid cells. Subsequent work showed 
that the level of the HLA-6.0 homologous transcripts in JEG-3 
cells was not induced by gamma-interferon (Rinke de Wit pers. 
comm.), whereas several reports have documented the induction 
of class I transcripts by this lymphokine (reviewed Rosa and 
Fellous, 1984).
That HLA-6.0 homologous transcripts have been 
detected in JEG-3 cells is interesting because HLA-6.0 itself 
has a much shortened cytoplasmic region. Studies of Murre et 
al. (1984) showed that CTL lysis of vesicular stomatitis 
virus-infected cells was significantly reduced when the 
cytoplasmic domain of H-2L^ was removed. However, the 
removal of this domain was previously found not to effect the 
surface expression levels of the this gene nor effect its 
interaction with CTL's, (Zuniga et al. 1983).
The lack of sera to the HLA-6.0 molecule is 
intriguing and suggests that the level of polymorphism at 
this particular locus is relatively low. One might suggest 
that the lack of sera could be due to the HLA-6.0-like 
product being expressed on only certain tissues at a 
particular stage of development; trophoblast is a good 
example of this. HLA-6.0 homologous transcripts are also 
present on EBV transformed lymphocytes (see Ward et al. 
1990) .
One would have expected HLA-6.0 homologous 
transcripts to have been represented in both the JEG-3 cDNA 
library and the BeWo cDNA library (Ellis et al. 1989). 
Classical class I probes are normally expected to hybridize 
to most class I sequences under relaxed stringency since the 
alpha-3 domains are highly conserved within the class I gene 
family, indeed, the HLA-C locus cDNA clones were isolated in 
this way. The possible reasons for HLA-6.0 homologous 
transcripts not being isolated here or by Ellis (Oxford) have 
been discussed in chapter 6. The JEG-3 cDNA library filters 
are currently being screened with the HLA-6.0 specific probe.
The expression of class I on some populations of 
trophoblast and not others has raised questions of their 
regulation, for example, whether MHC expression is
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irreversibly down regulated on normally negative 
trophoblasts.
The molecular mechanisms responsible for the 
regulation of MHC gene expression are beginning to be 
understood (see section 1.1.13). The effect of interferons 
on trophoblast cell lines has been described in section 1.2.7 
and chapter 4. Class I antigens can be induced by exposure 
to interferons on some populations of trophoblasts and not at 
all on others suggesting that regulation of these genes 
differs between trophoblast populations (Hunt et al. 1987). 
Interferons regulate class I expression in vitro as well as 
in vivo (Halloran et al. 1986) and may therefore influence 
class I gene expression at the placental interface (Chard et 
al. 1986; Duc-Goiran et al. 1986). Zuckerman and Head,
(1986) have shown that class I expression on non-malignant 
mouse trophoblasts can be induced with interferon.
The quantitative studies outlined in chapter 4 did 
not detect a significant increase in class I induction after 
gamma-interferon treatment in contrast to those studies of 
Hunt et al. (1987). The collaborative work described above
indicates the presence of an HLA-6.0 homologous transcript 
which was subsequently found not to be induced by gamma- 
interf eron. The immunoprecipitation data show that the 41kDa 
component is approximately in a 4-5 fold excess over the 
45kDa polypeptide. Tf one assumes that the relative levels 
of the corresponding mRNA's for these polypeptides are 
proportional to surface expression levels and that the 41kDa 
polypeptide is coded for by the HLA-6.0 homologous 
transcript, then the low levels of class I mRNA induction 
described in chapter 4 can possibly be explained. Any 
induction of classical class I mRNA would be masked by the 
more abundant HLA-6.0 homologous transcripts (under the 
assumption placed above). This would be particularly 
accentuated if the hybridization and washing procedures of 
Northern filters were carried out at relaxed stringency with 
the HLA-B7 cDNA probe. However, as mentioned previously, 
nothing is known of the actual or relative rates of turnover 
of either mRNA or protein of the two components.
If classical class I molecules are expressed on 
some trophoblasts (from extrapolation of choriocarcinoma data 
in chapter 3 and Stern et al. 1988), then this might render 
them susceptible to immune effectors such as cytotoxic
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lymphocytes and antibodies. Power et al. (1988) have shown 
that the antibodies present in rat pregnancy sera are 
directed against multiple epitopes on conventional/classical 
RT1A molecules rather than to the Pa antigenic determinant. 
Billington and Burrows (1989) suggested that foetal survival 
was ensured because no cell mediated immune reactions were 
generated against the paternal class I antigens.
In general, classical class I molecules provide a
context for the recognition of foreign antigens by CD8+ T
cells. Studies on T-lymphocyte subsets and their receptors
(TCR's) have shown that this recognition is largely dependent 
on the alpha/beta T-cell receptor heterodimer which is 
associated with the CD3 complex on the cell surface (reviewed 
Allison et al. 1987). However, the exact function of a
second gamma/delta TCR present on 1-10% of peripheral T cells 
is still unknown (reviewed, Strominger, 1989). Janeway et 
al. (1988) proposed that relatively non-polymorphic MHC Class 
I-like molecules might serve as ligands for gamma/delta TCR’s 
and there are examples of genes derived from both the TL 
(Bluestone et al. 1988) and Q region (Vidovic et al. 1989) 
which have been shown to act as restriction elements for this 
receptor.
One other example of molecules interacting with 
gamma/delta TCR’s are the surface glycoprotein cluster of 
differentiation 1 (CD1) molecules which have a low but
significant level of homology to MHC class I molecules 
(Bradbury et al. 1988; Calabi and Milstein, 1986;Calabi et 
al. 1989a,b ). They are also associated with B 2 ~m. Three 
homologous human proteins CDla,b and c have been detected 
serologically, but five potential CD1 genes (CDla,b,c,R2 and 
R3 falling into two classes) reside on chromosome 1 (Calabi 
et al. 1989b). Porcelli et al. (1989) suggested that CD1 
molecules may have a similar function to MHC class I
molecules, since CD8 +ve alpha/beta and gamma/delta TCR cells 
recognize CD1 molecules (although antigen presentation has
not yet been demonstrated). As yet, the function of the
relatively non-polymorphic class I gene products (which might 
include the 41kDa class I molecule on trophoblast) is largely 
unknown. As has been proposed above, non-polymorphic MHC 
class I-like moleules (Janeway et al. 1988) and CD1 products 
(Porcelli et al. 1989) may serve as ligands for gamma/delta 
TCR's. Strominger, (1989) suggested two reasons why class
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"Ib" polypeptides could be functionally linked to TCR 
gamma/delta cells. The first concerned the low numbers of 
receptor variants expressed, indicating that only a few are 
required to interact with the relatively small number of 
class Ib molecules. Secondly, the majority of gamma/delta 
TCR positive cells lack CD8 and CD4 which suggests that 
classical class I and class II antigens may not be their 
appropriate ligands. However, CD1 molecules are not 
expressed on JEG-3 cells (Rinke de Wit per. comm.).
The consequences of restricted expression of MHC 
class I to certain trophoblast populations- are largely 
unknown. It seems that class I antigens may have other 
physiological functions as well as presenting antigens to T 
cells, such as binding peptide hormones and epidermal growth 
factor (reviewed, Head et al. 1987). The implication here is 
that binding of such molecules may influence the growth and 
differentiation of the placenta. Head postulated that an 
aberrant class I molecule might continue to have such a
function without eliciting an allogeneic immune response.
This idea is supported by the fact that mainly proliferating 
trophoblasts express class I antigens. One further example 
of a different function for class I is the cloning of two Fc 
receptor subunits which are used in rats to remove 
immunoglobulin G from mother's milk (Simister and Mostov,
1989). Sequence analysis indicates that this molecule,
(FcRn) belongs to the class I gene family.
Hopefully, the localization of expression of 
individual class I genes will afford clues as to whether
their products have specific or more generalized functions. 
First of all it is necessary to obtain a number of cDNA 
clones from the choriocarcinoma cell line which correspond to 
the gene that codes for the 41kDa molecule. After sequencing 
has been completed, and a comparison made to other class I 
sequences, specific probes may be designed for screening cDNA 
libraries of class I positive extravillous trophoblasts. The 
use of these probes for in situ hybridization experiments on 
placental sections would enable the tissue localization of 
the expressed genes and would circumvent the problems of 
lymphocyte and maternal cell contamination. Indeed, the fact 
that HLA-6.0 homologous transcripts are also detected in EBV 
transformed lymphocytes reinforces the point of this problem 
(see Ward et al. 1990).
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